https://www.jazmp.si/2020/03/17/prac-priporocil-zacasni-odvzem-dovoljenja-za-promet-z-ulipristalacetatom-medtem-ko-poteka-ocena-tveganja-za-okvare-jeter/2020-03-23T12:06:43+01:00https://www.jazmp.si/2013/10/01/mrpdcp-revised-instructions-for-the-national-phase-of-the-ma-approval-in-slovenia/2020-03-31T06:25:01+02:00https://www.jazmp.si/2015/04/15/appointment-of-an-acting-director-of-the-agency-of-the-republic-of-slovenia-for-medicinal-products-and-medical-devices/2020-03-30T19:42:27+02:00https://www.jazmp.si/2012/01/24/nova-priporocila-glede-spremljanja-bolnikov-ki-se-zdravijo-z-zdravilom-gilenya-fingolimod/2020-03-30T23:29:34+02:00https://www.jazmp.si/2012/02/27/priporocila-ema-za-preprecevanje-napak-pri-uporabi-zdravila-velcade-bortezomib/2020-03-30T23:29:16+02:00https://www.jazmp.si/2012/03/02/ema-izdala-priporocilo-o-preklicu-odvzema-dovoljenja-za-promet-z-aprotininom/2020-03-30T23:29:00+02:00https://www.jazmp.si/2012/03/02/odmerjanje-zdravil-za-zdravljenje-tuberkuloze-pri-otrocih/2020-03-30T23:28:39+02:00https://www.jazmp.si/2012/03/13/motena-preskrba-z-zdravilom-vfend-vorikonazol-v-nekaterih-drzavah-eu/2020-03-30T23:28:22+02:00https://www.jazmp.si/2012/03/27/napoved-aprilskega-strokovnega-izobrazevanja-jazmp/2020-03-30T23:28:08+02:00https://www.jazmp.si/2012/03/28/pravilnik-o-spremembah-pravilnika-o-dolocanju-cen-zdravil-za-uporabo-v-humani-medicini/2020-03-30T23:27:43+02:00https://www.jazmp.si/2012/03/29/sporocilo-za-javnost-razvrstitev-glede-izdelkov-z-glukozaminom-in-hondroitinom/2020-03-30T23:27:08+02:00https://www.jazmp.si/2012/04/10/obvestilo-o-novi-razlicici-qrd-predloge-80-za-zdravila-za-uporabo-v-humani-medicini/2020-03-30T23:26:49+02:00https://www.jazmp.si/2012/04/25/nova-priporocila-ema-za-zdravilo-gilenya-fingolimod/2020-03-30T23:25:16+02:00https://www.jazmp.si/2012/04/25/nov-obrazec-2-za-uvoz-zdravil-ki-nimajo-dovoljenja-za-promet-v-rs-v-nujnih-primerih-posamicnega-zdravljenja/2020-03-31T06:25:09+02:00https://www.jazmp.si/2012/04/30/prosnja-za-prevzem-rms-v-dcp-postopkih-pridobitve-dovoljenja-za-promet-z-zdravilom/2020-03-30T23:17:27+02:00https://www.jazmp.si/2012/05/04/javni-natecaj-za-direktorja-javne-agencije-republike-slovenije-za-zdravila-in-medicinske-pripomocke/2020-03-30T23:35:30+02:00https://www.jazmp.si/2012/05/22/obvestilo-o-ukinitvi-nacionalnih-dovoljenj-za-promet-nekaterih-proti-zajedavskih-ovratnic-za-macke-in-pse/2020-03-30T23:14:29+02:00https://www.jazmp.si/2012/05/23/seznam-zdravil-s-spremenjeno-oznako-atc/2020-03-30T23:14:13+02:00https://www.jazmp.si/2012/05/23/atc-2012/2020-03-30T23:13:57+02:00https://www.jazmp.si/2012/05/24/neustrezna-kakovost-zdravila-anapen-adrenalin-raztopina-za-injiciranje-v-napolnjeni-injekcijski-brizgi/2020-03-30T23:13:09+02:00https://www.jazmp.si/2012/05/31/ema-potrdila-pozitivno-razmerje-med-koristjo-in-tveganjem-za-zdravilo-mabthera/2020-03-30T23:12:56+02:00https://www.jazmp.si/2012/05/31/posodobljeni-podatki-o-zdravilu-pradaxa-dabigatran-eteksilat/2020-03-30T23:12:41+02:00https://www.jazmp.si/2012/06/01/ema-objavila-spletno-stran-o-nezelenih-ucinkih-zdravil/2020-03-30T23:12:29+02:00https://www.jazmp.si/2012/06/04/vprasanja-in-odgovori-ema-glede-izvajanja-nekaterih-dolocb-nove-farmakovigilancne-zakonodaje/2020-03-30T23:11:51+02:00https://www.jazmp.si/2012/06/20/imenovanje-novega-direktorja-javne-agencije-republike-slovenije-za-zdravila-in-medicinske-pripomocke/2020-03-30T23:11:30+02:00https://www.jazmp.si/2012/06/27/ukrepi-ema-glede-nepravilnosti-druzbe-roche-v-sistemu-porocanja-nezelenih-ucinkov-zdravil/2020-03-30T23:11:23+02:00https://www.jazmp.si/2012/07/02/imenovanje-namestnika-direktorja-javne-agencije-republike-slovenije-za-zdravila-in-medicinske-pripomocke/2020-03-30T23:10:55+02:00https://www.jazmp.si/2012/07/04/obvestilo-o-nadomestnem-adrenalinskem-avtoinjektorju/2020-03-30T23:10:44+02:00https://www.jazmp.si/2012/07/09/zamenjava-adrenalinskih-avtoinjektorjev/2020-03-30T23:10:27+02:00https://www.jazmp.si/2012/07/19/prvo-dopolnilo-k-tretji-izdaji-formulariuma-slovenicuma-fs-31/2020-03-30T23:10:13+02:00https://www.jazmp.si/2012/07/19/obvestilo-o-potrjenem-ponaredku-zdravila-xenical-120-mg-trde-kapsule-v-okviru-spletne-prodaje-v-zda/2020-03-30T23:02:51+02:00https://www.jazmp.si/2012/08/03/obvestilo-o-novih-omejitvah-odmerka-ondansetrona-zdravila-zofran-in-generikov-za-intravensko-uporabo/2020-03-30T23:07:27+02:00https://www.jazmp.si/2012/08/21/obvestilo-o-ukinitvi-dovoljenja-za-promet-z-zdravilom-mabcampath-alemtuzumab-v-drzavah-evropske-unije/2020-03-30T23:01:27+02:00https://www.jazmp.si/2012/08/31/nova-priporocila-in-omejitve-uporabe-kalcitonina/2020-03-30T23:04:13+02:00https://www.jazmp.si/2012/09/08/obvestilo-o-objavi-novih-obrazcev-za-pridobitev-dovoljenja-za-vnos-oziroma-uvoz-zdravil-ki-nimajo-dovoljenja-za-promet-z-zdravilom/2020-03-30T23:06:39+02:00https://www.jazmp.si/2012/09/12/vabilo-na-strokovno-posvetovanje-ob-predstavitvi-prvega-dopolnila-k-tretji-izdaji-formulariuma-slovenicuma-fs-31/2020-03-30T22:58:21+02:00https://www.jazmp.si/2012/09/16/odpoklic-zdravila-zapilux-neo-orodisperzibilni-film/2020-03-30T23:04:38+02:00https://www.jazmp.si/2012/10/02/vabilo-vsem-zainteresiranim-da-se-vkljucijo-v-pilotni-projekt-cesp/2020-03-30T23:00:06+02:00https://www.jazmp.si/2012/10/08/obvestilo-glede-organizacijskih-sprememb-na-podrocju-delovanja-regulative-zdravil-za-uporabo-v-humani-medicini/2020-03-30T22:56:42+02:00https://www.jazmp.si/2012/10/08/prosnja-za-prevzem-vloge-referencne-drzave-clanice-rms-v-postopkih-za-pridobitev-dovoljenja-za-promet-z-zdravilom-po-dcp/2020-03-30T22:56:35+02:00https://www.jazmp.si/2012/10/10/spremembe-zakonodaje-eu-o-medicinskih-pripomockih-in-invitro-diagnosticnih-medicinskih-pripomockih/2020-03-30T22:55:39+02:00https://www.jazmp.si/2012/10/16/odlocitev-cmc-central-management-committee-glede-informacij-ki-so-potrebne-v-zvezi-z-naslovom-proizvajalca-medicinskih-pripomockov/2020-03-30T22:55:17+02:00https://www.jazmp.si/2012/10/22/informacije-iz-nezanesljivih-virov-o-zdravilih-ki-vsebujejo-diklofenak/2020-03-30T22:54:54+02:00https://www.jazmp.si/2012/11/16/izvajanje-dejavnosti-preskrbe-s-krvotvornimi-celicami-iz-mlecnih-zob/2020-03-30T22:54:38+02:00https://www.jazmp.si/2012/11/23/ema-izdala-nova-priporocila-za-varnejso-uporabo-fibrinskih-lepil/2020-03-30T22:54:26+02:00https://www.jazmp.si/2012/12/05/obvestilo-o-skrajsanem-delovnem-casu-24-in-31-decembra/2020-03-30T23:08:27+02:00https://www.jazmp.si/2012/12/22/ema-zacela-s-pregledom-zdravil-tredaptive-pelzont-in-trevaclyn/2020-03-30T21:31:58+02:00https://www.jazmp.si/2013/01/19/zacasni-odvzem-dovoljenja-za-promet-z-zdravili-tredaptive-pelzont-in-trevaclyn/2020-03-30T21:31:46+02:00https://www.jazmp.si/2013/01/29/ema-zacela-s-pregledom-peroralnih-kontraceptivov-tretje-in-cetrte-generacije/2020-03-30T21:31:34+02:00https://www.jazmp.si/2013/01/31/sporocilo-glede-zdravila-diane-35-in-genericnih-zdravil-za-zdravljenje-aken/2020-03-30T21:31:23+02:00https://www.jazmp.si/2013/02/11/pricetek-formalnega-postopka-za-pregled-zdravila-diane-35-in-genericnih-zdravil-ter-kombiniranih-peroralnih-kontraceptivov/2020-03-30T21:31:10+02:00https://www.jazmp.si/2013/02/15/seznam-zdravil-katerim-se-je-v-obdobju-od-112012-do-112013-spremenila-atc-oznaka/2020-03-30T21:30:59+02:00https://www.jazmp.si/2013/02/28/varnostna-vprasanja-pri-uporabi-kodeina-pri-otrocih/2020-03-30T21:30:25+02:00https://www.jazmp.si/2013/03/08/skupna-ocena-tveganja-fenilbutazon-v-konjskem-mesu/2020-03-30T21:30:11+02:00https://www.jazmp.si/2013/03/28/ucinki-agonistov-glp-1-na-trebusno-slinavko-pri-zdravljenju-diabetesa-2/2020-03-30T21:30:02+02:00https://www.jazmp.si/2013/03/28/novosti-povezane-z-objavo-novega-seznama-nujno-potrebnih-zdravil-za-uporabo-v-humani-medicini/2020-03-30T21:26:31+02:00https://www.jazmp.si/2013/04/10/ministrstvo-za-zdravje-je-z-odlocbo-st-021-52201311-ugodilo-predlogu-druzbe-ll-grosist-doo/2020-03-30T21:24:52+02:00https://www.jazmp.si/2013/04/16/fenilbutazon-v-konjskem-mesu-skupno-porocilo-ema-in-efsa/2020-03-30T21:29:31+02:00https://www.jazmp.si/2013/04/17/uporaba-antibiotikov-pri-zivalih-nasvet-evropske-agencije-za-zdravila-ema-evropski-komisiji-glede-vpliva-na-javno-zdravje-in-zdravje-zivali/2020-03-30T21:28:57+02:00https://www.jazmp.si/2013/05/03/seznam-zdravil-za-katera-se-zahteva-dodatno-spremljanje-varnosti/2020-03-19T01:29:30+01:00https://www.jazmp.si/2013/05/03/omejitve-uporabe-zdravila-protelos-stroncijev-ranelat/2020-03-19T01:29:30+01:00https://www.jazmp.si/2013/05/03/motnje-v-preskrbi-z-zdravilom-caelyx-doksorubicinijev-klorid-odpravljene/2020-03-19T01:29:30+01:00https://www.jazmp.si/2013/05/17/koristi-zdravila-diane-35-in-genericnih-zdravil-odtehtajo-tveganja-v-doloceni-skupini-bolnikov/2020-03-30T21:21:58+02:00https://www.jazmp.si/2013/05/22/socasna-uporaba-vec-zdravil-ki-delujejo-na-sistem-renin-angiotenzin-pri-zdravljenju-hipertenzije-in-kongestivnega-srcnega-popuscanja/2020-03-30T21:21:46+02:00https://www.jazmp.si/2013/05/31/omejitev-uporabe-zdravila-trobalt-retigabin-zaradi-tveganja-za-pigmentacijo-mreznice/2020-03-30T21:21:23+02:00https://www.jazmp.si/2013/05/23/azuriranje-podatkov-v-spletni-podatkovni-bazi-zdravil-bpz-2/2020-03-30T21:21:34+02:00https://www.jazmp.si/2013/06/18/zacasni-umik-dovoljenja-za-promet-z-raztopinami-za-infundiranje-ki-vsebujejo-hes/2020-03-30T21:21:11+02:00https://www.jazmp.si/2013/06/18/za-diklofenak-enaki-previdnostni-ukrepi-kot-za-zaviralce-cox-2/2020-03-30T21:21:03+02:00https://www.jazmp.si/2013/06/18/omejitev-uporabe-kodeina-pri-lajsanju-bolecine-pri-otrocih/2020-03-30T21:20:40+02:00https://www.jazmp.si/2013/07/02/nova-omejitev-uporabe-zdravil-ki-vsebujejo-derivate-ergot-alkaloidov-2/2020-03-30T21:19:52+02:00https://www.jazmp.si/2013/07/02/nova-priporocila-za-obvladovanje-tveganja-za-alergijske-reakcije-pri-intravenskih-zdravilih-ki-vsebujejo-zelezo-2/2020-03-30T21:19:31+02:00https://www.jazmp.si/2013/07/04/sporocilo-za-strokovno-javnost-glede-zdravil-ki-vsebujejo-hes/2020-03-30T21:17:17+02:00https://www.jazmp.si/2013/07/15/obvestilo-o-novi-razlicici-qrd-predloge-90-za-zdravila-za-uporabo-v-humani-medicini/2020-03-30T21:16:53+02:00https://www.jazmp.si/2013/07/15/pregled-zdravil-ki-vsebujejo-zolpidem/2020-03-30T21:16:40+02:00https://www.jazmp.si/2013/07/23/izid-drugega-dopolnila-k-tretji-izdaji-formulariuma-slovenicuma-fs-32/2020-03-30T21:16:25+02:00https://www.jazmp.si/2013/07/29/koncan-pregled-zdravil-za-diabetes-ki-delujejo-na-inkretinski-sistem/2020-03-30T21:16:03+02:00https://www.jazmp.si/2013/07/29/ema-priporoca-spremembe-pri-uporabi-metoklopramida/2020-03-30T21:15:28+02:00https://www.jazmp.si/2013/07/30/priporocilo-za-zacasno-ukinitev-dovoljenja-za-promet-s-peroralnim-ketokonazolom/2020-03-30T21:15:15+02:00https://www.jazmp.si/2013/08/02/objava-novega-cenika-storitev-uradnega-kontrolnega-laboratorija/2020-03-30T21:15:00+02:00https://www.jazmp.si/2013/08/05/obvestilo-o-novi-razlicici-qrd-predloge-90-za-zdravila-za-uporabo-v-humani-medicini-popravek/2020-03-30T21:14:46+02:00https://www.jazmp.si/2013/08/06/odpoklic-zdravila-persen-oblozene-tablete/2020-03-30T21:14:26+02:00https://www.jazmp.si/2013/08/16/okrogla-miza-oznacevanje-zdravil-za-uporabo-zdravil-v-veterinarski-medicini-spletni-vprasalnik/2020-03-30T21:14:12+02:00https://www.jazmp.si/2013/09/05/obvestilo-o-uporabi-dopolnjene-uredbe-komisije-es-st-12342008/2020-03-30T21:13:38+02:00https://www.jazmp.si/2013/09/13/prac-priporoca-omejitev-uporabe-kratkodelujocih-beta-agonistov-za-indikacije-v-porodnistvu/2020-03-30T21:12:34+02:00https://www.jazmp.si/2013/09/13/pregled-zdravil-z-bromokriptinom-za-preprecevanje-ali-zaviranje-tvorjenja-materinega-mleka-laktacije/2020-03-30T21:12:17+02:00https://www.jazmp.si/2013/09/17/slovenija-v-vlogi-referencne-drzave-clanice-rms-v-decentraliziranih-postopkih-dcp-pridobitve-dovoljenja-za-promet-z-zdravilom/2020-03-30T21:12:01+02:00https://www.jazmp.si/2013/09/17/strokovno-posvetovanje-ob-predstavitvi-fs-32/2020-03-30T21:10:44+02:00https://www.jazmp.si/2013/09/30/obvestilo-predlagateljem-o-moznosti-izdaje-dzp-z-angleskimi-besedili-za-vloge-po-mrpdcp-postopku/2020-03-30T21:10:07+02:00https://www.jazmp.si/2013/10/01/obvestilo-za-proizvajalce-medicinskih-pripomockov-potrjeni-ukrepi-drzav-clanic-eu-o-statusu-avtomatskih-pipet-in-nastavkov-pipet-za-splosno-laboratorijsko-uporabo/2020-03-30T21:09:53+02:00https://www.jazmp.si/2013/10/01/obvestilo-za-poslovne-subjekte-ki-opravljajo-promet-z-medicinskimi-pripomocki-na-debelo-potrjeni-ukrepi-drzav-clanic-eu-o-statusu-avtomatskih-pipet-in-nastavkov-pipet-za-splosno-laboratorijsko-uporabo/2020-03-30T21:09:29+02:00https://www.jazmp.si/2013/10/07/priporocila-prac-o-varnostnih-signalih/2020-03-30T21:08:10+02:00https://www.jazmp.si/2013/10/14/zacetek-pregleda-valproata-in-sorodnih-ucinkovin/2020-03-30T21:07:57+02:00https://www.jazmp.si/2013/10/14/raztopine-za-infundiranje-ki-vsebujejo-hes-le-se-za-omejeno-populacijo-bolnikov/2020-03-30T21:07:42+02:00https://www.jazmp.si/2013/10/14/koristi-kombiniranih-peroralnih-kontraceptivov-vecje-od-z-njimi-povezanih-tveganj/2020-03-30T21:07:26+02:00https://www.jazmp.si/2013/10/18/oznacevanje-zdravil-ki-se-posebej-pozorno-spremljajo/2020-03-30T21:07:12+02:00https://www.jazmp.si/2013/10/23/popravek-sporocila-za-javnost-glede-kombiniranih-hormonskih-kontraceptivov-z-dne-14102013/2020-03-30T21:06:59+02:00https://www.jazmp.si/2013/11/26/razpisana-delovna-mesta/2020-03-19T01:29:28+01:00https://www.jazmp.si/2013/12/12/prac-potrdil-da-koristi-zdravil-kogenate-bayerhelixate-nexgen-odtehtajo-tveganja-pri-predhodno-nezdravljenih-bolnikih/2020-03-30T21:03:27+02:00https://www.jazmp.si/2014/01/02/cesp-informativni-dan/2020-03-19T01:29:28+01:00https://www.jazmp.si/2014/01/13/prac-priporocil-zacasni-odvzem-dovoljenja-za-promet-z-zdravilom-protelos-stroncijev-ranelat/2020-03-30T20:31:57+02:00https://www.jazmp.si/2014/01/15/s-e-z-n-a-m-zdravil-ki-se-jim-je-obdobju-od-112013-do-112014-spremenila-oznaka-atc/2020-03-31T06:24:53+02:00https://www.jazmp.si/2014/01/20/objava-ankete-o-delovanju-inspekcij-v-letu-2013/2020-03-30T20:31:34+02:00https://www.jazmp.si/2014/01/31/zacasni-odvzem-dzp-z-zdraviloma-redergin-in-ditamin/2020-03-30T20:31:21+02:00https://www.jazmp.si/2014/01/31/letne-pristojbine-poziv/2020-03-30T20:31:07+02:00https://www.jazmp.si/2014/02/17/sporocilo-za-javnost-kombinirani-hormonski-kontraceptivi/2020-03-30T20:29:52+02:00https://www.jazmp.si/2014/02/25/zdravilo-protelos-stroncijev-ranelat-le-za-omejeno-populacijo-bolnikov/2020-03-30T20:29:32+02:00https://www.jazmp.si/2014/03/19/raziskava-trzisca-glede-ponudbe-poslovnih-prostor-za-najem/2020-03-30T20:29:06+02:00https://www.jazmp.si/2014/03/19/omejitev-uporabe-zdravil-ki-vsebujejo-domperidon/2020-03-30T20:28:11+02:00https://www.jazmp.si/2014/03/19/nova-priporocila-pri-uporabi-zdravil-ki-vsebujejo-zolpidem/2020-03-30T20:27:56+02:00https://www.jazmp.si/2014/03/24/prenehanje-veljavnosti-dveh-pravilnikov/2020-03-30T20:27:42+02:00https://www.jazmp.si/2014/04/07/navajamo-nekaj-najpomembnejsih-informacij-ki-so-vezane-na-prvo-obdobje-od-uveljavitev-zzdr-2/2020-03-30T20:27:23+02:00https://www.jazmp.si/2014/04/09/informacije-o-medsebojni-zamenljivosti-zdravil-z-gliklazidom/2020-03-30T20:26:46+02:00https://www.jazmp.si/2014/04/10/obvestilo-o-pripravi-in-zbiranje-pripomb-k-predlogu-smernic-za-opredelitev-izdelkov-za-uporabo-pri-ljudeh/2020-03-30T20:26:25+02:00https://www.jazmp.si/2014/04/15/javna-obravnava-pravilnikov-s-podrocja-zdravil-za-uporabo-v-humani-medicini/2020-03-30T20:25:52+02:00https://www.jazmp.si/2014/04/16/priporocilo-odbora-prac-glede-socasne-uporabe-vec-zdravil-ki-delujejo-na-sistem-renin-angiotenzin/2020-03-30T20:25:15+02:00https://www.jazmp.si/2014/04/16/pregled-zdravil-ki-vsebujejo-ambroksol-in-bromheksin/2020-03-30T20:24:42+02:00https://www.jazmp.si/2014/04/16/pregled-zdravil-ki-vsebujejo-testosteron/2020-03-30T20:24:28+02:00https://www.jazmp.si/2014/04/16/pregled-zdravil-ki-vsebujejo-metadon-in-povidon/2020-03-30T20:24:12+02:00https://www.jazmp.si/2014/04/16/varnostna-vprasanja-pri-uporabi-kodeina-pri-otrocih-2/2020-03-30T20:24:02+02:00https://www.jazmp.si/2014/04/18/obvestilo-o-objavi-seznama-nujno-potrebnih-zdravil/2020-03-30T20:23:33+02:00https://www.jazmp.si/2014/05/09/pregled-zdravil-ki-vsebujejo-hidroksizin/2020-03-30T20:23:04+02:00https://www.jazmp.si/2014/05/09/pregled-zdravila-corlentorprocoralan-ivabradin/2020-03-30T20:22:15+02:00https://www.jazmp.si/2014/05/19/jazmp-in-komisija-za-zdravila/2020-03-30T20:21:57+02:00https://www.jazmp.si/2014/06/03/spletni-obrazec-za-porocanje-o-nezelenih-ucinkih-zdravil-za-uporabo-v-veterinarski-medicini/2020-03-30T20:20:37+02:00https://www.jazmp.si/2014/06/23/pregled-srcno-zilnega-tveganja-pri-dolgotrajnem-jemanju-visokih-odmerkov-ibuprofena/2020-03-30T20:19:47+02:00https://www.jazmp.si/2014/06/24/obvestilo-imetnikom-dovoljenj-za-promet-z-zdravili-glede-zdruzevanja-sprememb-ki-zadevajo-povzetek-glavnih-znacilnosti-zdravila-smpc-in-navodila-za-uporabo-pl-v-skladu-s-7-clenom-uredbe-12342008es-o-s/2020-03-30T20:19:33+02:00https://www.jazmp.si/2014/07/05/odgovori-na-vprasanja-giz-foruma-o-uvajanju-podobnih-bioloskih-zdravi/2020-03-30T20:19:14+02:00https://www.jazmp.si/2014/07/10/obvestilo-imetnikom-dovoljenj-za-promet-z-zdravili-glede-posodobitve-obrazca-za-podaljsanje-dovoljenja-za-promet-z-zdravilom-in-obrazca-za-spremembe-dovoljenja-za-promet-z-zdravilom/2020-03-30T20:19:00+02:00https://www.jazmp.si/2014/07/10/posodobljeno-obvestilo-o-novi-razlicici-qrd-predloge-90-za-zdravila-za-uporabo-v-humani-medicini/2020-03-30T20:18:11+02:00https://www.jazmp.si/2014/07/14/prac-priporocil-omejitev-uporabe-bromokriptina-pri-preprecevanju-ali-zaustavitvi-tvorjenja-materinega-mleka-laktacije-pri-zenskah-po-porodu/2020-03-30T20:17:52+02:00https://www.jazmp.si/2014/07/31/porocilo-o-prejetih-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2013/2020-03-30T20:10:38+02:00https://www.jazmp.si/2014/08/08/cesp-spremeba-zahtev-jazmp/2020-03-30T20:10:19+02:00https://www.jazmp.si/2014/08/08/obvestilo-imetnikom-dzp-glede-posredovanja-podatkov-v-povezavi-z-izvedbo-bioekvivalencnih-studij-na-mestu-gvk-biosciences-private-ltd-gvk-bio-swarna-jayanthi-commercial-comple-ameerpet-hyderabad-india/2020-03-30T20:09:51+02:00https://www.jazmp.si/2014/08/08/obvestilo-imetnikom-dovoljenj-za-promet-z-zdravili-glede-obrazca-za-prenos-dovoljenja-za-promet-z-zdravilom-in-obrazca-za-ukinitev-dovoljenja-za-promet-z-zdravilom/2020-03-30T20:09:30+02:00https://www.jazmp.si/2014/08/18/e-obrazec-za-predloge-pohvale-pripombe-ali-pritozbe/2020-03-30T20:09:09+02:00https://www.jazmp.si/2014/08/29/webinar-osnove-varnih-elektronskih-podpisov-z-demonstracijo/2020-03-30T20:16:40+02:00https://www.jazmp.si/2014/09/23/kako-porocati-o-domnevnem-nezelenem-ucinku-zdravila/2020-03-30T20:08:01+02:00https://www.jazmp.si/2014/10/10/obvestilo-o-objavi-smernic-za-opredelitev-izdelkov/2020-03-30T20:07:52+02:00https://www.jazmp.si/2014/10/20/prac-priporocil-strozjo-omejitev-omejitev-uporabe-valprojske-kislinenatrijevega-valproata/2020-03-30T20:07:20+02:00https://www.jazmp.si/2014/10/21/obvestilo-vsem-imetnikom-dovoljenj-za-opravljanje-dejavnosti-preskrbe-s-cloveskimi-tkivi-in-celicami/2020-03-30T20:07:03+02:00https://www.jazmp.si/2014/10/22/zakljucen-pregled-zdravil-ki-vsebujejo-testosteron/2020-03-30T20:06:40+02:00https://www.jazmp.si/2014/10/22/prac-priporocil-nadaljnje-ukrepe-za-zmanjsanje-tveganja-za-nastajanje-krvnih-strdkov-pri-zdravljenju-z-zdravilom-iclusig-ponatinib/2020-03-30T20:06:14+02:00https://www.jazmp.si/2014/10/24/dopolnitev-podatkov-v-evropski-spletni-bazi-porocil-o-domnevnih-nezelenih-ucinkih-zdravil/2020-03-30T20:17:31+02:00https://www.jazmp.si/2014/11/07/razvoj-podrocja-urejanja-zdravil-v-r-sloveniji-1991-2014/2020-03-30T20:05:23+02:00https://www.jazmp.si/2014/11/25/informacija-za-zdravstvene-delavce-izobrazevalna-gradiva-ki-predstavljajo-dodaten-ukrep-za-zmanjsevanje-tveganj-povezanih-z-zdravili/2020-03-30T20:05:04+02:00https://www.jazmp.si/2014/11/27/priporocila-za-zmanjsanje-tveganja-za-tezave-s-srcem-pri-simptomatskem-zdravljenju-kronicne-stabilne-angine-pektoris-z-ivabradinom/2020-03-30T20:04:42+02:00https://www.jazmp.si/2014/12/02/obvestilo-o-selitvi-jazmp-einspielerjeva-6-na-novo-lokacijo/2020-03-30T20:03:56+02:00https://www.jazmp.si/2014/12/04/prac-zakljucil-da-ni-dokazov-za-povezanost-med-smrtnimi-primeri-po-cepljenju-in-cepivom-fluad-v-italiji/2020-03-30T20:00:09+02:00https://www.jazmp.si/2014/12/08/zakon-o-zdravilih-zzdr-2-neuradni-angleski-prevod/2020-03-30T19:59:53+02:00https://www.jazmp.si/2014/12/15/obvestilo-o-obveznem-poslovanju-z-eracuni/2020-03-30T19:59:38+02:00https://www.jazmp.si/2015/01/14/prac-zakljucil-pregled-zdravil-ki-vsebujejo-ambroksol-in-bromheksin/2020-03-30T19:57:56+02:00https://www.jazmp.si/2015/01/20/poziv-za-posredovanje-izpolnjenega-vprasalnika-ki-se-nanasa-na-izvajanje-farmakovigilancnih-aktivnosti/2020-03-19T01:29:26+01:00https://www.jazmp.si/2015/01/30/priporocilo-odbora-za-zdravila-za-uporabo-v-humani-medicini-chmp-pri-evropski-agenciji-za-zdravila-glede-neskladnosti-klinicnih-studij-z-dobro-klinicno-prakso-izvedenih-na-mestu-gvk-biosciences-privat/2020-03-30T19:50:06+02:00https://www.jazmp.si/2015/01/30/obvestilo-o-nacinu-placila-pristojbin-2/2020-03-30T19:48:55+02:00https://www.jazmp.si/2015/01/30/zahteva-dr-mateja-breznika-za-razresitev-z-mesta-direktorja-javne-agencije-za-zdravila-in-medicinske-pripomocke-jazmp-iz-osebnih-razlogov/2020-03-30T19:48:21+02:00https://www.jazmp.si/2015/02/05/obvestilo-zavezancem-za-placilo-letnih-pristojbin-v-letu-2015/2020-03-30T19:48:03+02:00https://www.jazmp.si/2015/02/09/pricetek-objave-seznama-zdravil-za-uporabo-v-humani-medicini-ki-so-pridobila-dovoljenje-za-vnos-oziroma-uvoz-zdravil/2020-03-30T19:55:02+02:00https://www.jazmp.si/2015/02/09/prenos-nalog-uradnega-kontrolnega-laboratorija-z-jazmp-na-nlzoh/2020-03-30T19:46:53+02:00https://www.jazmp.si/2015/02/20/priporocila-prac-za-zmanjsanje-ucinkov-na-srcni-ritem-pri-uporabi-zdravil-s-hidroksizinom/2020-03-30T19:46:18+02:00https://www.jazmp.si/2015/02/20/prevodi-posodobitev-informacij-o-zdravilih-po-oceni-varnostnih-signalov-objavljeni-na-spletni-strani-ema/2020-03-30T19:45:42+02:00https://www.jazmp.si/2015/02/20/obvestilo-uradni-kontrolni-laboratorij/2020-03-30T19:44:50+02:00https://www.jazmp.si/2015/03/06/posodobitev-navodila-za-predlozitev-vloge-za-pregled-izobrazevalnih-gradiv-ki-so-del-ukrepov-za-zmanjsevanje-tveganj/2020-03-30T19:44:19+02:00https://www.jazmp.si/2015/03/25/omejitev-uporabe-kodeina-pri-lajsanju-kaslja-in-prehlada-pri-otrocih/2020-03-30T19:43:53+02:00https://www.jazmp.si/2015/04/09/jazmp-je-izdala-zacasno-odlocbo-s-katero-je-siq-imenovala-za-priglaseni-organ-na-podrocju-medicinskih-pripomockov/2020-03-30T19:43:35+02:00https://www.jazmp.si/2015/04/15/imenovanje-vrsilke-dolznosti-direktorice-javne-agencije-republike-slovenije-za-zdravila-in-medicinske-pripomocke/2020-03-30T19:43:20+02:00https://www.jazmp.si/2015/04/21/posodobitev-priporocil-glede-uporabe-visokih-odmerkov-ibuprofena/2020-03-30T19:41:45+02:00https://www.jazmp.si/2015/05/13/obvestilo-za-imetnike-dovoljenj-za-promet-z-zdravili-pregledovanje-literature-s-podrocja-medicine-in-porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-v-podatkovno-bazo-eudravigilance/2020-03-30T19:42:02+02:00https://www.jazmp.si/2015/05/11/pregled-zdravila-tysabri-natalizumab/2020-03-30T19:41:01+02:00https://www.jazmp.si/2015/05/11/pregled-inhalacijskih-kortikosteroidov-ki-se-uporabljajo-za-zdravljenje-kronicne-obstruktivne-pljucne-bolezni/2020-03-30T19:40:25+02:00https://www.jazmp.si/2015/05/26/predlozitev-spremembe-tipa-ib-za-zdravila-ki-vsebujejo-finasterid-flukonazol-fluvastatin-jobitridol-jodiksanol-joheksol-gabapentin-propofol-ropinorol-ropivakain-venlafaksin/2020-03-30T19:39:25+02:00https://www.jazmp.si/2015/06/03/obvestilo-za-imetnike-dovoljenj-za-promet-z-zdravili-dopolnitev-navodila-za-predlozitev-vloge-za-pregled-izobrazevalnih-gradiv-ki-so-del-ukrepov-za-zmanjsevanje-tveganj/2020-03-30T19:39:08+02:00https://www.jazmp.si/2015/06/17/mnenje-odbora-za-zdravila-za-uporabo-v-veterinarski-medicini-cvmp-glede-upotrabe-lidokaina-pri-zivalih-za-prehrano-ljudi/2020-03-30T19:38:28+02:00https://www.jazmp.si/2015/06/18/spletni-obrazec-za-porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini/2020-03-30T19:37:54+02:00https://www.jazmp.si/2015/06/18/kako-porocati-o-domnevnem-nezelenem-ucinku-zdravila-2/2025-05-14T16:32:38+02:00https://www.jazmp.si/2015/06/18/dva-vecja-dogodka-na-euegp-ravni-v-organizaciji-jazmp/2020-03-30T13:21:41+02:00https://www.jazmp.si/2015/06/18/ema-zacela-s-pregledom-zaviralcev-sglt2-glede-tveganja-za-diabeticno-ketoacidozo/2020-03-30T14:32:07+02:00https://www.jazmp.si/2015/07/15/ema-pricela-pregled-cepiv-proti-humanim-papilomavirusom-hpv-zaradi-dodatne-razjasnitve-nekaterih-varnostnih-vidikov/2020-03-30T13:20:54+02:00https://www.jazmp.si/2015/07/16/javni-natecaj-za-direktorja-javne-agencije-republike-slovenije-za-zdravila-in-medicinske-pripomocke-3/2020-03-30T13:20:30+02:00https://www.jazmp.si/2015/08/03/poziv-ek-za-clanstvo-predstavnikov-civilne-druzbe-v-prac-in-cat/2020-03-30T13:20:17+02:00https://www.jazmp.si/2015/08/04/porocilo-o-prejetih-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2014/2020-03-30T13:20:04+02:00https://www.jazmp.si/2015/08/14/prijave-na-javni-natecaj-za-direktorja-jazmp-odprte/2020-03-30T13:19:51+02:00https://www.jazmp.si/2015/09/08/predlog-za-imenovanje-nove-direktorice-jazmp/2020-03-30T13:19:34+02:00https://www.jazmp.si/2015/09/25/preklic-certifikata-es-proizvajalca-silimed-silikonski-vsadki-za-plasticno-kirurgijo/2020-03-30T13:19:19+02:00https://www.jazmp.si/2015/10/02/obvestilo-predlagateljem-glede-pricetka-obvezne-uporabe-revidiranega-obrazca-za-pridobitev-dovoljenja-za-promet-z-zdravilom/2020-03-30T13:18:56+02:00https://www.jazmp.si/2015/10/12/odlocba-vlade-rs-o-imenovanju-direktorice-jazmp/2020-03-30T13:18:11+02:00https://www.jazmp.si/2015/10/14/sporocilo-za-javnost-o-prenehanju-delovanja-ustanove-za-tkiva-in-celice-druzbe-neocelica-doo/2020-03-30T13:17:56+02:00https://www.jazmp.si/2015/11/06/prac-zakljucil-pregled-cepiv-proti-humanim-papilomavirusom-hpv/2020-03-30T13:16:53+02:00https://www.jazmp.si/2015/11/16/eaf-obvezna-uporaba-in-izobrazevanje-za-predlagatelje/2020-03-30T13:16:32+02:00https://www.jazmp.si/2015/11/26/navodila-za-pripravo-e-racunov-eslog-verzija-15-in-16-z-obveznimi-podatki-in-dodatno-obveznimi-podatki-v-skladu-z-veljavno-zakonodajo/2020-03-30T13:16:14+02:00https://www.jazmp.si/2015/12/10/s-preprecevanjem-napak-pri-uporabi-zdravil-do-varnejse-uporabe-zdravil/2020-03-30T13:17:07+02:00https://www.jazmp.si/2015/12/17/namera-o-sklenitvi-pogodbe-o-prodaji-sistema-ups/2020-03-30T13:07:22+02:00https://www.jazmp.si/2016/01/04/odziv-jazmp-na-revizijsko-porocilo-racunskega-sodisca-republike-slovenije-delovanje-jazmp/2020-03-30T13:06:18+02:00https://www.jazmp.si/2016/01/04/oddaja-eaf-v-papirni-obliki/2020-03-30T13:05:34+02:00https://www.jazmp.si/2016/01/05/uporaba-organskih-kislin-v-cebelarstvu/2020-03-30T13:05:22+02:00https://www.jazmp.si/2016/01/11/preskrba-s-cloveskimi-tkivi-in-celicami-namenjenimi-za-zdravljenje-sporocilo-za-javnost-o-prejemu-obvestila-v-sistemu-ratc/2020-03-30T13:05:05+02:00https://www.jazmp.si/2016/01/25/obvestilo-zavezancem-za-placilo-letnih-pristojbin-v-letu-2016/2020-03-30T13:04:45+02:00https://www.jazmp.si/2016/02/05/pregled-zdravil-ki-vsebujejo-metformin/2020-03-30T13:01:12+02:00https://www.jazmp.si/2016/02/19/dopolnjena-priporocila-za-zmanjsanje-tveganja-za-progresivno-multifokalno-levkoencefalopatijo-pri-zdravljenju-z-zdravilom-tysabri-natalizumab/2020-03-30T12:59:43+02:00https://www.jazmp.si/2016/02/19/priporocila-za-zmanjsanje-tveganja-za-diabeticno-ketoacidozo-pri-zdravljenju-z-zaviralci-sglt2-kanagliflozin-dapagliflozin-empagliflozin/2020-03-30T12:59:28+02:00https://www.jazmp.si/2016/03/03/poziv-pravnim-osebam-uporabnicam-storitev-agencije-za-mnenja-pripombe-in-predloge-glede-nacrtovane-izdaje-pravilnika-o-pristojbinah-na-podrocju-zdravil-krvi-tkiv-in-celic-ter-o-nadomestilih-za-izvajan/2020-03-30T12:59:14+02:00https://www.jazmp.si/2016/03/16/obvestilo-za-izvajalce-zdravstvene-dejavnosti-glede-izobrazevalnih-gradiv-za-katere-je-jazmp-izdala-soglasje-in-so-pripravljena-z-namenom-zmanjsevanja-tveganj-povezanih-z-zdravili/2020-03-30T07:49:44+02:00https://www.jazmp.si/2016/03/17/sprejeti-ukrepi-pri-darovanju-krvi-tkiv-in-celic-zaradi-moznosti-prenosa-virusa-zika/2020-03-30T07:49:15+02:00https://www.jazmp.si/2016/04/11/pojasnilo-in-ukrepanje-jazmp-v-zadevi-panama-papers/2020-03-30T07:49:02+02:00https://www.jazmp.si/2016/05/03/preklic-dovoljenj-za-promet-za-prsila-s-fuzafunginom-za-zdravljenje-okuzb-dihalnih-poti/2020-03-30T07:48:47+02:00https://www.jazmp.si/2016/05/03/pregled-zdravil-ki-vsebujejo-vankomicin/2020-03-30T07:48:08+02:00https://www.jazmp.si/2016/05/03/nova-varnostna-priporocila-pri-zdravljenju-z-zdravilom-zydelig-idelalizib/2020-03-30T07:48:00+02:00https://www.jazmp.si/2016/05/03/pregled-zdravil-z-direktnim-delovanjem-na-viruse-za-zdravljenje-hepatitisa-c/2020-03-30T07:47:29+02:00https://www.jazmp.si/2016/05/05/zakljucen-pregled-inhalacijskih-kortikosteroidov-ki-se-uporabljajo-za-zdravljenje-kronicne-obstruktivne-pljucne-bolezni-za-ponovno-oceno-tveganja-za-razvoj-pljucnice/2020-03-30T07:47:21+02:00https://www.jazmp.si/2016/05/05/pregled-zdravil-za-zdravljenje-sladkorne-bolezni-tipa-2-ki-vsebujejo-kanagliflozin/2020-03-30T07:46:55+02:00https://www.jazmp.si/2016/06/06/objava-namere-prodaje-rabljenih-premicnin/2020-03-30T07:46:40+02:00https://www.jazmp.si/2016/06/13/obvestilo-za-imetnike-dovoljenj-za-promet-z-zdravili-za-uporabo-v-humani-medicini-obvezna-uporaba-elektronske-zbirke-psur-psur-repozitorija-za-oddajo-rednih-posodobljenih-porocil-o-varnosti-zdravila/2020-03-30T07:46:01+02:00https://www.jazmp.si/2016/06/16/pirolizidinski-alkaloidi-poziv-imetnikom-dovoljenj-za-promet-s-tradicionalnim-zdravilom-rastlinskega-izvora/2020-03-30T07:45:22+02:00https://www.jazmp.si/2016/06/16/obvestilo-imetnikom-dovoljenj-za-promet-z-zdravili-glede-veljavnosti-ich-q3d-smernice-o-kovinskih-necistotah/2020-03-30T07:45:07+02:00https://www.jazmp.si/2016/06/21/objava-izobrazevalnih-gradiv-ki-so-odobrena-kot-dodaten-ukrep-za-zmanjsevanje-tveganj-povezanih-z-zdravili-za-uporabo-v-humani-medicini-na-spletni-strani-jazmp/2020-03-30T07:44:48+02:00https://www.jazmp.si/2016/06/23/posodobljena-anketa-o-spremljanju-farmakovigilancnih-obvestil-na-spletni-strani-jazmp/2020-03-30T07:44:36+02:00https://www.jazmp.si/2016/06/25/sporocilo-za-javnost-o-problematiki-uporabe-neveljavnih-cen-zdravil-in-vpliv-na-preskrbo-pacientov-z-zdravili/2020-03-30T07:44:12+02:00https://www.jazmp.si/2016/06/29/ema-opozarja-da-se-zdravili-noxafil-tablete-in-noxafil-peroralna-suspenzija-ne-sme-uporabljati-medsebojno-zamenljivo-ker-se-odmerjanje-med-oblikama-razlikuje/2020-03-30T07:44:00+02:00https://www.jazmp.si/2016/06/29/omejitev-zdravila-adempas-pri-bolnikih-s-pljucno-hipertenzijo-nastalo-zaradi-idiopatske-intersticijske-pljucnice/2020-03-30T07:43:45+02:00https://www.jazmp.si/2016/07/13/pregled-zdravil-s-paracetamolom-v-farmacevtskih-oblikah-s-prirejenimpodaljsanim-sproscanjem-za-oceno-tveganja-za-preveliko-odmerjanje/2020-03-30T07:42:19+02:00https://www.jazmp.si/2016/07/13/pregled-zdravil-ki-vsebujejo-retinoide-za-oceno-ucinkovitosti-programov-zascite-pred-zanositvijo-in-ukrepov-za-zmanjsanje-moznega-tveganja-za-psihiatricne-motnje/2020-03-30T07:42:01+02:00https://www.jazmp.si/2016/07/13/pregled-zdravil-ki-vsebujejo-koagulacijski-faktor-viii-faktor-strjevanja-krvi-viii-za-oceno-tveganja-za-nastanek-nevtralizirajocih-protiteles-zaviralcev-pri-bolnikih-ki-se-za-hemofilijo-a-zdravijo-prv/2020-03-30T07:41:53+02:00https://www.jazmp.si/2016/07/13/zakljucen-pregled-zdravila-zydelig-idelalizib-in-posodobljena-priporocila-glede-uporabe-zdravila/2020-03-30T07:41:17+02:00https://www.jazmp.si/2016/07/20/obvestilo-o-zacasnem-odvzemu-dovoljenja-za-promet-zdravila-velactis-za-uporabo-v-veterinarski-medicini/2020-03-30T07:41:02+02:00https://www.jazmp.si/2016/08/16/ukrepi-glede-klinicno-pomembnega-medsebojnega-delovanja-levonorgestrela-kot-nujnega-hormonskega-kontracepcijskega-sredstva-z-zdravili-ki-inducirajo-jetrne-encime/2020-03-30T07:40:49+02:00https://www.jazmp.si/2016/09/06/odpoklic-serije-zdravila-glucagen-hypokit-v-sloveniji/2020-03-30T07:40:38+02:00https://www.jazmp.si/2016/09/19/porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2015/2020-03-30T07:39:43+02:00https://www.jazmp.si/2016/09/20/objava-namere-prodaje-rabljenih-premicnin-2/2020-03-30T07:39:28+02:00https://www.jazmp.si/2016/10/04/predlog-novih-uredb-o-mp-ter-o-in-vitro-diagnosticnih-mp/2020-03-30T07:38:58+02:00https://www.jazmp.si/2016/10/11/proizvodi-s-konopljo-cbd-obvestilo-lekarniski-zbornici-s-prosnjo-za-posredovanje-lekarnam/2020-03-30T07:38:24+02:00https://www.jazmp.si/2016/10/27/ema-priporoca-ukrepe-za-zagotavljanje-varne-uporabe-peroralne-raztopine-keppra-in-ostalih-peroralnih-raztopin-ki-vsebujejo-levetiracetam/2020-03-30T07:36:35+02:00https://www.jazmp.si/2016/11/07/s-porocanjem-o-domnevnih-nezelenih-ucinkih-lahko-vsak-prispeva-k-varnejsi-uporabi-zdravil/2020-03-30T07:36:19+02:00https://www.jazmp.si/2016/11/08/zika-virus-pacienti-ki-jemljejo-zdravila-proizvedena-iz-krvne-plazme-ali-iz-urina-niso-izpostavljeni-povecanemu-tveganju-za-okuzbo-z-virusom-zika/2020-03-30T07:36:04+02:00https://www.jazmp.si/2016/11/22/povzetek-sporocila-ema-v-zvezi-z-revizijo-smernice-za-klinicna-preskusanja-zdravil-ki-se-prvic-uporabljajo-pri-ljudeh/2020-03-30T07:35:29+02:00https://www.jazmp.si/2016/12/07/stalisce-jazmp-v-zvezi-s-predlogom-o-spremembi-razvrstitve-konoplje-in-ureditvi-gojenja-konoplje/2020-03-30T07:34:48+02:00https://www.jazmp.si/2016/12/13/obvestilo-o-neustrezni-kakovosti-zdravila-aspirin-plus-c-400-mg240-mg-sumece-tablete-st-serije-btagz50-rok-uporabnosti-11-2018/2020-03-31T16:03:26+02:00https://www.jazmp.si/2016/12/14/odpoklic-zdravila-aspirin-plus-c-400-mg240-mg-sumece-tablete-st-serije-btagz50-jazmp-razsirja-do-ravni-uporabnikov/2020-03-30T07:34:15+02:00https://www.jazmp.si/2016/12/16/pregled-zdravil-z-metilprednizolonom-v-obliki-raztopine-za-injiciranje-ali-infundiranje-ki-vsebujejo-laktozo-pridobljeno-iz-kravjega-mleka-in-se-uporabljajo-za-zdravljenje-akutnih-alergijskih-reakcij/2020-03-30T07:34:01+02:00https://www.jazmp.si/2016/12/22/izjava-za-javnost-v-zadevi-bupropion/2020-03-30T07:33:45+02:00https://www.jazmp.si/2016/12/23/pravilnika-ki-urejata-podrocje-proizvodnje-zdravil-in-proizvodnje-veletrgovine-in-uvoza-ucinkovin-objavljana-v-uradnem-listu-rs/2020-03-30T07:33:32+02:00https://www.jazmp.si/2016/12/30/obvestilo-o-preskrbi-z-imuranom/2020-03-30T07:32:49+02:00https://www.jazmp.si/2017/01/04/zakljucen-pregled-zdravil-z-direktnim-delovanjem-na-viruse-za-zdravljenje-hepatitisa-c/2020-03-30T07:32:34+02:00https://www.jazmp.si/2017/02/28/dienogestetinilestradiol-se-lahko-uporabljata-za-zdravljenje-aken-ko-so-drugi-nacini-zdravljenja-neuspesni/2020-03-30T07:32:20+02:00https://www.jazmp.si/2017/02/28/zakljucen-pregled-zdravil-za-zdravljenje-sladkorne-bolezni-tipa-2-ki-vsebujejo-zaviralce-sglt2-kanagliflozin-dapagliflozin-empagliflozin/2020-03-30T07:32:07+02:00https://www.jazmp.si/2017/02/28/pregled-fluorokinolonov-in-drugih-kinolonskih-antibiotikov-glede-vztrajajocih-nezelenih-ucinkov-na-misicno-skeletni-sistem-in-zivcevje/2020-03-30T07:31:49+02:00https://www.jazmp.si/2017/03/15/prac-zakljucil-oceno-gadolinijevih-kontrastnih-sredstev-in-priporocil-regulativne-ukrepe-vkljucno-z-zacasnim-prenehanjem-nekaterih-dovoljenj-za-promet/2020-03-30T07:31:32+02:00https://www.jazmp.si/2017/03/17/posodobljena-strategija-esubmission-roadmap/2020-03-30T07:31:09+02:00https://www.jazmp.si/2017/03/20/mnenje-pripombe-in-predlogi-glede-osnutka-tarife/2020-03-30T07:30:19+02:00https://www.jazmp.si/2017/03/29/ponovni-pregled-uporabe-valproata-v-nosecnosti-ter-pri-zenskah-v-rodni-dobi/2020-03-30T07:30:04+02:00https://www.jazmp.si/2017/03/29/objava-seznama-nujno-potrebnih-zdravil/2020-03-30T07:29:44+02:00https://www.jazmp.si/2017/03/30/pregled-zdravil-za-zdravljenje-raka-ki-vsebujejo-docetaksel/2020-03-30T07:29:28+02:00https://www.jazmp.si/2017/04/12/odpoklic-serije-avtoinjektorjev-epipen-junior-0-15-mg-epinefrin-zaradi-mozne-okvare-naprave/2020-03-30T07:29:02+02:00https://www.jazmp.si/2017/04/24/jazmp-prispeva-k-izmenjavi-podatkov-o-cenah-zdravil-med-27-drzavami/2020-03-30T07:27:34+02:00https://www.jazmp.si/2017/05/10/obvestilo-o-objavi-nove-uredbe-o-medicinskih-pripomockih-ter-uredbe-o-in-vitro-diagnosticnih-medicinskih-pripomockih/2020-03-30T07:27:00+02:00https://www.jazmp.si/2017/05/24/opravljanje-prometa-z-medicinskimi-pripomocki-na-drobno-in-vpis-poslovnih-subjektov-v-register-dejavnosti/2020-03-30T07:25:17+02:00https://www.jazmp.si/2017/05/30/spremembe-pri-predpisovanju-antibiotikov-z-vankomicinom/2020-03-30T07:24:18+02:00https://www.jazmp.si/2017/06/07/objava-seznama-nujno-potrebnih-zdravil-3/2020-03-30T07:23:46+02:00https://www.jazmp.si/2017/06/07/strokovni-posvet-o-varni-rabi-zdravil-10-let-delovanja-jazmp/2020-03-30T07:23:11+02:00https://www.jazmp.si/2017/06/08/vabljeni-k-posredovanju-mnenja-o-evropski-zakonodaji-na-podrocju-krvi-tkiv-in-celic-evropska-komisija-vabi-k-izpolnitvi-vprasalnika/2020-03-30T07:17:55+02:00https://www.jazmp.si/2017/06/20/prac-zakljucil-da-ni-jasnih-in-doslednih-dokazov-o-razliki-v-razvoju-nevtralizirajocih-protiteles-med-skupinama-zdravil-s-koagulacijskim-faktorjem-viii/2020-03-30T07:17:35+02:00https://www.jazmp.si/2017/06/20/zelena-luc-za-nov-eudravigilance-sistem-za-zbiranje-in-spremljanje-domnevnih-nezelenih-ucinkov-zdravil-za-uporabo-v-humani-medicini/2020-03-30T07:17:20+02:00https://www.jazmp.si/2017/06/20/pregled-zdravila-zinbryta-daklizumab-za-zdravljenje-multiple-skleroze/2020-03-30T07:15:39+02:00https://www.jazmp.si/2017/06/20/prac-zakljucil-da-ni-dokazov-o-spremembi-ze-znanega-tveganja-za-nevtropenicni-enterokolitis-v-primerih-povezanih-z-docetakselom/2020-03-30T07:15:13+02:00https://www.jazmp.si/2017/06/20/prac-dolocil-datum-javne-predstavitve-mnenj-v-zvezi-z-uporabo-valproata/2020-03-30T07:14:52+02:00https://www.jazmp.si/2017/06/29/imenovanje-jazmp-za-nacionalni-center-za-farmakovigilanco-informacija-za-imetnike-dovoljenj-za-promet-z-zdravili/2020-03-30T07:14:31+02:00https://www.jazmp.si/2017/06/29/informacije-za-zdravstvene-delavce-v-zvezi-z-delovanjem-nacionalnega-centra-za-farmakovigilanco/2020-03-30T07:13:53+02:00https://www.jazmp.si/2017/06/29/informacije-za-javnost-ob-imenovanju-jazmp-za-nacionalni-center-za-farmakovigilanco/2020-03-30T07:13:17+02:00https://www.jazmp.si/2017/07/05/nujno-varnostno-obvestilo-za-osebe-s-sladkorno-boleznijo-ki-uporabljajo-injekcijski-peresnik-novopen-echo/2020-03-30T07:16:25+02:00https://www.jazmp.si/2017/07/11/omejitve-uporabe-zdravila-za-zdravljenje-multiple-skleroze-zinbryta-daklizumab/2020-03-30T07:12:01+02:00https://www.jazmp.si/2017/07/12/prac-potrdil-omejitve-uporabe-linearnih-gadolinijevih-kontrastnih-sredstev/2020-03-30T07:11:34+02:00https://www.jazmp.si/2017/07/14/prac-priporocil-naj-se-metilprednizolon-za-injiciranje-ali-infundiranje-ki-vsebuje-laktozo-ne-uporablja-pri-bolnikih-alergicnih-na-beljakovine-kravjega-mleka/2020-03-30T07:11:13+02:00https://www.jazmp.si/2017/07/20/novost-s-podrocja-organizacije-in-vodenja-podrocij-jazmp/2020-03-30T07:10:51+02:00https://www.jazmp.si/2017/07/25/obvestilo-imetnikom-dovoljenj-za-opravljanje-dejavnosti-preskrbe-s-cloveskimi-tkivi-in-celicami-namenjenimi-za-zdravljenje/2020-03-30T07:10:30+02:00https://www.jazmp.si/2017/07/28/povabilo-k-prijavi-na-javno-predstavitev-mnenj-na-evropski-agenciji-za-zdravila-ema-v-zvezi-z-obravnavo-varnosti-uporabe-valproata/2020-03-30T07:10:10+02:00https://www.jazmp.si/2017/07/28/povabilo-strokovnjakom-da-se-pridruzijo-odboru-za-oceno-tveganja-na-podrocju-farmakovigilance-prac-pri-evropski-agenciji-za-zdravila-ema/2020-03-30T07:09:24+02:00https://www.jazmp.si/2017/07/28/koncno-mnenje-ema-potrjuje-omejitve-uporabe-linearnih-kontrastnih-sredstev-z-gadolinijem/2020-03-30T07:08:43+02:00https://www.jazmp.si/2017/08/09/vabilo-predlagateljem-k-javni-razpravi-o-usmeritvah-jazmp-v-povezavi-z-uvedbo-zascitnih-elementov-pri-zdravilih-za-uporabo-v-humani-medicini/2020-03-30T07:06:45+02:00https://www.jazmp.si/2017/08/14/obvescanje-zdravnikov-o-dobavljivosti-zdravil-brez-dovoljenja-za-promet-s-seznama-nujno-potrebnih-zdravil/2020-03-30T07:06:10+02:00https://www.jazmp.si/2017/08/22/zdravilo-bravecto-za-zdravljenje-infestacije-s-klopi-in-bolhami-na-psih-je-sprejemljivo-za-uporabo/2020-03-30T07:05:53+02:00https://www.jazmp.si/2017/08/22/sprememba-pravilnika-o-dzp-v-humani-medicini/2020-03-30T07:05:22+02:00https://www.jazmp.si/2017/08/23/objava-dopolnjene-tretje-izdaje-formulariuma-slovenicuma-fs-331/2020-03-30T07:04:42+02:00https://www.jazmp.si/2017/08/28/objava-neposrednih-obvestil-za-zdravstvene-delavce/2020-03-30T07:04:25+02:00https://www.jazmp.si/2017/08/29/izbrane-vsebine-jazmp-odslej-tudi-na-twitterju/2020-03-30T07:03:46+02:00https://www.jazmp.si/2017/08/30/opozorilo-testi-za-samotestiranje-na-okuzbo-z-virusom-hiv/2020-03-30T07:02:10+02:00https://www.jazmp.si/2017/09/11/objava-seznama-nujno-potrebnih-zdravil-2/2020-03-30T06:48:53+02:00https://www.jazmp.si/2017/09/14/obvescanje-v-primeru-neustrezne-kakovosti-zdravila-v-skladu-s-23-clenom-zakona-o-zdravilih/2020-03-30T06:48:33+02:00https://www.jazmp.si/2017/09/18/prac-priporocil-zacasni-odvzem-dovoljenja-za-promet-z-zdravili-s-paracetamolom-v-farmacevtskih-oblikah-s-prirejenimpodaljsanim-sproscanjem/2020-03-30T06:48:10+02:00https://www.jazmp.si/2017/09/18/ema-objavila-anketo-za-oceno-zavedanja-pacientov-in-zdravstvenih-delavcev-glede-zahtev-za-porocanje-o-nezelenih-ucinkih-zdravil/2020-03-30T01:28:30+02:00https://www.jazmp.si/2017/09/19/obvestilo-o-odpoklicu-infuzijski-seti-medtronic-minimed/2020-03-31T16:02:41+02:00https://www.jazmp.si/2017/09/26/danes-bo-na-evropski-agenciji-za-zdravila-ema-potekala-prva-javna-predstavitev-mnenj-drzavljani-eu-prispevajo-k-zmanjsanju-tveganja-pri-zdravljenju-z-valproatom/2020-03-30T01:27:39+02:00https://www.jazmp.si/2017/09/26/dodatno-pojasnilo-glede-statusa-zdravil-s-paracetamolom-ki-so-v-oblikah-s-prirejenimpodaljsanim-sproscanjem/2020-03-30T01:27:16+02:00https://www.jazmp.si/2017/10/06/zaprosilo-vsem-imetnikom-dovoljenj-za-posredovanje-nacrtovanih-sprememb-v-letu-2018/2020-03-30T01:26:54+02:00https://www.jazmp.si/2017/10/25/obvestilo-o-uporabi-izdelkov-ki-vsebujejo-ucinkovino-gentamicin/2020-03-30T01:26:15+02:00https://www.jazmp.si/2017/10/25/novi-regulativni-pristopi-za-povecanje-dostopnosti-zdravil/2020-03-30T01:25:28+02:00https://www.jazmp.si/2017/11/07/obvestilo-o-prehodu-na-nov-sistem-eudravigilance/2020-03-30T01:25:11+02:00https://www.jazmp.si/2017/11/07/prac-priporocil-nadaljnje-omejitve-uporabe-zdravila-za-zdravljenje-multiple-skleroze-zinbryta-daklizumab-zaradi-tveganja-za-resne-poskodbe-jeter/2020-03-30T01:24:25+02:00https://www.jazmp.si/2017/11/07/ponovni-pregled-zdravil-ki-vsebujejo-hidroksietilskrob/2020-03-30T01:23:37+02:00https://www.jazmp.si/2017/11/17/obvestilo-poslovnim-subjektom-ki-so-vpisani-v-register-proizvajalcev-veletrgovcev-in-uvoznikov-ucinkovin-glede-letnih-porocil-in-sporocanja-sprememb/2024-04-04T14:20:46+02:00https://www.jazmp.si/2017/11/17/obvestilo-poslovnim-subjektom-ki-so-vpisani-v-register-proizvajalcev-ucinkovin-veletrgovcev-z-ucinkovinami-in-uvoznikov-ucinkovin/2020-03-30T01:22:48+02:00https://www.jazmp.si/2017/11/28/uvoz-in-izvoz-prepovedanih-drog-skupin-ii-in-iii/2025-04-07T09:27:50+02:00https://www.jazmp.si/2017/12/01/evropska-komisija-je-objavila-smernice-dobre-proizvodne-prakse-za-proizvodnjo-zdravil-za-napredno-zdravljenje/2020-03-30T01:22:11+02:00https://www.jazmp.si/2017/12/05/jazmp-od-danes-objavlja-seznam-esencialnih-zdravil/2020-03-30T01:21:44+02:00https://www.jazmp.si/2017/12/06/nacrt-uvebe-zascitnih-elementov-na-ovojnino-zdravil-za-uporabo-v-humani-medicini/2020-03-30T01:21:05+02:00https://www.jazmp.si/2017/12/15/preskrba-z-zdravili-ki-so-uvrscena-na-seznam-esencialnih-in-seznam-nujno-potrebnih-zdravil/2020-03-30T01:20:15+02:00https://www.jazmp.si/2017/12/20/opozorilo-glede-tveganj-pri-socasni-uporabi-zdravila-xofigo-z-zdravilom-zytiga-in-prednizolonomprednizonom/2020-03-30T01:19:13+02:00https://www.jazmp.si/2017/12/20/pregled-zdravila-esmya-ulipristalacetat-zaradi-primerov-jetrne-okvare/2020-03-30T01:18:50+02:00https://www.jazmp.si/2017/12/20/nadzor-trga-zdravil-in-medicinskih-pripomockov-ter-prijava-krsitev/2020-03-30T01:18:24+02:00https://www.jazmp.si/2017/12/20/smernice-imetnikom-dovoljenj-za-proizvodnjo-zdravil-glede-obvescanja-o-spremembah-proizvodnih-aktivnosti-in-ne-dovoljenje-za-proizvodnjo-zdravil-pravilnik-o-proizvodni-zdravil-uradni-list-rs-st-8116/2020-03-30T01:18:06+02:00https://www.jazmp.si/2017/12/22/revidirano-navodilo-za-dolocanje-stevilk-postopkov/2020-03-30T01:17:17+02:00https://www.jazmp.si/2017/12/27/regulatorne-usmeritve-farmacevtski-industriji-za-pripravo-na-izstop-zdruzenega-kraljestva-iz-evropske-unije-brexit/2020-03-30T01:17:03+02:00https://www.jazmp.si/2017/12/27/zacasni-odvzem-dovoljenja-za-promet-z-zdravili-s-paracetamolom-v-farmacevtskih-oblikah-s-prirejenimpodaljsanim-sproscanjem/2020-03-30T01:16:20+02:00https://www.jazmp.si/2017/12/27/pregled-porocanja-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2016/2020-03-30T01:15:38+02:00https://www.jazmp.si/2018/01/10/znizanje-pristojbin-za-priglasitev-paralelne-distribucije/2020-03-30T01:15:03+02:00https://www.jazmp.si/2018/01/16/vzpostavitev-spletnega-porocanja-o-domnevnih-nezelenih-ucinkih-zdravil/2020-03-30T01:14:39+02:00https://www.jazmp.si/2018/01/16/prac-priporocil-zacasni-odvzem-dovoljenja-za-promet-z-zdravili-ki-vsebujejo-hidroksietilskrob-hes/2020-03-30T01:14:02+02:00https://www.jazmp.si/2018/01/22/obvestilo-za-zdravstvene-delavce/2020-03-30T01:13:36+02:00https://www.jazmp.si/2018/01/24/obvestilo-za-zdravstvene-delavce-26/2020-03-30T01:11:40+02:00https://www.jazmp.si/2018/02/14/interpretacija-prehodnih-dolocb-uredb-mdr-in-ivdr/2020-03-30T01:05:23+02:00https://www.jazmp.si/2018/02/05/skupina-za-usklajevanje-cmdh-potrdila-priporocilo-prac-za-zacasni-odvzem-dovoljenja-za-promet-z-zdravili-ki-vsebujejo-hidroksietilskrob-hes/2020-03-30T01:07:10+02:00https://www.jazmp.si/2018/02/07/dodatno-pojasnilo-glede-statusa-zdravil-s-hidroksietilskrobom-hes/2020-03-30T01:06:38+02:00https://www.jazmp.si/2018/02/09/smernice-za-ugotavljanje-usposobljenosti-odgovornih-oseb-za-sproscanje-posameznih-serij-zdravil/2020-03-30T01:06:16+02:00https://www.jazmp.si/2018/02/14/jazmp-opozarja-zavajajoce-reklamiranje-in-prodaja-izdelka-hondrocream-na-spletnih-straneh/2020-03-30T01:02:37+02:00https://www.jazmp.si/2018/02/16/javna-agencija-republike-slovenije-za-zdravila-in-medicinske-pripomocke-opozarja-zavajajoce-oglasevanje-in-prodaja-izdelka-beezmax-ortho-krema/2020-03-30T01:02:05+02:00https://www.jazmp.si/2018/02/19/prac-priporocil-zacasno-omejitev-predpisovanja-zdravila-esmya-ulipristalacetat-in-redno-spremljanje-delovanja-jeter/2020-03-30T01:01:26+02:00https://www.jazmp.si/2018/02/19/tarife-jazmp/2020-03-30T01:00:38+02:00https://www.jazmp.si/2018/02/21/obvestilo-za-zdravstvene-delavce-25/2020-03-30T01:00:23+02:00https://www.jazmp.si/2018/02/26/posodobitev-ukrepov-za-preprecevanje-nosecnosti-med-zdravljenjem-z-zdravili-ki-vsebujejo-retinoide/2020-03-30T01:00:04+02:00https://www.jazmp.si/2018/02/28/obvestilo-za-zdravstvene-delavce-24/2020-03-30T00:59:41+02:00https://www.jazmp.si/2018/03/01/ministrstvo-za-zdravje-je-0103-na-portalu-e-demokracija-objavilo-predlog-sprememb-pravilnika-o-cenah-zdravil/2020-03-30T00:59:24+02:00https://www.jazmp.si/2018/03/02/novosti-pri-pristojbinah/2020-03-30T00:58:59+02:00https://www.jazmp.si/2018/03/05/poziv-za-izpolnitev-vprasalnika-o-izvajanju-farmakovigilancnih-aktivnosti/2020-03-30T00:58:25+02:00https://www.jazmp.si/2018/03/05/ema-zacela-nujni-pregled-zdravila-za-zdravljenje-multiple-skleroze-zinbryta-zaradi-primerov-vnetnih-bolezni-mozganov-imetnik-dovoljenja-za-promet-z-zdravilom-napovedal-prostovoljni-umik-zdra/2020-03-30T00:57:12+02:00https://www.jazmp.si/2018/03/07/ema-priporocila-takojsen-odvzem-dovoljenja-za-promet-z-zdravilom-za-zdravljenje-multiple-skleroze-zinbryta-in-takojsen-umik-zdravila-s-trga-zaradi-tveganja-za-hude-vnetne-bolezni-mozganov/2020-03-30T00:56:49+02:00https://www.jazmp.si/2018/03/13/novosti-na-podrocju-drugacnega-oznacevanja-zdravil/2020-03-30T00:56:26+02:00https://www.jazmp.si/2018/03/13/obvestilo-za-zdravstvene-delavce-23/2020-03-30T00:56:10+02:00https://www.jazmp.si/2018/03/15/obvestilo-za-zdravstvene-delavce-22/2020-03-30T00:55:54+02:00https://www.jazmp.si/2018/03/16/zdravilo-za-zdravljenje-raka-prostate-xofigo-naj-se-ne-uporablja-v-kombinaciji-z-zdravilom-zytiga-in-prednizonomprednizolonom/2020-03-30T00:55:38+02:00https://www.jazmp.si/2018/03/20/obvestilo-za-zdravstvene-delavce-21/2020-03-30T00:55:10+02:00https://www.jazmp.si/2018/03/23/poziv-deleznikom-da-se-vkljucijo-v-sistem-za-preverjanje-avtenticnosti-zdravil-emvs/2020-03-30T00:54:31+02:00https://www.jazmp.si/2018/03/30/ema-bo-pregledala-in-ovrednotila-uporabo-zdravil-z-omega-3-mascobnimi-kislinami-pri-bolnikih-ki-so-preboleli-srcni-infarkt/2020-03-31T06:24:38+02:00https://www.jazmp.si/2018/04/03/obvestilo-za-zdravstvene-delavce-20/2020-03-30T00:53:10+02:00https://www.jazmp.si/2018/04/05/obvestilo-za-zdravstvene-delavce-19/2020-03-30T00:52:45+02:00https://www.jazmp.si/2018/04/18/informacijska-zlozenka-glede-eu-predpisov-o-zascitnih-elementih-za-zdravila/2020-03-30T00:52:11+02:00https://www.jazmp.si/2018/04/30/pregled-tveganja-za-napake-pri-odmerjanju-metotreksata/2020-03-30T00:50:52+02:00https://www.jazmp.si/2018/05/04/obvestilo-za-zdravstvene-delavce-18/2020-03-30T00:49:34+02:00https://www.jazmp.si/2018/05/08/poskodbe-oci-pri-ljudeh-po-nenamerni-izpostavljenosti-oci-zdravilu-osurnia-gel-za-uho-za-pse/2020-03-30T00:48:58+02:00https://www.jazmp.si/2018/05/08/obvestilo-za-zdravstvene-delavce-17/2020-03-30T00:48:38+02:00https://www.jazmp.si/2018/05/17/obvestilo-za-zdravstvene-delavce-16/2020-03-30T00:48:16+02:00https://www.jazmp.si/2018/05/23/nebulizatorji-inhalatorji-aquilon-neskladni-medicinski-pripomocki-na-trgu-eu/2020-03-30T00:47:57+02:00https://www.jazmp.si/2018/05/25/vlada-imenovala-vrsilca-dolznosti-direktorja-javne-agencije-rs-za-zdravila-in-medicinske-pripomocke/2020-03-30T00:47:21+02:00https://www.jazmp.si/2018/05/30/prac-priporocil-nove-ukrepe-za-zmanjsanje-tveganja-za-redke-a-resne-okvare-jeter-pri-bolnicah-ki-se-zdravijo-z-esmyo/2020-03-30T00:46:41+02:00https://www.jazmp.si/2018/05/31/nova-studija-kaze-na-tveganje-za-prirojene-okvare-pri-dojenckih-rojenim-zenskam-ki-so-jemale-dolutegravir-v-casu-zanositve/2020-03-30T00:46:01+02:00https://www.jazmp.si/2018/05/31/vpliv-brexita-na-dovoljenja-za-promet-z-zdravili/2020-03-30T00:45:09+02:00https://www.jazmp.si/2018/06/06/obvestilo-za-zdravstvene-delavce-15/2020-03-30T00:44:45+02:00https://www.jazmp.si/2018/06/06/evrocanje-vabilo-k-pristopu/2020-03-30T00:44:30+02:00https://www.jazmp.si/2018/06/06/smernice-za-izdelavo-ocene-tveganja-za-magistralna-in-galenska-zdravila-83-clen-zakona-o-lekarniski-dejavnosti/2020-03-30T00:43:05+02:00https://www.jazmp.si/2018/06/07/javna-predstavitev-mnenj-na-evropski-agenciji-za-zdravila-ema-v-zvezi-z-obravnavo-varnosti-kinolonov-in-fluorokinolonov/2020-03-30T00:42:42+02:00https://www.jazmp.si/2018/06/11/evropska-agencija-za-zdravila-ema-zacenja-s-pregledom-zdravil-ki-vsebujejo-metamizol/2020-03-31T06:24:30+02:00https://www.jazmp.si/2018/06/11/evropska-agencija-za-zdravila-ema-omejuje-uporabo-zdravil-keytruda-in-tecentriq-pri-raku-na-mehurju/2020-03-31T06:24:22+02:00https://www.jazmp.si/2018/06/13/regulatorni-posvet-na-temo-uvedbe-zascitnih-elementov/2020-03-30T00:40:34+02:00https://www.jazmp.si/2018/06/13/javna-predstavitev-mnenj-na-evropski-agenciji-za-zdravila-ema-v-zvezi-z-obravnavo-varnosti-kinolonov-in-fluorokinolonov-2/2020-03-30T00:40:06+02:00https://www.jazmp.si/2018/06/13/smernice-za-izvajanje-54-clena-zakona-o-zdravilih/2020-03-30T00:39:45+02:00https://www.jazmp.si/2018/06/14/memorandum-o-sodelovanju-med-ministrstvoma-kraljevine-nizozemske-in-republike-slovenije/2020-03-30T00:39:30+02:00https://www.jazmp.si/2018/06/15/vabilo-na-regulatorni-posvet-na-temo-uvedbe-zascitnih-elementov/2020-03-30T00:39:14+02:00https://www.jazmp.si/2018/06/21/dopolnjeni-ukrepi-za-preprecevanje-izpostavljenosti-valproatu-med-nosecnostjo/2020-03-30T00:37:41+02:00https://www.jazmp.si/2018/06/26/obvestilo-za-zdravstvene-delavce-14/2020-03-30T00:37:12+02:00https://www.jazmp.si/2018/06/26/obvestilo-za-zdravstvene-delavce-13/2020-03-30T00:36:20+02:00https://www.jazmp.si/2018/07/09/evropska-agencija-za-zdravila-ema-obravnava-primer-prisotnosti-necistote-v-zdravilih-ki-vsebujejo-ucinkovino-valsartan-proizvedeno-v-podjetju-zhejiang-huahai/2020-03-30T00:35:47+02:00https://www.jazmp.si/2018/07/10/obvestilo-za-zdravstvene-delavce-12/2020-03-30T00:35:23+02:00https://www.jazmp.si/2018/07/10/obvestilo-za-zdravstvene-delavce-11/2020-03-30T00:34:54+02:00https://www.jazmp.si/2018/07/18/obvestilo-za-ponudnike-ikt-resitev/2020-03-30T00:10:45+02:00https://www.jazmp.si/2018/07/18/strokovno-posvetovanje-ob-predstavitvi-cetrte-izdaje-formulariuma-slovenicuma-fs-40/2020-03-30T00:09:26+02:00https://www.jazmp.si/2018/07/19/prac-priporocil-omejitev-uporabe-zdravila-za-zdravljenje-raka-prostate-xofigo/2020-03-30T00:09:10+02:00https://www.jazmp.si/2018/07/27/zacasni-odvzem-dovoljenja-za-promet-z-zdravili-za-uporabo-v-veterinarski-medicini-ki-vsebujejo-pomozno-snov-dietanolamin/2020-03-30T00:08:39+02:00https://www.jazmp.si/2018/08/01/obvestilo-za-zdravstvene-delavce-10/2020-03-30T00:07:59+02:00https://www.jazmp.si/2018/08/03/dodatni-ukrepi-za-okrepitev-obstojecih-omejitev-uporabe-hidroksiestilskroba-hes/2020-03-30T00:07:38+02:00https://www.jazmp.si/2018/08/03/obvestilo-za-zdravstvene-delavce-9/2020-03-30T00:07:08+02:00https://www.jazmp.si/2018/08/07/obvestilo-za-zdravstvene-delavce-8/2020-03-30T00:06:52+02:00https://www.jazmp.si/2018/08/08/obvestilo-za-zdravstvene-delavce-7/2020-03-30T00:06:35+02:00https://www.jazmp.si/2018/08/08/obvestilo-za-zdravstvene-delavce-6/2020-03-30T00:06:19+02:00https://www.jazmp.si/2018/08/10/nove-informacije-v-zvezi-z-odpoklicanimi-zdravili-ki-vsebujejo-valsartan-proizvajalca-zhejiang-huahai-pharmaceuticals/2020-03-30T00:05:34+02:00https://www.jazmp.si/2018/08/13/navodilo-o-kontaktnih-tockah-v-klinicnih-preskusanjih/2020-03-30T00:06:05+02:00https://www.jazmp.si/2018/08/14/povabilo-zainteresirane-javnosti-k-sodelovanju-v-razpravi/2020-03-30T00:04:21+02:00https://www.jazmp.si/2018/08/20/odpoklic-serij-durex-real-feel-in-durex-latex-free/2020-03-30T00:01:28+02:00https://www.jazmp.si/2018/08/23/izid-nove-cetrte-izdaje-formulariuma-slovenicuma-fs-40/2020-03-30T00:01:04+02:00https://www.jazmp.si/2018/08/30/javni-natecaj-za-direktorja-javne-agencije-republike-slovenije-za-zdravila-in-medicinske-pripomocke-2/2020-03-30T00:00:45+02:00https://www.jazmp.si/2018/09/04/navodila-proizvajalcem-medicinskih-pripomockov-ob-implementaciji-uredb-mdr-in-ivdr/2020-03-30T00:00:13+02:00https://www.jazmp.si/2018/09/07/obvestilo-za-zdravstvene-delavce-5/2020-03-29T23:59:22+02:00https://www.jazmp.si/2018/09/12/poziv-javnim-in-bolnisnicnim-lekarnam-k-implementaciji-uredbe-o-zascitnih-elementih/2020-03-29T23:59:00+02:00https://www.jazmp.si/2018/10/03/formularium-slovenicum-slovenski-dodatek-k-evropski-farmakopeji-2018/2020-03-29T23:58:36+02:00https://www.jazmp.si/2018/10/04/zaprosilo-za-posredovanje-nacrtovanih-sprememb-v-letu-2019-proizvodnja-in-promet-z-zdravili-in-ucinkovinami/2020-03-29T23:58:09+02:00https://www.jazmp.si/2018/10/04/zaprosilo-za-posredovanje-nacrtovanih-sprememb-v-letu-2019-dejavnost-preskrbe-s-krvjo/2020-03-29T23:57:18+02:00https://www.jazmp.si/2018/10/04/zaprosilo-za-posredovanje-nacrtovanih-sprememb-v-letu-2019-dejavnost-preskrbe-s-cloveskimi-tkivi-in-celicami-namenjenimi-za-zdravljenje/2020-03-29T23:56:47+02:00https://www.jazmp.si/2018/10/05/obvestilo-za-zdravstvene-delavce-4/2020-03-29T23:56:19+02:00https://www.jazmp.si/2018/10/09/obvestilo-za-zdravstvene-delavce-3/2020-03-29T23:55:35+02:00https://www.jazmp.si/2018/10/11/prac-priporocil-nove-omejitve-uporabe-kinolonov-in-fluorokinolonov/2020-03-29T23:55:16+02:00https://www.jazmp.si/2018/10/12/obvestilo-za-zdravstvene-delavce-2/2020-03-29T23:54:50+02:00https://www.jazmp.si/2018/10/16/reklamiranje-izdelka-hondrocream-na-spletnih-straneh-na-zavajajoc-nacin-ter-prodaja-izdelka/2020-03-29T23:54:31+02:00https://www.jazmp.si/2018/10/16/valsartan-razsiritev-pregleda-necistot-na-druge-sartane/2020-03-29T23:53:45+02:00https://www.jazmp.si/2018/10/17/dodatek-k-objavi-reklamiranje-izdelka-hondocream-na-spletnih-straneh-ter-zavajajoc-nacin-ter-prodaja-izdelka-z-dne-16102018/2020-03-29T23:51:56+02:00https://www.jazmp.si/2018/10/18/hidroklorotiazid-obvestilo-za-zdravstvene-delavce/2020-03-29T23:49:43+02:00https://www.jazmp.si/2018/10/19/evropska-komisija-opozarja-deleznike-glede-izvajanja-eu-zakonodaje-o-ponarejenih-zdravilih/2020-03-29T23:49:07+02:00https://www.jazmp.si/2018/10/22/reklamiranje-izdelka-biostenix-sensi-oil-na-spletnih-straneh-na-zavajajoc-nacin-ter-prodaja-izdelka/2020-03-29T23:48:14+02:00https://www.jazmp.si/2018/10/24/fluorokinoloni-obvestilo-za-zdravstvene-delavce/2020-03-29T23:47:42+02:00https://www.jazmp.si/2018/10/30/moznost-prenosa-vloge-referencne-drzave-clanice-rms-iz-zdruzenega-kraljestva-na-slovenijo-v-mrp-in-dcp-postopkih-kot-posledice-brexit-a/2020-03-29T23:47:20+02:00https://www.jazmp.si/2018/11/14/smernice-za-izdelavo-ocene-tveganja-za-magistralna-in-galenska-zdravila/2020-03-29T23:45:27+02:00https://www.jazmp.si/2018/11/19/porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-prispeva-k-njihovi-varnejsi-uporabi/2020-03-29T23:44:55+02:00https://www.jazmp.si/2018/11/20/obvestilo-proizvajalcem-ucinkovin-veletrgovcem-z-ucinkovinami-ter-uvoznikom-ucinkovin-glede-letnih-porocil-za-leto-2018/2024-04-04T14:21:08+02:00https://www.jazmp.si/2018/11/22/prosnja-za-prevzem-vloge-referencne-drzave-clanice-rms-v-postopkih-za-pridobitev-dovoljenja-za-promet-z-zdravilom-po-mrp-ali-dcp/2020-03-29T23:39:37+02:00https://www.jazmp.si/2018/11/26/jazmp-v-zvezi-z-objavami-icij-o-varnosti-medicinskih-pripomockov-podaja-izjavo-za-javnost/2020-03-29T23:38:49+02:00https://www.jazmp.si/2018/11/29/odbor-za-zdravila-za-uporabo-v-humani-medicini-chmp-potrdil-priporocilo-prac-o-omejitvi-uporabe-kinolonov-in-fluorokinolonov/2020-03-29T23:38:27+02:00https://www.jazmp.si/2018/12/11/valproat-obvestilo-za-zdravstvene-delavce/2020-03-29T23:38:08+02:00https://www.jazmp.si/2018/12/19/poslovanje-jazmp-24-in-31-decembra-2018/2020-03-29T23:37:52+02:00https://www.jazmp.si/2018/12/21/xyrem-natrijev-oksibat-obvestilo-za-zdravstvene-delavce/2020-03-29T23:37:37+02:00https://www.jazmp.si/2018/12/28/porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2017/2020-03-29T23:37:25+02:00https://www.jazmp.si/2019/01/08/evropska-agencija-za-zdravila-ema-je-zacela-pregled-zdravil-ki-vsebujejo-fosfomicin/2020-03-29T23:36:33+02:00https://www.jazmp.si/2019/01/08/ema-priporoca-uskladitev-odmerjanja-zdravil-ki-vsebujejo-metamizol-in-njihovega-jemanja-med-nosecnostjo-in-dojenjem/2020-03-29T23:36:12+02:00https://www.jazmp.si/2019/01/08/zdravila-z-omega-3-mascobnimi-kislinami-ne-veljajo-vec-za-ucinkovite-kot-preventiva-pred-boleznimi-srca-in-ozilja/2020-03-29T23:35:59+02:00https://www.jazmp.si/2019/01/11/informacije-za-proizvajalce-medicinskih-pripomockov-na-spletni-strani-evropske-komisije/2020-03-29T23:35:18+02:00https://www.jazmp.si/2019/01/17/karbimazol-tiamazol-obvestilo-za-zdravstvene-delavce/2020-03-29T23:34:59+02:00https://www.jazmp.si/2019/01/22/zaviralci-sglt2-obvestilo-za-zdravstvene-delavce/2020-03-29T23:34:41+02:00https://www.jazmp.si/2019/01/23/zdravilo-lartruvo-neucinkovito-pri-zdravljenju-raka-mehkih-tkiv/2020-03-29T23:34:25+02:00https://www.jazmp.si/2019/01/23/poziv-imetnikom-dovoljenj-za-promet-z-zdravili-za-posredovanje-kod-zdravil-uporabljenih-v-edinstveni-oznaki/2020-03-29T23:32:59+02:00https://www.jazmp.si/2019/01/29/lartruvo%e2%96%bc-olaratumab-obvestilo-za-zdravstvene-delavce-2/2020-03-29T23:31:16+02:00https://www.jazmp.si/2019/02/05/poziv-javnim-in-bolnisnicnim-lekarnam-k-pripravam-na-obvezno-preverjanje-zascitnih-elementov-na-zdravilih/2020-03-29T23:31:03+02:00https://www.jazmp.si/2019/02/07/objava-podatkov-o-zascitnih-elementih-v-cbz/2020-03-31T06:25:41+02:00https://www.jazmp.si/2019/02/08/stabilizacijsko-obdobje-navodila-koncnim-uporabnikom-za-izdajo-zdravil-med-9-februarjem-in-9-majem-2019/2020-03-29T23:28:10+02:00https://www.jazmp.si/2019/02/11/skupna-izjava-jazmp-mz-lzs-in-zapaz-o-zacetku-izvajanja-delegirane-uredbe-o-zascitnih-elementih/2020-03-29T23:27:41+02:00https://www.jazmp.si/2019/02/13/ema-porocilo-z-delavnice-na-temo-dostopnosti-zdravil/2020-03-29T23:26:59+02:00https://www.jazmp.si/2019/02/18/najpogostejsa-vprasanja-in-odgovori-na-podrocju-klinicnih-preskusanj-zdravil/2020-03-31T16:01:05+02:00https://www.jazmp.si/2019/02/18/reklamiranje-izdelka-krema-za-zdravljenje-hemoroidov-hemorrhostop-na-spletnih-straneh-na-zavajajoc-nacin-ter-prodaja-izdelka/2020-03-29T23:26:09+02:00https://www.jazmp.si/2019/02/22/obvestilo-v-zvezi-z-morebitnim-izstopom-uk-iz-eu-brez-sporazuma-in-medicinskimi-pripomocki-na-trgu-eu/2020-03-29T23:25:44+02:00https://www.jazmp.si/2019/02/28/ozurdex-700-mikrogramov-intravitrealni-vsadek-v-aplikatorju-deksametazon-obvestilo-za-zdravstvene-delavce/2020-03-29T23:25:10+02:00https://www.jazmp.si/2019/03/04/raztopine-za-infundiranje-ki-vsebujejo-hidroksietilskrob-hes-obvestilo-za-zdravstvene-delavce/2020-03-29T23:24:53+02:00https://www.jazmp.si/2019/03/05/kaj-morate-vedeti-informativni-pregledi-o-spremembi-zakonodaje-na-podrocju-medicinskih-pripomockov/2020-03-29T23:23:27+02:00https://www.jazmp.si/2019/03/05/skupne-specifikacije-za-pripomocke-brez-predvidenega-medicinskega-namena-neformalno-javno-posvetovanje/2020-03-29T23:23:03+02:00https://www.jazmp.si/2019/03/08/slovenija-podpisala-medicrime-konvencijo/2020-03-29T23:21:23+02:00https://www.jazmp.si/2019/03/22/odpoklic-in-priporocila-za-obravnavo-bolnikov-s-srcnimi-spodbujevalniki-proizvajalca-medtronic/2025-02-07T11:32:58+01:00https://www.jazmp.si/2019/03/22/informativni-video-o-zascitnih-elementih/2020-03-29T23:19:58+02:00https://www.jazmp.si/2019/03/26/povecano-tveganje-za-pljucno-embolijo-in-smrt-pri-bolnikih-z-revmatoidnim-artritisom-zdravljenih-z-visjimi-odmerki-zdravila-xeljanz-tofacitinib/2020-03-29T23:19:38+02:00https://www.jazmp.si/2019/03/26/ema-pricela-s-pregledom-obstojecih-presejalnih-metod-pred-uvedbo-zdravljenja-s-fluorouracilom-kapecitabinom-tegafurjem-in-flukitozinom/2020-03-29T23:18:26+02:00https://www.jazmp.si/2019/03/27/elvitegravirkobicistat-obvestilo-za-zdravstvene-delavce/2020-03-29T23:18:02+02:00https://www.jazmp.si/2019/03/27/zakljucena-ocena-podatkov-v-zvezi-z-moznim-vplivom-biotina-na-izide-dolocenih-laboratorijskih-testov/2020-03-29T23:14:38+02:00https://www.jazmp.si/2019/03/28/tofacitinib-xeljanz%e2%96%bc-obvestilo-za-zdravstvene-delavce-2/2020-03-29T23:14:15+02:00https://www.jazmp.si/2019/03/28/belimumab-benlysta%e2%96%bc-obvestilo-za-zdravstvene-delavce/2020-03-29T23:13:56+02:00https://www.jazmp.si/2019/04/01/javno-posvetovanje-o-smernicah-za-ftalate-v-medicinskih-pripomockih/2020-03-29T23:13:34+02:00https://www.jazmp.si/2019/04/03/objava-seznama-nujno-potrebnih-zdravil-za-uporabo-v-humani-medicini/2020-03-29T23:13:11+02:00https://www.jazmp.si/2019/04/05/zdravila-z-omega-3-mascobnimi-kislinami-niso-ucinkovita-pri-preprecevanju-nadaljnjih-tezav-s-srcem-po-prebolelem-srcnem-infarktu/2020-03-31T06:26:22+02:00https://www.jazmp.si/2019/04/09/kinoloni-in-fluorokinoloni-obvestilo-za-zdravstvene-delavce/2020-03-29T23:11:56+02:00https://www.jazmp.si/2019/04/10/jazmp-objavlja-seznam-esencialnih-zdravil-za-uporabo-v-veterinarski-medicini/2020-03-31T06:18:50+02:00https://www.jazmp.si/2019/04/16/domperidon-tametil-%e2%96%bc-obvestilo-za-zdravstvene-delavce/2020-03-29T23:10:16+02:00https://www.jazmp.si/2019/04/16/retinoidi-obvestilo-za-zdravstvene-delavce/2020-03-29T23:09:56+02:00https://www.jazmp.si/2019/04/16/zascitni-elementi-posodobljen-dokument-vprasanj-in-odgovorov/2020-03-31T06:25:31+02:00https://www.jazmp.si/2019/04/25/alemtuzumab-lemtrada-obvestilo-za-zdravstvene-delavce/2020-03-29T23:08:01+02:00https://www.jazmp.si/2019/04/26/sprejet-nov-pravilnik-o-pristojbinah-na-podrocju-medicinskih-pripomockov/2020-03-29T23:06:32+02:00https://www.jazmp.si/2019/04/30/omejitev-uporabe-zdravila-lemtrada-pri-novih-bolnikih-medtem-ko-poteka-ocena-koristi-in-tveganj-zdravila/2020-03-29T23:03:46+02:00https://www.jazmp.si/2019/05/06/ema-priporocila-odvzem-dovoljenja-za-promet-z-zdravilom-za-zdravljenje-raka-lartruvo/2020-03-29T23:02:47+02:00https://www.jazmp.si/2019/05/07/lartruvo%e2%96%bc-olaratumab-obvestilo-za-zdravstvene-delavce/2020-03-29T23:01:55+02:00https://www.jazmp.si/2019/05/09/popravki-uredb-eu-2017745-in-eu-2017746-evropskega-parlamenta-in-sveta-z-dne-5-aprila-2017/2020-03-29T23:01:17+02:00https://www.jazmp.si/2019/05/09/obvestilo-o-podaljsanju-stabilizacijskega-obdobja/2020-03-29T23:00:51+02:00https://www.jazmp.si/2019/05/13/modafinil-altasomil-obvestilo-za-zdravstvene-delavce/2020-03-29T23:00:42+02:00https://www.jazmp.si/2019/05/15/tyverb-lapatinib-obvestilo-za-zdravstvene-delavce/2020-03-29T23:00:12+02:00https://www.jazmp.si/2019/05/20/ponovni-pregled-tveganj-pri-uporabi-vaginalnih-krem-z-visoko-vsebnostjo-estradiola/2020-03-29T22:59:55+02:00https://www.jazmp.si/2019/05/20/omejitev-uporabe-zdravila-xeljanz-tofacitinib-medtem-ko-poteka-ocena-tveganja-za-nastanek-krvnih-strdkov-v-pljucih/2020-03-29T22:59:12+02:00https://www.jazmp.si/2019/05/22/apiksaban-dabigatran-eteksilat-edoksaban-in-rivaroksaban-obvestilo-za-zdravstvene-delavce/2020-03-29T22:58:34+02:00https://www.jazmp.si/2019/05/22/jazmp-objavlja-varnostna-obvestila-za-medicinske-pripomocke/2020-03-29T22:58:11+02:00https://www.jazmp.si/2019/05/29/tofacitinib-xeljanz%e2%96%bc-obvestilo-za-zdravstvene-delavce/2020-03-29T22:57:49+02:00https://www.jazmp.si/2019/05/30/navodilo-za-predlozitev-neposrednega-obvestila-za-zdravstvene-delavce-v-pregled-jazmp/2020-03-29T22:57:31+02:00https://www.jazmp.si/2019/06/05/obvestilo-o-ponarejenem-medicinskem-pripomocku/2020-03-29T22:56:39+02:00https://www.jazmp.si/2019/06/17/varnostna-obvestila-za-medicinske-pripomocke-maj-2019/2020-03-29T22:56:03+02:00https://www.jazmp.si/2019/06/19/obvezna-oddaja-vlog-v-formatu-ectd-in-vnees-tudi-za-vloge-po-np/2020-03-31T06:18:25+02:00https://www.jazmp.si/2019/06/21/pregled-napak-pri-pripravi-in-aplikaciji-zdravil-ki-vsebujejo-levprorelin-v-depo-farmacevtskih-oblikah/2020-03-29T22:53:43+02:00https://www.jazmp.si/2019/06/24/daratumumab-darzalex%e2%96%bc-obvestilo-za-zdravstvene-delavce/2020-03-29T22:53:21+02:00https://www.jazmp.si/2019/06/26/informativni-pregledi-o-spremembi-zakonodaje-na-podrocju-medicinskih-pripomockov/2020-03-29T22:53:02+02:00https://www.jazmp.si/2019/06/26/v-drugi-polovici-2019-bo-evropska-komisija-objavila-klic-za-klinicne-in-druge-strokovnjake-s-podrocja-medicinskih-pripomockov/2020-03-29T22:52:43+02:00https://www.jazmp.si/2019/06/27/febuksostat-obvestilo-za-zdravstvene-delavce/2020-03-29T22:52:19+02:00https://www.jazmp.si/2019/06/28/tocilizumab-roactemra-obvestilo-za-zdravstvene-delavce/2020-03-29T22:00:55+02:00https://www.jazmp.si/2019/06/28/izsla-je-druga-dopolnjena-in-pregledana-izdaja-farmacevtskega-terminoloskega-slovarja/2020-03-29T22:00:35+02:00https://www.jazmp.si/2019/07/01/oglasevanje-in-prodaja-izdelka-inteligentni-ojacevalec-sluha-audisin-maxi-ear-sound-na-zavajajoc-nacin/2020-03-29T21:59:47+02:00https://www.jazmp.si/2019/07/03/poziv-vsem-sponzorjem-klinicnih-preskusanj-da-objavljajo-rezultate-preskusanj-v-zbirki-podatkov-eudract/2020-03-29T21:59:06+02:00https://www.jazmp.si/2019/07/05/zdravila-za-respiratorne-bolezni-ki-vsebujejo-lizat-bakterij/2020-03-29T21:58:01+02:00https://www.jazmp.si/2019/07/08/varnostna-obvestila-za-medicinske-pripomocke-junij-2019/2020-03-29T21:57:22+02:00https://www.jazmp.si/2019/07/09/obvestilo-o-podaljasanju-stabilizacijskega-obdobja/2020-03-29T21:55:42+02:00https://www.jazmp.si/2019/07/15/pregled-tveganja-za-meningiome-pri-zdravljenju-s-ciproteronom/2020-03-29T21:55:07+02:00https://www.jazmp.si/2019/07/15/oglasevanje-zdravil-v-sirsi-javnosti/2020-03-29T21:53:44+02:00https://www.jazmp.si/2019/07/16/novi-ukrepi-za-preprecevanje-napak-pri-odmerjanju-metotreksata/2020-03-29T21:44:36+02:00https://www.jazmp.si/2019/07/24/porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2018/2020-03-29T21:43:44+02:00https://www.jazmp.si/2019/07/30/zdravilo-gilenya-fingolimod-kontraindicirano-med-nosecnostjo-in-pri-zenskah-v-rodni-dobi-ki-ne-uporabljajo-zanesljive-metode-kontracepcije/2020-03-29T21:43:05+02:00https://www.jazmp.si/2019/08/06/oglasevanje-ter-prodaja-izdelka-auresoil-sensi-secure-na-spletnih-straneh-na-zavajajoc-nacin/2020-03-29T21:42:14+02:00https://www.jazmp.si/2019/08/20/olaparib-lynparza%e2%96%bc-obvestilo-za-zdravstvene-delavce/2020-03-29T21:42:08+02:00https://www.jazmp.si/2019/08/19/izid-prvega-dopolnila-k-cetrti-izdaji-formulariuma-slovenicuma-fs-41/2020-03-29T21:39:19+02:00https://www.jazmp.si/2019/08/27/varnostna-obvestila-za-medicinske-pripomocke-julij-2019/2020-03-29T21:36:50+02:00https://www.jazmp.si/2019/08/29/nova-uredba-s-podrocja-medicinskih-pripomockov-pogosta-vprasanja-in-odgovori-v-zvezi-z-udi/2020-03-29T21:36:01+02:00https://www.jazmp.si/2019/09/03/zdravila-za-parenteralno-prehrano-obvestilo-za-zdravstvene-delavce/2020-03-29T21:35:45+02:00https://www.jazmp.si/2019/09/03/fingolimod-gilenya%e2%96%bc-obvestilo-za-zdravstvene-delavce/2020-03-29T21:35:25+02:00https://www.jazmp.si/2019/09/04/blincyto%e2%96%bc-blinatumomab-obvestilo-za-zdravstvene-delavce/2020-03-29T21:35:08+02:00https://www.jazmp.si/2019/09/12/pregled-podatkov-za-oceno-tveganja-za-razvoj-koznega-raka-pri-bolnikih-zdravljenih-z-zdravilom-picato-ingenolmebutat/2020-03-29T21:34:50+02:00https://www.jazmp.si/2019/09/17/podrobnejsa-priporocila-v-zvezi-z-novimi-ukrepi-za-preprecevanje-napak-pri-odmerjanju-metotreksata/2020-03-29T21:34:25+02:00https://www.jazmp.si/2019/09/18/objava-seznama-nujno-potrebnih-zdravil-za-uporabo-v-humani-medicini-2/2020-03-29T21:31:45+02:00https://www.jazmp.si/2019/09/19/obvestilo-o-novi-formulaciji-zdravila-euthyrox/2020-03-31T06:23:55+02:00https://www.jazmp.si/2019/09/19/evropska-agencija-za-zdravila-ema-pregleduje-zdravila-z-ranitidinom-zaradi-zaznave-necistote-ndma/2020-03-31T06:23:46+02:00https://www.jazmp.si/2019/09/20/euthyrox-levotiroksin-tablete-z-novo-formulacijo-obvestilo-za-zdravstvene-delavce/2020-03-29T21:29:31+02:00https://www.jazmp.si/2019/09/23/varnostna-obvestila-za-medicinske-pripomocke-avgust-2019/2020-03-29T21:29:07+02:00https://www.jazmp.si/2019/09/23/izdaja-certifikatov-o-dobri-distribucijski-praksi/2020-03-29T21:28:26+02:00https://www.jazmp.si/2019/09/24/ingenolmebutat-picato%e2%96%bc-obvestilo-za-zdravstvene-delavce/2020-03-29T21:28:00+02:00https://www.jazmp.si/2019/09/26/obvestilo-o-delnem-podaljsanju-stabilizacijskega-obdobja/2020-03-29T21:26:45+02:00https://www.jazmp.si/2019/09/27/ema-svetuje-podjetjem-glede-ukrepov-za-preprecevanje-prisotnosti-necistot-iz-skupine-nitrozaminov-v-zdravilih-za-uporabo-v-humani-medicini/2020-03-29T21:26:06+02:00https://www.jazmp.si/2019/10/02/ondansetron-obvestilo-za-zdravstvene-delavce/2020-03-29T21:25:41+02:00https://www.jazmp.si/2019/10/03/metotreksat-obvestilo-za-zdravstvene-delavce/2020-03-29T21:24:11+02:00https://www.jazmp.si/2019/10/08/razpis-evropski-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke/2020-03-29T21:22:43+02:00https://www.jazmp.si/2019/10/10/postopki-za-obvladovanje-odzivov-in-alarmov/2020-03-29T21:22:11+02:00https://www.jazmp.si/2019/10/15/oglasevanje-ter-prodaja-izdelka-prolesan-pure-na-spletnih-straneh-na-zavajajoc-nacin/2020-03-29T21:21:25+02:00https://www.jazmp.si/2019/10/16/varnostna-obvestila-za-medicinske-pripomocke-september-2019/2020-03-29T21:20:37+02:00https://www.jazmp.si/2019/10/17/zakonodaja-o-zdravilih-in-dostopnost-zdravil-za-redke-bolezni/2020-03-29T21:19:54+02:00https://www.jazmp.si/2019/10/21/uporaba-vaginalnih-krem-z-visoko-vsebnostjo-estradiola-omejena-na-enkratno-zdravljenje-do-najvec-4-tedne/2020-03-29T21:19:15+02:00https://www.jazmp.si/2019/10/29/kaj-moram-vedeti-o-podobnih-bioloskih-zdravilih/2020-03-29T21:18:39+02:00https://www.jazmp.si/2019/11/08/obvestilo-proizvajalcem-ucinkovin-vpisanih-v-register-proizvajalcev-ucinkovin-veletrgovcem-z-ucinkovinami-vpisanih-v-register-veletrgovcev-z-ucinkovinami-ter-uvoznikom-ucinkovin-vpisanih-v-register-uv/2024-04-04T14:23:00+02:00https://www.jazmp.si/2019/11/08/oglasevanje-ter-prodaja-izdelka-oblizi-za-hujsanje-mibiomi-patches-na-zavajajoc-nacin/2020-03-29T21:16:57+02:00https://www.jazmp.si/2019/11/11/9112019-je-zacela-veljati-uredba-o-izvajanju-delegirane-uredbe-eu-o-zascitnih-elementih/2020-03-29T21:16:11+02:00https://www.jazmp.si/2019/11/21/s-1-12-2019-se-v-sloveniji-zakljucuje-stabilizacijsko-obdobje-pri-izvajanju-delegirane-uredbe-za-zascitne-elemente/2020-03-29T21:14:54+02:00https://www.jazmp.si/2019/11/25/mednarodni-teden-ozavescanja-o-pomenu-porocanja-o-nezelenih-ucinkih-zdravil-medsafetyweek-letos-na-temo-porocanja-pri-bolnikih-ki-socasno-jemljejo-vec-zdravil/2020-03-29T21:13:24+02:00https://www.jazmp.si/2019/11/27/varnostna-obvestila-za-medicinske-pripomocke-oktober-2019/2020-03-29T21:12:27+02:00https://www.jazmp.si/2019/12/03/ponoven-poziv-imetnikom-dzp-za-posredovanje-kod-zdravil-uporabljenih-v-edinstvenih-oznakah/2020-03-29T21:05:57+02:00https://www.jazmp.si/2019/12/04/onivyde-liposomski-irinotekan-obvestilo-za-zdravstvene-delavce/2020-03-29T20:54:19+02:00https://www.jazmp.si/2019/12/04/ukrepi-za-zmanjsevanje-tveganj-pri-uporabi-zdravila-za-zdravljenje-multiple-skleroze-lemtrada-alemtuzumab/2020-03-29T20:53:31+02:00https://www.jazmp.si/2019/12/09/previdnost-pri-uporabi-zdravila-xeljanz-tofacitinib-pri-bolnikih-z-velikim-tveganjem-za-nastanek-krvnih-strdkov/2020-03-29T20:52:40+02:00https://www.jazmp.si/2019/12/09/obvestilo-o-zaznavi-nitrozaminske-necistote-v-zdravilih-ki-vsebujejo-metformin/2020-03-29T20:51:35+02:00https://www.jazmp.si/2019/12/10/obvestilo-o-javni-obravnavi-osnutka-spremembe-tarife-jazmp/2020-03-29T20:50:42+02:00https://www.jazmp.si/2019/12/16/obvestilo-o-skrajsanem-delovnem-casu-pred-praznikoma/2020-03-29T20:47:58+02:00https://www.jazmp.si/2019/12/24/nov-obrazec-za-porocanje-o-zapletu-z-medicinskimi-pripomocki/2020-03-29T20:46:20+02:00https://www.jazmp.si/2020/01/08/poziv-imetnikom-dovoljenj-za-promet-z-zdravilom-in-proizvajalcem-zdravil/2020-03-19T01:28:18+01:00https://www.jazmp.si/2020/01/31/ecalta-100-mg-prasek-za-koncentrat-za-raztopino-za-infundiranje-anidulafungin-obvestilo-za-zdravstvene-delavce/2020-03-23T12:11:30+01:00https://www.jazmp.si/2020/01/28/ingenolmebutat-picato%e2%96%bc-obvestilo-za-zdravstvene-delavce-2/2020-03-23T12:12:40+01:00https://www.jazmp.si/2020/01/27/alemtuzumab-lemtrada%e2%96%bc-obvestilo-za-zdravstvene-delavce/2020-03-23T12:13:46+01:00https://www.jazmp.si/2020/01/21/podpis-protokola-z-agencijo-za-zdravila-in-medicinske-pripomocke-crne-gore-calims/2020-03-23T12:15:57+01:00https://www.jazmp.si/2020/01/20/ema-priporocila-zacasni-odvzem-dovoljenja-za-promet-z-zdravilom-picato-ingenolmebutat-iz-previdnostnih-razlogov-zaradi-tveganja-za-razvoj-koznega-raka/2020-03-23T12:17:27+01:00https://www.jazmp.si/2020/01/16/objava-seznama-nujno-potrebnih-zdravil-v-humani-medicini/2020-03-23T12:18:34+01:00https://www.jazmp.si/2020/01/15/varnostna-obvestila-za-medicinske-pripomocke-november-2019/2020-03-29T21:03:08+02:00https://www.jazmp.si/2020/02/27/obvestilo-o-moznem-vplivu-izbruha-koronavirusa-covid-19-na-oskrbo-trga-z-zdravili-v-republiki-sloveniji-ter-aktivnostih-ki-potekajo-na-eu-ravni/2020-03-31T06:22:06+02:00https://www.jazmp.si/2020/02/27/obvestilo-o-spremembi-poimenovanja-zdravil-ki-vsebujejo-ucinkovino-v-liposomski-obliki-z-namenom-zmanjsanja-medicinskih-napak/2020-03-29T20:24:57+02:00https://www.jazmp.si/2020/02/21/jazmp-je-so-organizirala-strokovno-delavnico-benefit-risk-workshop-for-clinical-assessors/2020-03-23T12:32:02+01:00https://www.jazmp.si/2020/02/10/tofacitinib-xeljanz%e2%96%bc-obvestilo-za-zdravstvene-delavce-3/2020-03-23T12:33:47+01:00https://www.jazmp.si/2020/02/05/varnostna-obvestila-za-medicinske-pripomocke-december-2019/2020-03-31T15:55:30+02:00https://www.jazmp.si/2020/03/20/opozorilo-glede-kupovanja-izdelkov-za-preprecevanje-in-zdravljenje-bolezni-covid-19-na-spletu/2020-03-23T12:46:15+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2020-04-10T12:51:39+02:00https://www.jazmp.si/2020/03/19/covid-19-poziv-k-zdruzevanju-raziskovalnih-virov-za-izvajanje-obseznih-multicentricnih-klinicnih-preskusanj-z-vec-kraki-z-namenom-pridobiti-zanesljive-dokaze-o-zdravljenju-okuzb-z-virusom/2020-03-23T12:46:57+01:00https://www.jazmp.si/2020/03/19/ulipristalacetat-5-mg-esmya-obvestilo-za-zdravstvene-delavce/2020-03-23T12:47:13+01:00https://www.jazmp.si/2020/03/18/uporaba-nesteroidnih-protivnetnih-zdravil-nsaid-in-zaviralcev-angiotenzinske-konvertaze-zaviralcev-ace-ter-antagonistov-angiotenzina-ii-sartanov-pri-okuzbi-z-novim-koronavirusom-covid-19/2020-03-23T12:47:35+01:00https://www.jazmp.si/2020/03/13/koronavirus-covid-19-obvestilo-glede-poslovanja-jazmp/2021-03-04T10:33:08+01:00https://www.jazmp.si/2020/03/12/zacetek-arbitraznega-postopka-v-zvezi-z-izvajanjem-klinicnih-studij-pri-panexcell-clinical-laboratories-priv-ltd-v-indiji/2020-03-23T12:48:26+01:00https://www.jazmp.si/2020/03/11/zadeva-poziv-imetnikom-dovoljenj-za-promet-z-zdravili-za-porocanje-o-podpornih-programih-za-paciente-in-programih-raziskav-trga-v-sloveniji/2023-06-07T15:00:14+02:00https://www.jazmp.si/2020/03/10/omejitev-uporabe-ciproterona-zaradi-tveganja-za-meningiome/2020-03-23T12:49:07+01:00https://www.jazmp.si/2020/03/02/oglasevanje-zdravil-v-sirsi-javnosti-2/2020-03-23T12:49:42+01:00https://www.jazmp.si/2020/03/24/covid-19-evropska-agencija-za-zdravila-ema-je-objavila-poziv-sirsi-javnosti/2020-03-26T06:38:10+01:00https://www.jazmp.si/2020/03/24/covid-19-obvestilo-sponzorjem-klinicnih-preskusanj-in-njihovim-partnerjem/2020-03-26T06:39:35+01:00https://www.jazmp.si/2020/03/25/covid-19-obvestilo-veletrgovcem-in-paralelnim-distributerjem/2020-03-26T06:53:08+01:00https://www.jazmp.si/2020/03/25/covid-19-zahteve-glede-podatkov-potrebnih-v-klinicnih-preskusanjih-faze-i-za-cepiva-proti-virusu-opredeljene-s-strani-svetovnih-regulatornih-organov/2020-03-26T06:52:01+01:00https://www.jazmp.si/2020/04/07/covid-19-regulatorna-obravnava-zascitnih-mask/2022-10-12T10:05:43+02:00https://www.jazmp.si/2020/03/25/pregled-nekaterih-zdravil-ki-vsebujejo-ifosfamid/2020-03-26T06:59:03+01:00https://www.jazmp.si/2020/03/26/nova-priporocila-glede-testiranja-in-zdravljenja-s-fluorouracilom-kapecitabinom-tegafurjem-in-flukitozinom/2020-03-26T06:57:37+01:00https://www.jazmp.si/2020/03/30/ema-med-pandemijo-covid-19-svetuje-nadaljevanje-uporabe-zaviralcev-angiotenzinske-konvertaze-zaviralcev-ace-ter-antagonistov-angiotenzina-ii-sartanov-za-zdravljenje-povisanega-krvnega-tlaka-bolez/2020-03-31T16:32:09+02:00https://www.jazmp.si/2020/03/30/obvestilo-imetnikom-dovoljenj-za-promet-z-zdravili-glede-nitrozaminskih-necistot/2020-03-31T16:33:27+02:00https://www.jazmp.si/2020/03/31/obvestilo-o-ponarejenem-medicinskem-pripomocku-2/2020-04-03T17:16:36+02:00https://www.jazmp.si/2020/04/02/covid-19-klorokin-in-hidroksiklorokin-se-lahko-uporabljata-le-v-okviru-klinicnih-preskusanj-ali-nujnih-nacionalnih-protokolov/2020-04-02T07:46:27+02:00https://www.jazmp.si/2020/04/03/ema-priporocila-v-zvezi-s-socutno-uporabo-zdravila-remdesivir-pri-covid-19/2020-04-03T22:21:56+02:00https://www.jazmp.si/2020/04/03/covid-19-zdravila-in-magistralna-priprava-zdravil-za-otroke-ki-bi-bila-lahko-uporabna-pri-zdravljenju-covid-19/2020-04-03T22:09:23+02:00https://www.jazmp.si/2020/04/06/posodobljene-informacije-glede-zdravil-za-in-cepiv-proti-covid-19-v-razvoju/2020-04-06T15:18:05+02:00https://www.jazmp.si/2020/04/07/priporocila-za-omejitev-uporabe-antibiotika-fosfomicin/2020-04-07T16:10:05+02:00https://www.jazmp.si/2020/04/07/evropska-studija-pod-okriljem-ema-je-pokazala-da-pri-uporabi-peroralnih-antikoagulantov-niso-potrebne-spremembe/2020-04-07T16:11:24+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2020-04-10T12:50:19+02:00https://www.jazmp.si/2020/04/10/ukrepi-jazmp-in-drugih-pristojnih-organov-eu-v-povezavi-z-razpolozljivostjo-in-preskrbo-zdravil-zaradi-covid-19/2020-04-10T12:12:23+02:00https://www.jazmp.si/2020/04/21/odvzem-dovoljenja-za-promet-z-zdravilom-picato-ingenolmebutat/2020-04-22T12:26:01+02:00https://www.jazmp.si/2020/04/22/smernice-evropske-komisije-za-imetnike-dovoljenj-za-promet-z-zdravili-proizvajalce-zdravil-in-ucinkovin-ter-veletrgovce-z-zdravili-in-ucinkovinami-v-zvezi-z-regulativnimi-pricakovanji-in-proznostjo-v/2020-04-22T19:41:42+02:00https://www.jazmp.si/2020/04/24/kisik-98-odstotni-evropska-farmakopeja-zeli-povratne-informacije-glede-predloga-besedila-za-novo-monografijo/2020-04-24T14:08:26+02:00https://www.jazmp.si/2020/04/24/covid-19-opozorilo-glede-moznih-resnih-nezelenih-ucinkov-klorokina-in-hidroksiklorokina/2020-04-24T14:27:36+02:00https://www.jazmp.si/2020/04/24/porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-pri-bolnikih-s-covid-19/2020-04-24T14:27:49+02:00https://www.jazmp.si/2020/05/04/ema-zacenja-s-sprotnim-pregledovanjem-podatkov-za-uporabo-zdravila-remdesivir-pri-bolezni-covid-19/2020-05-04T15:10:27+02:00https://www.jazmp.si/2020/05/07/smernice-jazmp-v-povezavi-z-regulativnimi-pricakovanji-v-casu-pandemije-covid-19/2020-05-07T17:51:48+02:00https://www.jazmp.si/2020/05/07/smernice-evropske-komisije-za-imetnike-dovoljenj-za-promet-z-zdravili-proizvajalce-zdravil-in-ucinkovin-ter-veletrgovce-z-zdravili-in-ucinkovinami-v-zvezi-z-regulativnimi-pricakovanji-in-proznostjo-2/2020-05-07T17:54:17+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2020-05-12T16:17:19+02:00https://www.jazmp.si/2020/05/13/ema-priporocila-za-razsiritev-programa-socutne-uporabe-zdravila-remdesivir-tudi-za-bolnike-ki-niso-na-mehanski-ventilaciji/2020-05-18T10:58:01+02:00https://www.jazmp.si/2020/05/13/objava-nove-razlicice-smernic-guidance-on-the-management-of-clinical-trials-during-the-covid-19-coronavirus-pandemic-razlicica-3-0/2020-05-13T19:20:27+02:00https://www.jazmp.si/2020/05/13/brivudin-premovir-obvestilo-za-zdravstvene-delavce/2020-05-13T19:34:41+02:00https://www.jazmp.si/2020/05/13/varnostna-obvestila-za-medicinske-pripomocke-marec-2020/2020-05-18T11:00:40+02:00https://www.jazmp.si/2020/05/19/eritromicin-obvestilo-za-zdravstvene-delavce/2020-05-19T13:09:27+02:00https://www.jazmp.si/2020/05/29/covid-19-opomnik-v-zvezi-s-tveganji-pri-uporabi-klorokina-in-hidroksiklorokina/2020-05-29T17:59:23+02:00https://www.jazmp.si/2020/06/01/ciproteronacetat-obvestilo-za-zdravstvene-delavce/2020-06-01T09:35:37+02:00https://www.jazmp.si/2020/06/03/obvezna-oddaja-vlog-v-obliki-ectd-tudi-za-zdravila-ki-so-pridobila-dzp-po-nacionalnem-postopku/2020-10-16T06:45:44+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2020-06-03T15:51:13+02:00https://www.jazmp.si/2020/06/05/zdravila-ki-vsebujejo-5-fluorouracil-i-v-kapecitabin-in-tegafur-obvestilo-za-zdravstvene-delavce/2020-06-05T09:14:39+02:00https://www.jazmp.si/2020/06/05/varnostna-obvestila-za-medicinske-pripomocke-april-2020/2020-06-05T09:50:45+02:00https://www.jazmp.si/2020/06/08/brezplacno-dostopna-besedila-evropske-farmakopeje-s-podrocja-cepiv/2020-06-08T09:09:21+02:00https://www.jazmp.si/2020/06/09/ema-je-prejela-vlogo-za-pridobitev-pogojnega-dovoljenja-za-promet-s-prvim-zdravilom-v-eu-proti-bolezni-covid-19/2020-06-09T10:08:04+02:00https://www.jazmp.si/2020/06/10/nova-priporocila-za-preprecevanje-napak-pri-uporabi-zdravil-ki-vsebujejo-levprorelin-v-depo-farmacevtskih-oblikah/2020-06-10T08:47:52+02:00https://www.jazmp.si/2020/06/10/svetovni-dan-boja-proti-ponaredkom/2020-06-10T08:54:02+02:00https://www.jazmp.si/2020/06/12/najnovejsi-podatki-podpirajo-nadaljnjo-uporabo-zaviralcev-angiotenzinske-konvertaze-zaviralcev-ace-ter-antagonistov-angiotenzina-ii-sartanov-med-pandemijo-covid-19/2020-06-12T14:59:12+02:00https://www.jazmp.si/2020/06/24/zascitni-elementi-posodobljen-dokument-vprasanj-in-odgovorov-2/2020-07-08T10:25:12+02:00https://www.jazmp.si/2020/06/29/prvo-zdravilo-za-zdravljenje-bolezni-covid-19-s-priporocilom-za-odobritev-dovoljenja-za-promet-v-eu/2020-06-29T11:26:00+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2020-07-13T13:27:16+02:00https://www.jazmp.si/2020/07/24/ema-zacenja-pregled-deksametazona-za-zdravljenje-odraslih-s-covid-19-ki-potrebujejo-dihalno-podporo/2020-07-24T12:26:10+02:00https://www.jazmp.si/2020/07/31/zdravila-ki-vsebujejo-levprorelin-v-depo-farmacevtskih-oblikah-obvestilo-za-zdravstvene-delavce/2020-07-31T11:12:43+02:00https://www.jazmp.si/2020/08/05/varnostna-obvestila-za-medicinske-pripomocke-junij-2020/2020-08-05T10:26:25+02:00https://www.jazmp.si/2020/08/17/najpogostejsa-vprasanja-in-odgovori-s-podrocja-oglasevanja-zdravil/2022-02-24T16:56:53+01:00https://www.jazmp.si/2020/08/17/konoplja-in-kanabinoidi/2020-08-17T12:55:40+02:00https://www.jazmp.si/2020/08/26/izid-pete-izdaje-formulariuma-slovenicuma-fs-5-0/2020-08-26T15:43:07+02:00https://www.jazmp.si/2020/08/27/porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2019/2020-08-27T14:35:28+02:00https://www.jazmp.si/2020/09/03/varnostna-obvestila-za-medicinske-pripomocke/2020-09-03T09:38:22+02:00https://www.jazmp.si/2020/09/07/prac-priporocil-odvzem-dovoljenja-za-promet-z-ulipristalacetatom-za-zdravljenje-miomov-maternice/2020-09-09T16:03:18+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2020-09-09T15:52:32+02:00https://www.jazmp.si/2020/09/17/varnostna-obvestila-za-medicinske-pripomocke-avgust-2020/2020-09-17T14:32:14+02:00https://www.jazmp.si/2020/09/21/ema-podpira-uporabo-deksametazona-pri-covid-19-pacientih-na-podporni-terapiji-s-kisikom-ali-mehanski-ventilaciji/2020-09-21T10:28:21+02:00https://www.jazmp.si/2020/09/25/namera-o-sklenitvi-neposredne-pogodbe-za-prodajo-racunalniske-in-kamp-opreme/2020-09-25T14:59:10+02:00https://www.jazmp.si/2020/10/01/ema-opominja-zdravnike-naj-uporabijo-tecentriq-v-kombinaciji-z-nab-paklitakselom-za-zdravljenje-raka-dojke/2020-10-01T10:06:14+02:00https://www.jazmp.si/2020/10/06/prac-ocenjuje-varnostni-signal-za-zdravilo-veklury/2020-10-06T09:12:25+02:00https://www.jazmp.si/2020/10/09/health-canada-opravila-varnostni-pregled-izdelkov-ki-vsebujejo-metilrozanilinijev-klorid-gencijana-violet/2020-10-09T08:59:37+02:00https://www.jazmp.si/2020/10/14/varnostna-obvestila-za-medicinske-pripomocke-september-2020/2020-10-14T11:02:11+02:00https://www.jazmp.si/2020/10/21/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje/2020-10-21T10:13:49+02:00https://www.jazmp.si/2020/10/29/pirfenidon-esbriet-obvestilo-za-zdravstvene-delavce/2020-10-29T09:52:09+01:00https://www.jazmp.si/2020/10/30/fluorokinoloni-obvestilo-za-zdravstvene-delavce-2/2020-11-10T14:11:07+01:00https://www.jazmp.si/2020/11/02/mednarodni-teden-ozavescanja-o-pomenu-porocanja-o-nezelenih-ucinkih-zdravil-medsafetyweek/2020-11-02T10:24:22+01:00https://www.jazmp.si/2020/11/11/evropska-komisija-objavila-poziv-za-prijavo-interesa-neodvisnih-znanstvenih-strokovnjakov-da-se-pridruzijo-odboru-za-oceno-tveganja-na-podrocju-farmakovigilance-prac/2020-11-11T10:21:18+01:00https://www.jazmp.si/2020/11/11/fingolimod-gilenya%e2%96%bc-obvestilo-za-zdravstvene-delavce-2/2020-11-11T11:21:09+01:00https://www.jazmp.si/2020/11/13/dimetilfumarat-tecfidera-obvestilo-za-zdravstvene-delavce/2020-11-13T09:21:49+01:00https://www.jazmp.si/2020/11/16/ema-pricenja-s-tekocim-pregledom-mrna-cepiva-proti-covid-19-podjetja-moderna-biotech-spain-s-l/2020-11-16T12:32:14+01:00https://www.jazmp.si/2020/11/17/poziv-imetnikom-dovoljenj-za-promet-z-zdravili-za-posredovanje-podatkov-uporabljenih-v-edinstveni-oznaki-zdravil/2020-11-17T08:22:35+01:00https://www.jazmp.si/2020/11/18/varnostna-obvestila-za-medicinske-pripomocke-oktober-2020/2020-11-18T14:23:47+01:00https://www.jazmp.si/2020/11/19/odlocevanja-ema-e-glede-odobritve-cepiv-proti-covid-19/2020-11-19T13:05:49+01:00https://www.jazmp.si/2020/11/23/obvestilo-glede-remdesivirja-ema-bo-obravnavala-nove-podatke-iz-klinicnega-preskusanja-solidarity/2020-11-23T12:03:12+01:00https://www.jazmp.si/2020/11/23/evropska-agencija-za-zdravila-priporocila-omejitev-uporabe-ulipristalacetata-za-zdravljenje-miomov-maternice/2020-11-23T16:27:30+01:00https://www.jazmp.si/2020/11/24/namera-o-sklenitvi-neposredne-pogodbe-za-prodajo-racunalniske-in-kamp-opreme-2/2020-11-24T20:26:03+01:00https://www.jazmp.si/2020/11/30/obvestilo-imetnikom-dzp-in-imetnikom-zacasnih-dovoljenj-za-vnos-oziroma-uvoz-zdravil-glede-nitrozaminskih-necistot/2020-12-01T08:07:03+01:00https://www.jazmp.si/2020/11/30/posodobitev-informacij-glede-psihiatricnih-motenj-za-klorokin-in-hidroksiklorokin/2020-11-30T15:42:14+01:00https://www.jazmp.si/2020/12/01/ema-je-prejela-vlogo-za-pogojno-dovoljenje-za-promet-s-cepivom-proti-covid-19-podjetja-moderna/2020-12-01T11:36:45+01:00https://www.jazmp.si/2020/12/01/ema-je-prejela-vlogo-za-pogojno-dovoljenje-za-promet-z-mrna-cepivom-bnt162b2-proti-covid-19/2020-12-01T13:51:13+01:00https://www.jazmp.si/2020/12/01/ema-pricenja-s-tekocim-pregledom-cepiva-proti-covid-19-ad26-cov2-s-podjetja-janssen/2020-12-01T15:30:06+01:00https://www.jazmp.si/2020/12/02/gliolan-5-aminolevulinska-kislina-obvestilo-za-zdravstvene-delavce/2020-12-02T13:23:54+01:00https://www.jazmp.si/2020/12/10/europol-opozarja-na-veliko-tveganje-ponarejanja-cepiv-proti-covid-19/2020-12-10T15:16:34+01:00https://www.jazmp.si/2020/12/11/varnostna-obvestila-za-medicinske-pripomocke-november-2020/2020-12-11T14:12:20+01:00https://www.jazmp.si/2020/12/16/metamizol-obvestilo-za-zdravstvene-delavce/2020-12-16T10:37:05+01:00https://www.jazmp.si/2020/12/21/ema-priporoca-odobritev-prvega-cepiva-proti-covid-19-v-eu/2021-03-29T20:40:10+02:00https://www.jazmp.si/2020/12/21/comirnaty-mrna-cepivo-proti-covid-19-s-spremenjenimi-nukleozidi/2021-01-06T16:07:06+01:00https://www.jazmp.si/2020/12/22/brexit-informacije-za-imetnike-dzp-v-povezavi-z-zakljuckom-prehodnega-obdobja-po-izstopu-zdruzenega-kraljestva-iz-evropske-unije/2020-12-22T09:43:48+01:00https://www.jazmp.si/2020/12/22/zerbaxa-ceftolozan-tazobaktam-1-g-0-5-g-prasek-za-koncentrat-za-raztopino-za-infundiranje-obvestilo-za-zdravstvene-delavce/2020-12-22T11:06:19+01:00https://www.jazmp.si/2020/12/22/skrajsani-poslovni-cas/2020-12-22T13:46:48+01:00https://www.jazmp.si/2020/12/28/kaksni-postopki-se-uporabljajo-za-razvoj-in-odobritev-cepiv-proti-covid-19-ter-kako-se-spremlja-varnost-po-odobritvi/2020-12-28T10:59:21+01:00https://www.jazmp.si/2020/12/31/nove-informacije-glede-tekocega-pregleda-cepiva-proti-covid-19-podjetja-astrazeneca/2020-12-31T10:27:12+01:00https://www.jazmp.si/2021/01/05/pogosta-vprasanja-in-odgovori-v-zvezi-z-registracijo-in-izpolnjevanjem-zahtev-poslovnih-subjektov-z-dejavnostmi-na-podrocju-medicinskih-pripomockov/2021-01-05T15:10:45+01:00https://www.jazmp.si/2021/01/06/ema-priporoca-odobritev-cepiva-proti-covid-19-podjetja-moderna-v-eu/2021-03-29T20:40:50+02:00https://www.jazmp.si/2021/01/06/cepivo-proti-covid-19-moderna-mrna-cepivo-proti-covid-19-s-spremenjenimi-nukleozidi/2021-03-29T20:42:13+02:00https://www.jazmp.si/2021/01/07/sporocilo-za-medije-v-zvezi-z-zacasno-odlocbo-zd-ljubljana/2021-01-07T18:13:16+01:00https://www.jazmp.si/2021/01/08/dodatni-odmerek-iz-vial-cepiva-proti-covid-19-comirnaty/2021-01-08T15:32:02+01:00https://www.jazmp.si/2021/01/08/sporocilo-za-medije-v-zvezi-z-izvajanjem-nadzor-antigen-sars-cov-2-testnega-kompleta-proizvajalca-shenzen-ultra-diagnostic-biotec-co/2021-01-08T17:48:50+01:00https://www.jazmp.si/2021/01/12/ema-je-prejela-vlogo-za-pogojno-dovoljenje-za-promet-s-cepivom-proti-covid-19-astrazeneca/2021-03-29T20:42:10+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2021-01-20T16:02:19+01:00https://www.jazmp.si/2021/01/21/sporocilo-za-medije-v-zvezi-s-potekom-izvajanja-inspekcijskega-nadzora-glede-antigen-sars-cov-2-testnega-kompleta-proizvajalca-shenzen-ultra-diagnostic-biotec-co-kitajska-ki-ga-je-dobavilo-podje/2021-01-25T12:47:54+01:00https://www.jazmp.si/2021/01/28/pojasnitev-glede-intervala-med-posameznimi-odmerki-cepiva-comirnaty/2021-01-28T15:51:32+01:00https://www.jazmp.si/2021/01/29/ulipristalacetat-5-mg-esmya-obvestilo-za-zdravstvene-delavce-2/2021-01-29T10:46:43+01:00https://www.jazmp.si/2021/01/29/evropska-agencija-za-zdravila-ema-objavila-prvo-posodobljeno-porocilo-o-varnosti-cepiva-proti-covid-19-comirnaty/2021-01-29T16:35:28+01:00https://www.jazmp.si/2021/01/29/ema-priporoca-odobritev-cepiva-proti-covid-19-astrazeneca-v-eu/2021-03-29T20:42:06+02:00https://www.jazmp.si/2021/02/01/cepivo-proti-covid-19-astrazeneca/2021-02-01T11:32:54+01:00https://www.jazmp.si/2021/02/03/brexit-poziv-imetnikom-dovoljen-za-promet-z-zdravili-za-uskladitev-dovoljenj-za-promet-s-pravnim-redom-unije-na-farmacevtskem-podrocju-po-izteku-prehodnega-obdobja/2021-02-03T08:53:21+01:00https://www.jazmp.si/2021/02/03/sporocilo-za-medije-v-zvezi-s-potekom-izvajanja-inspekcijskega-nadzora-glede-antigen-sars-cov-2-testnega-kompleta-proizvajalca-shenzen-ultra-diagnostic-biotec-co-kitajska-ki-ga-je-dobavilo-podjetj/2021-02-03T11:36:39+01:00https://www.jazmp.si/2021/02/04/varnostna-obvestila-za-medicinske-pripomocke-december-2020/2021-02-04T11:52:02+01:00https://www.jazmp.si/2021/02/15/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-2/2021-02-15T12:03:59+01:00https://www.jazmp.si/2021/02/16/ema-je-prejela-vlogo-za-pogojno-dovoljenje-za-promet-s-cepivom-proti-covid-19-janssen/2021-03-29T20:41:58+02:00https://www.jazmp.si/2021/02/22/nove-informacije-s-februarske-seje-odbora-prac/2021-02-22T15:13:26+01:00https://www.jazmp.si/2021/02/25/varnostna-obvestila-za-medicinske-pripomocke-januar-2021/2021-02-25T11:30:46+01:00https://www.jazmp.si/2021/02/26/prilagoditev-cepiv-proti-covid-19-novim-razlicicam-sars-cov-2-navodila-za-proizvajalce-cepiv/2021-02-26T10:51:20+01:00https://www.jazmp.si/2021/02/26/ema-je-izdala-nasvet-glede-uporabe-kombinacije-protiteles-regn-cov2-casirivimab-imdevimab/2021-02-26T12:58:13+01:00https://www.jazmp.si/2021/03/03/poziv-za-izpolnitev-vprasalnika-o-izvajanju-farmakovigilancnih-aktivnosti-2/2021-03-03T15:08:30+01:00https://www.jazmp.si/2021/03/08/objava-nove-razlicice-smernic-guidance-on-the-management-of-ct-during-the-covid-19/2021-03-08T10:56:25+01:00https://www.jazmp.si/2021/03/08/ema-je-izdala-nasvet-glede-uporabe-kombinacije-protiteles-bamlanivimab-etesevimab/2021-03-08T14:37:03+01:00https://www.jazmp.si/2021/03/11/covid-19-cepivo-astrazeneca-po-prvem-pregledu-podatkov-je-mnenje-odbora-prac-da-s-serijo-ki-se-uporablja-v-avstriji-ni-posebnih-tezav/2021-03-11T11:53:09+01:00https://www.jazmp.si/2021/03/11/poziv-proizvajalcem-ucinkovin-vpisanih-v-register-proizvajalcev-ucinkovin-veletrgovcem-z-ucinkovinami-vpisanih-v-register-veletrgovcev-z-ucinkovinami-ter-uvoznikom-ucinkovin-vpisanih-v-register-uv/2021-03-11T14:28:15+01:00https://www.jazmp.si/2021/03/11/ema-priporoca-odobritev-cepiva-proti-covid-19-janssen-v-eu/2021-03-11T14:52:56+01:00https://www.jazmp.si/2021/03/11/ema-objavila-zakljucke-drugega-mesecnega-porocila-o-varnosti-cepiva-comirnaty-pfizer-biontech-in-prvega-za-cepivo-covid-19-moderna/2021-03-11T16:04:55+01:00https://www.jazmp.si/2021/03/11/cepivo-covid-19-astrazeneca-prac-pregleduje-primere-trombembolicnih-dogodkov-koristi-cepiva-trenutno-se-vedno-prevladajo-nad-tveganji/2021-03-11T19:00:50+01:00https://www.jazmp.si/2021/03/18/nove-informacije-s-seje-odbora-prac-v-mesecu-marcu/2021-03-18T10:15:35+01:00https://www.jazmp.si/2021/03/18/covid-19-cepivo-astrazeneca-koristi-cepiva-se-vedno-prevladajo-nad-tveganji-vendar-je-mozna-povezava-z-izjemno-redkimi-krvnimi-strdki-z-nizko-vrednostjo-trombocitov/2021-03-18T18:46:51+01:00https://www.jazmp.si/2021/03/19/zolgensma%e2%96%bc-onasemnogen-abeparvovek-obvestilo-za-zdravstvene-delavce/2021-03-19T09:12:30+01:00https://www.jazmp.si/2021/03/19/obvestilo-interpola-o-razkritju-kriminalne-mreze-ponarejevalcev-cepiv-proti-covid-19/2021-03-19T14:14:23+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2021-03-23T16:13:17+01:00https://www.jazmp.si/2021/03/24/cepivo-covid-19-vaccine-astrazeneca%e2%96%bc-obvestilo-za-zdravstvene-delavce/2021-03-24T09:24:22+01:00https://www.jazmp.si/2021/03/25/tofacitinib-xeljanz%e2%96%bc-obvestilo-za-zdravstvene-delavce-4/2021-03-25T09:14:52+01:00https://www.jazmp.si/2021/03/25/tecentriq%e2%96%bc-atezolizumab-obvestilo-za-zdravstvene-delavce/2021-03-25T09:23:18+01:00https://www.jazmp.si/2021/03/26/cepivo-covid-19-vaccine-astrazeneca-informacija-o-poteku-nadaljnjega-ocenjevanja-primerov-krvnih-strdkov/2021-03-26T10:04:11+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2021-04-12T07:38:00+02:00https://www.jazmp.si/2021/03/26/ema-je-izdala-nasvet-glede-uporabe-regdanvimaba-za-zdravljenje-covid-19/2021-03-26T14:57:37+01:00https://www.jazmp.si/2021/04/01/varnostna-obvestila-za-medicinske-pripomocke-februar-2021/2021-04-01T09:25:03+02:00https://www.jazmp.si/2021/04/01/ema-objavila-posodobljeno-mesecno-porocilo-o-varnosti-cepiv-proti-covidu-19/2021-04-01T13:11:43+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2021-04-12T07:37:09+02:00https://www.jazmp.si/2021/04/08/cepivo-vaxzevria-prej-covid-19-vaccine-astrazeneca-ema-potrdila-mozno-povezanost-cepiva-s-sicer-zelo-redkimi-primeri-neobicajnih-krvnih-strdkov-s-socasnim-nizkim-stevilom-trombocitov/2021-04-08T14:25:48+02:00https://www.jazmp.si/2021/04/12/objava-najave-razpisa-za-prijavo-interesa-hera-incubator-horizon-hlth-2021-corona-01-obzorje-evropa/2021-04-12T08:08:55+02:00https://www.jazmp.si/2021/04/12/nove-informacije-s-seje-odbora-prac-v-mesecu-aprilu/2021-04-12T11:34:19+02:00https://www.jazmp.si/2021/04/13/cepivo-vaxzevria-covid-19-vaccine-astrazeneca%e2%96%bc-obvestilo-za-zdravstvene-delavce/2021-04-13T09:43:51+02:00https://www.jazmp.si/2021/04/15/cepivo-vaxzevria-prej-covid-19-vaccine-astrazeneca-ema-bo-nadalje-opredelila-tveganje-za-neobicajne-krvne-strdke-s-socasnim-nizkim-stevilom-trombocitov/2021-04-15T12:07:01+02:00https://www.jazmp.si/2021/04/15/cepivo-covid-19-vaccine-janssen-ema-nadaljuje-oceno-primerov-neobicajnih-krvnih-strdkov/2021-04-15T14:48:54+02:00https://www.jazmp.si/2021/04/16/eylea-40-mg-ml-raztopina-za-intravitrealno-injiciranje-aflibercept-obvestilo-za-zdravstvene-delavce/2021-04-16T08:59:51+02:00https://www.jazmp.si/2021/04/20/ema-objavila-posodobljena-mesecna-porocila-o-varnosti-cepiv-proti-covidu-19/2021-04-20T10:24:46+02:00https://www.jazmp.si/2021/04/20/cepivo-covid-19-vaccine-janssen-ema-ugotovila-mozno-povezanost-cepiva-s-sicer-zelo-redkimi-primeri-neobicajnih-krvnih-strdkov-s-socasnim-nizkim-stevilom-trombocitov/2021-04-20T17:06:55+02:00https://www.jazmp.si/2021/04/23/cepivo-proti-covid-19-podjetja-astrazeneca-koristi-in-tveganja-postavljena-v-kontekst/2021-04-23T17:38:49+02:00https://www.jazmp.si/2021/04/26/covid-19-vaccine-janssen%e2%96%bc-obvestilo-za-zdravstvene-delavce/2021-04-26T08:22:45+02:00https://www.jazmp.si/2021/05/06/varnostna-obvestila-za-medicinske-pripomocke-marec-2021/2021-05-06T11:31:25+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2021-05-10T16:08:21+02:00https://www.jazmp.si/2021/05/11/nove-informacije-s-seje-odbora-prac-v-mesecu-maju/2021-05-11T11:13:38+02:00https://www.jazmp.si/2021/05/24/cepivo-vaxzevria-dodatna-priporocila-glede-krvnih-strdkov-in-trombocitopenije/2021-05-24T09:24:34+02:00https://www.jazmp.si/2021/05/25/odlocba-st-314-3-2021-15-z-dne-14-5-2021-s-katero-je-bilo-odobreno-dajanje-v-uporabo-medicinskih-pripomockov/2021-05-25T08:11:51+02:00https://www.jazmp.si/2021/05/25/varnostna-obvestila-za-medicinske-pripomocke-april-2021/2021-05-25T13:15:26+02:00https://www.jazmp.si/2021/05/27/za-uporabo-inhalacijskih-kortikosteroidov-pri-zdravljenju-covid-19-ni-dovolj-podatkov/2021-05-27T13:35:31+02:00https://www.jazmp.si/2021/06/01/posodobljena-mesecna-porocila-o-varnosti-cepiv-proti-covidu-19/2021-06-01T13:14:46+02:00https://www.jazmp.si/2021/06/02/vaxzevria-%e2%96%bcprej-covid-19-vaccine-astrazeneca-obvestilo-za-zdravstvene-delavce/2021-06-02T10:29:23+02:00https://www.jazmp.si/2021/06/08/ema-spodbuja-ozavescenost-glede-priporocil-za-klinicno-oskrbo-ob-sumu-na-sindrom-tromboze-s-trombocitopenijo/2021-06-08T11:23:55+02:00https://www.jazmp.si/2021/06/09/8-junij-svetovni-dan-boja-proti-ponarejanju/2021-06-09T19:50:23+02:00https://www.jazmp.si/2021/06/11/venclyxto-%e2%96%bc-venetoklaks-filmsko-oblozene-tablete-obvestilo-za-zdravstvene-delavce/2021-06-11T09:05:39+02:00https://www.jazmp.si/2021/06/11/ema-odsvetuje-cepljenje-oseb-z-anamnezo-sindroma-kapilarnega-prepuscanja-s-cepivom-vaxzevria/2021-06-11T15:10:33+02:00https://www.jazmp.si/2021/06/11/cepiva-proti-covidu-19-informacija-o-nadaljnjem-poteku-ocenjevanja-primerov-miokarditisa-in-perikarditisa/2021-06-11T15:33:01+02:00https://www.jazmp.si/2021/06/14/poudarki-s-seje-odbora-prac-v-mesecu-juniju/2021-06-14T10:20:56+02:00https://www.jazmp.si/2021/06/17/navodilo-za-predlozitev-vloge-za-pregled-izobrazevalnega-gradiva/2021-07-07T15:55:21+02:00https://www.jazmp.si/2021/06/17/varnostna-obvestila-za-medicinske-pripomocke-maj-2021/2021-06-30T09:44:08+02:00https://www.jazmp.si/2021/06/23/vaxzevria-%e2%96%bcprej-covid-19-vaccine-astrazeneca-obvestilo-za-zdravstvene-delavce-2/2021-07-05T17:19:47+02:00https://www.jazmp.si/2021/06/30/nujno-varnostno-obvestilo-v-zvezi-s-philips-respironics-ventilatorji-cpap-bi-level-in-bipap-medicinskimi-pripomocki/2021-06-30T10:57:01+02:00https://www.jazmp.si/2021/07/07/tofacitinib-xeljanz%e2%96%bc-obvestilo-za-zdravstvene-delavce-5/2021-07-07T13:24:07+02:00https://www.jazmp.si/2021/07/09/comirnaty-in-spikevax-mozna-povezavost-z-zelo-redkimi-primeri-miokarditisa-in-perikarditisa/2021-07-09T14:16:06+02:00https://www.jazmp.si/2021/07/09/skupni-sestanek-generalnih-direktorjev-za-zdravila-drzav-clanic-eu-in-odbora-za-farmacijo/2021-07-09T18:06:04+02:00https://www.jazmp.si/2021/07/13/ema-odsvetuje-uporabo-cepiva-covid-19-vaccine-janssen-pri-osebah-s-sindromom-kapilarnega-prepuscanja-v-anamnezi/2021-07-13T08:46:36+02:00https://www.jazmp.si/2021/07/13/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-3/2021-07-14T10:12:56+02:00https://www.jazmp.si/2021/07/13/poudarki-s-seje-odbora-prac-v-mesecu-juliju/2021-07-13T15:42:52+02:00https://www.jazmp.si/2021/07/14/obvestilo-ema-in-ecdc-glede-covid-19/2021-07-14T15:05:50+02:00https://www.jazmp.si/2021/07/16/champix-vareniklin-obvestilo-za-zdravstvene-delavce/2021-07-16T08:42:30+02:00https://www.jazmp.si/2021/07/19/comirnaty%e2%96%bc-in-spikevax%e2%96%bc-mrnk-cepivi-proti-covid-19-obvestilo-za-zdravstvene-delavce/2021-07-19T09:25:11+02:00https://www.jazmp.si/2021/07/19/covid-19-vaccine-janssen%e2%96%bc-obvestilo-za-zdravstvene-delavce-2/2021-07-19T09:26:37+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2021-07-19T15:15:21+02:00https://www.jazmp.si/2021/07/22/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19/2021-07-22T12:06:53+02:00https://www.jazmp.si/2021/07/23/guillain-barrejev-sindrom-opredeljen-kot-zelo-redek-nezeleni-ucinek-cepiva-covid-19-vaccine-janssen/2021-07-23T08:18:15+02:00https://www.jazmp.si/2021/07/29/doreta-sr-75-mg-650-mg-tablete-s-podaljsanim-sproscanjem-obvestilo-za-zdravstvene-delavce/2021-07-29T09:51:57+02:00https://www.jazmp.si/2021/07/29/navodilo-za-predlozitev-neposrednega-obvestila-za-zdravstvene-delavce-dhpc-v-pregled-jazmp/2021-07-29T13:26:27+02:00https://www.jazmp.si/2021/08/03/varnostna-obvestila-za-medicinske-pripomocke-julij-2021/2021-08-03T11:20:52+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2021-08-09T15:56:42+02:00https://www.jazmp.si/2021/08/11/zdravila-ki-vsebujejo-dinoproston-obvestilo-za-zdravstvene-delavce/2021-08-11T08:53:57+02:00https://www.jazmp.si/2021/08/20/trisenox-arzenov-trioksid-obvestilo-za-zdravstvene-delavce/2021-08-20T14:16:04+02:00https://www.jazmp.si/2021/08/26/izid-pete-izdaje-formulariuma-slovenicuma-fs-5-1/2021-08-26T09:32:21+02:00https://www.jazmp.si/2021/09/02/smernica-mdcg-2021-23-objavljena-na-strani-evropske-komisije-namenjena-priglasenim-organom-distributerjem-in-uvoznikom-glede-certifikacijskih-aktivnosti-in-izdaje-certifikata-skladno-s-clenom-164-u/2021-09-02T09:03:36+02:00https://www.jazmp.si/2021/11/12/informacije-glede-hitrih-antigenskih-testov-ki-dolocijo-prisotnost-sars-cov-2-antigena/2022-01-20T14:27:49+01:00https://www.jazmp.si/2021/09/06/poudarki-s-seje-odbora-prac-v-mesecu-septembru/2021-09-06T10:18:31+02:00https://www.jazmp.si/2021/09/06/ecdc-in-ema-objavljata-premislek-o-dodatnih-in-obnovitvenih-odmerkih-cepiv-proti-covid-19/2021-09-06T15:31:46+02:00https://www.jazmp.si/2021/09/08/roactemra-tocilizumab-obvestilo-za-zdravstvene-delavce/2021-09-08T14:20:39+02:00https://www.jazmp.si/2021/09/11/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-2/2021-09-11T11:27:43+02:00https://www.jazmp.si/2021/09/14/prvo-redno-srecanje-vodji-agencij-pristojnih-za-zdravila-hma-i-v-okviru-slovenskega-predsedovanja-svetu-eu/2021-11-24T17:51:34+01:00https://www.jazmp.si/2021/11/24/postopek-vpisa-testa-namenjenega-samo-testiranju-v-centralno-bazo-zdravil/2022-01-20T14:27:21+01:00https://www.jazmp.si/2021/09/21/varnostna-obvestila-za-medicinske-pripomocke-avgust-2021/2021-09-21T14:15:12+02:00https://www.jazmp.si/2021/09/22/skupni-sestanek-prac-in-cmdh/2021-11-02T11:21:36+01:00https://www.jazmp.si/2021/09/22/podaljsanje-roka-uporabnosti-za-cepivo-comirnaty/2021-09-22T10:05:20+02:00https://www.jazmp.si/2021/09/29/fenobarbital-obvestilo-za-zdravstvene-delavce/2021-09-29T10:13:32+02:00https://www.jazmp.si/2021/10/01/champix-vareniklin-obvestilo-za-zdravstvene-delavce-2/2021-10-01T10:33:36+02:00https://www.jazmp.si/2021/10/03/mnenje-jazmp-glede-uporabe-zdravil-z-ucinkovino-ivermektin-pri-bolnikih-z-boleznijo-covid-19/2021-10-05T10:33:17+02:00https://www.jazmp.si/2021/10/04/49-srecanje-pristojnih-organov-za-medicinske-pripomocke-drzav-clanic-eu-egp-in-turcije-competent-authorities-for-medical-devices-camd/2021-11-24T17:51:49+01:00https://www.jazmp.si/2021/10/05/priporocila-ema-e-glede-dodatnih-in-pozivitvenih-odmerkov-cepiv-comirnaty-in-spikevax/2021-10-05T10:44:53+02:00https://www.jazmp.si/2021/10/05/poudarki-s-seje-odbora-prac/2021-10-05T12:34:34+02:00https://www.jazmp.si/2021/10/11/sestanek-odbora-za-zdravila-za-uporabo-v-veterinarski-medicini-cvmp-in-skupine-za-usklajevanje-postopkov-z-medsebojnim-priznavanjem-in-decentraliziranih-postopkov-za-zdravila-za-uporabo-v-veterinars/2021-10-11T18:05:31+02:00https://www.jazmp.si/2021/10/12/prilagoditev-podatkovne-baze-eudragmdp/2021-10-12T13:35:39+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2021-10-12T16:09:49+02:00https://www.jazmp.si/2021/10/13/vaxzevria-%e2%96%bc-in-covid-19-vaccine-janssen%e2%96%bc-obvestilo-za-zdravstvene-delavce/2021-10-13T11:37:14+02:00https://www.jazmp.si/2021/10/19/sestanek-odbora-za-zdravila-za-uporabo-v-humani-medicini-chmp-in-odbora-za-zdravila-za-napredno-zdravljenje-cat-ki-delujeta-v-okviru-evropske-agencije-za-zdravila-ema/2021-11-02T11:21:48+01:00https://www.jazmp.si/2021/10/20/revidirano-navodilo-za-dolocanje-stevilk-postopkov-2/2021-10-20T15:26:18+02:00https://www.jazmp.si/2021/10/21/sestanek-delovne-skupina-inspektorjev-za-podrocje-zdravil-wgeo/2021-11-02T11:21:45+01:00https://www.jazmp.si/2021/10/21/neskladni-medicinski-pripomocki-na-trgu-eu-ultrazvocni-geli-proizvajalca-eco-med-pharmaceuticals-inc-zda/2021-10-21T13:20:07+02:00https://www.jazmp.si/2021/10/21/varnostna-obvestila-za-medicinske-pripomocke-september-2021/2021-10-21T14:27:54+02:00https://www.jazmp.si/2021/10/21/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-3/2021-10-21T17:09:31+02:00https://www.jazmp.si/2021/11/02/mednarodna-medijska-kampanja-za-ozavescanje-o-pomenu-porocanja-o-nezelenih-ucinkih-po-cepljenju-medsafetyweek/2021-11-02T10:02:32+01:00https://www.jazmp.si/2021/11/02/dogodek-z-naslovom-second-virtual-matchmaking-event-on-covid-19-therapeutics/2021-11-02T10:43:28+01:00https://www.jazmp.si/2021/11/02/redni-sestanek-skupine-za-poenostavitev-in-koordinacijo-klinicnih-preskusanj-clinical-trials-facilitation-and-coordination-group-ctfg/2021-11-24T17:49:08+01:00https://www.jazmp.si/2021/11/02/forxiga-5-mg-filmsko-oblozene-tablete-obvestilo-za-zdravstvene-delavce/2021-11-02T14:30:24+01:00https://www.jazmp.si/2021/11/03/beovu%e2%96%bc-brolucizumab-obvestilo-za-zdravstvene-delavce/2021-11-03T14:34:15+01:00https://www.jazmp.si/2021/11/03/poudarki-s-seje-odbora-prac-2/2021-11-03T14:49:27+01:00https://www.jazmp.si/2021/11/09/sestanek-delovne-skupine-za-homeopatska-zdravila-hmpwg-ki-deluje-v-okviru-mreze-vodij-nacionalnih-organov-za-zdravila-hma/2021-11-24T17:49:18+01:00https://www.jazmp.si/2021/11/12/varnostna-obvestila-za-medicinske-pripomocke-oktober-2021/2021-11-12T10:54:33+01:00https://www.jazmp.si/2021/11/15/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-4/2021-11-15T15:39:45+01:00https://www.jazmp.si/2021/11/16/sprememba-tarife-javne-agencije-republike-slovenije-za-zdravila-in-medicinske-pripomocke/2021-12-20T09:04:01+01:00https://www.jazmp.si/2021/11/22/pomembno-obvestilo-glede-vpisov-v-eudragmdp-bazo-za-proizvajalce-zdravil-veletrgovce-z-zdravili-proizvajalce-ucinkovin-veletrgovce-z-ucinkovinami-ter-uvoznike-ucinkovin/2024-04-04T14:17:56+02:00https://www.jazmp.si/2021/11/22/drugo-redno-srecanje-direktorjev-agencij-pristojnih-za-zdravila-hma-v-okviru-slovenskega-predsedovanja-svetu-eu/2021-11-24T17:49:43+01:00https://www.jazmp.si/2021/11/22/poslovni-cas-jazmp/2022-01-24T11:08:51+01:00https://www.jazmp.si/2021/11/24/srecanje-delovne-skupine-vodij-sistema-kakovosti-wgqm/2021-11-24T17:45:40+01:00https://www.jazmp.si/2021/11/24/srecanje-delovne-skupine-strokovnjakov-za-komuniciranje-wgcp/2021-11-24T17:47:25+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2021-11-29T16:12:52+01:00https://www.jazmp.si/2021/11/30/zascitni-elementi-posodobljen-dokument-vprasanj-in-odgovorov-3/2021-11-30T09:48:05+01:00https://www.jazmp.si/2021/12/06/obvestilo-o-ponarejenih-medicinskih-pripomockih/2021-12-06T18:12:34+01:00https://www.jazmp.si/2021/12/06/obvestilo-za-poslovne-subjekte-ki-imajo-ali-zelijo-pridobiti-dovoljenje-za-proizvodnjo-zdravil-veletrgovino-z-zdravili-na-debelo-potrdilo-o-vpisu-v-register-proizvajalcev-ucinkovin-v-register-vel/2024-04-04T14:17:12+02:00https://www.jazmp.si/2021/12/08/stratesko-pregledno-in-izobrazevalno-srecanje-srlm-odbora-za-zdravila-rastlinskega-izvora-hmpc-ki-deluje-v-okviru-evropske-agencije-za-zdravila-ema/2021-12-08T10:26:10+01:00https://www.jazmp.si/2021/12/08/poudarki-s-seje-odbora-prac-3/2021-12-08T12:08:51+01:00https://www.jazmp.si/2021/12/16/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-5/2021-12-16T08:58:25+01:00https://www.jazmp.si/2021/12/16/porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2020/2021-12-16T11:42:35+01:00https://www.jazmp.si/2021/12/16/odpoklic-ukradenih-medicinskih-pripomockov-hyamira-forte-serijska-st-0306621-proizvajalca-nyuma-pharma-s-r-l/2021-12-20T10:50:24+01:00https://www.jazmp.si/2021/12/20/varnostna-obvestila-za-medicinske-pripomocke-november-2021/2021-12-20T11:26:10+01:00https://www.jazmp.si/2021/12/21/poslovanje-jazmp-24-in-31-decembra-2021/2021-12-21T14:31:19+01:00https://www.jazmp.si/2021/12/22/podaljsanje-roka-uporabnosti-za-cepivo-comirnaty-2/2021-12-22T07:19:07+01:00https://www.jazmp.si/2021/12/22/podaljsanje-roka-uporabnosti-za-cepivo-spikevax/2021-12-22T07:23:25+01:00https://www.jazmp.si/2022/01/03/svetovna-zdravstvena-organizacija-opozarja-na-tveganje-pojava-ponaredkov-novih-zdravil-za-zdravljenje-bolezni-covid-19/2022-01-03T19:47:39+01:00https://www.jazmp.si/2022/01/06/vprasanja-in-odgovori-glede-cepiv-proti-covidu-19/2022-01-06T14:51:40+01:00https://www.jazmp.si/2022/01/17/pregled-zdravil-ki-vsebujejo-terlipresin/2022-01-17T12:15:09+01:00https://www.jazmp.si/2022/01/18/nulojix-obvestilo-za-zdravstvene-delavce/2022-01-18T09:14:02+01:00https://www.jazmp.si/2022/01/18/poudarki-s-seje-odbora-prac-4/2022-01-18T11:27:04+01:00https://www.jazmp.si/2022/01/18/varnostna-obvestila-za-medicinske-pripomocke-december-2021/2022-01-18T11:22:54+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2022-01-18T16:19:39+01:00https://www.jazmp.si/2022/01/19/uporaba-mrna-cepiv-med-nosecnostjo/2022-01-19T13:36:32+01:00https://www.jazmp.si/2022/01/20/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-4/2022-01-20T14:26:18+01:00https://www.jazmp.si/2022/01/25/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-6/2022-01-25T13:59:30+01:00https://www.jazmp.si/2022/02/11/varnostna-obvestila-za-medicinske-pripomocke-januar-2022/2022-02-11T13:48:24+01:00https://www.jazmp.si/2022/02/14/pregled-zdravil-ki-vsebujejo-zaviralce-janus-kinaz/2022-02-14T09:37:54+01:00https://www.jazmp.si/2022/02/14/prac-priporocil-zacasni-odvzem-dovoljenja-za-promet-z-raztopinami-za-infundiranje-ki-vsebujejo-hidroksietilskrob-hes/2022-02-14T16:42:07+01:00https://www.jazmp.si/2022/02/15/mavenclad-obvestilo-za-zdravstvene-delavce/2022-02-15T08:50:15+01:00https://www.jazmp.si/2022/02/15/bcg-medac-prasek-in-vehikel-za-suspenzijo-za-intravezikalno-uporabo-obvestilo-za-zdravstvene-delavce/2022-02-15T09:19:52+01:00https://www.jazmp.si/2022/02/18/obvestilo-o-posodobljenem-eurogtp-ii-guide-on-good-practices-for-evaluating-quality-safety-and-efficacy-of-novel-tissue-and-cellular-therapies-and-products/2022-02-18T10:36:31+01:00https://www.jazmp.si/2022/02/21/poudarki-s-seje-odbora-prac-5/2022-02-21T14:58:39+01:00https://www.jazmp.si/2022/02/22/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-7/2022-02-22T12:14:23+01:00https://www.jazmp.si/2022/03/08/infliksimab-obvestilo-za-zdravstvene-delavce/2022-03-08T09:34:01+01:00https://www.jazmp.si/2022/03/08/anagrelid-obvestilo-za-zdravstvene-delavce/2022-03-08T16:30:31+01:00https://www.jazmp.si/2022/03/14/varnostna-obvestila-za-medicinske-pripomocke-februar-2022/2022-03-14T12:38:56+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2022-03-15T16:16:28+01:00https://www.jazmp.si/2022/03/24/poudarki-s-seje-odbora-prac-6/2022-03-24T10:59:09+01:00https://www.jazmp.si/2022/03/25/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-8/2022-03-25T14:03:01+01:00https://www.jazmp.si/2022/03/29/ema-priporoca-odobritev-covid-19-zdravila-evusheld/2022-03-29T12:44:11+02:00https://www.jazmp.si/2022/04/07/dovoljenja-za-promet-za-zdravila/2023-12-13T12:22:06+01:00https://www.jazmp.si/2022/04/11/poudarki-s-seje-odbora-prac-7/2022-04-11T09:56:05+02:00https://www.jazmp.si/2022/04/15/varnostna-obvestila-za-medicinske-pripomocke-marec-2022/2022-04-15T12:57:14+02:00https://www.jazmp.si/2022/04/22/ponarejeni-medicinski-pripomocki-z-logotipom-proizvajalca-finceramica-faenza-s-p-a-italija/2022-04-22T13:52:22+02:00https://www.jazmp.si/2022/04/25/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-9/2022-04-25T10:03:20+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2022-04-29T10:46:21+02:00https://www.jazmp.si/2022/05/03/obvestilo-o-odkritem-ponaredku-zdravila-molnupiravir-izven-evropske-unije/2022-05-03T12:45:39+02:00https://www.jazmp.si/2022/05/04/podaljsanje-roka-uporabnosti-za-cepivo-comirnaty-3/2022-05-04T13:54:16+02:00https://www.jazmp.si/2022/05/10/poudarki-s-seje-odbora-prac-8/2022-05-10T10:27:35+02:00https://www.jazmp.si/2022/05/18/20-maj-2022-mednarodni-dan-klinicnih-preskusanj-obvestilo-za-sponzorje/2022-05-19T08:52:22+02:00https://www.jazmp.si/2022/05/20/varnostna-obvestila-za-medicinske-pripomocke-april-2022/2022-05-20T12:03:31+02:00https://www.jazmp.si/2022/05/20/synchron-research-service-zacasen-umik-zdravil-zaradi-pomanjkljivih-studij/2022-05-20T18:20:58+02:00https://www.jazmp.si/2022/05/24/vabilo-na-brezplacni-spletni-seminar-oglasevanje-zdravil/2022-05-24T09:53:45+02:00https://www.jazmp.si/2022/06/03/obvestilo-o-novi-interakciji-zdravila-euthyrox-z-zaviralci-protonske-crpalke-zpc/2022-06-03T11:45:36+02:00https://www.jazmp.si/2022/06/03/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-10/2022-06-03T14:21:49+02:00https://www.jazmp.si/2022/06/10/jazmp-prejema-stevilna-obvestila-o-ponarejenem-zdravilu-botox/2022-06-10T09:43:33+02:00https://www.jazmp.si/2022/06/10/ocaliva%e2%96%bc-obetiholna-kislina-obvestilo-za-zdravstvene-delavce/2022-06-10T10:42:59+02:00https://www.jazmp.si/2022/06/14/defitelio%e2%96%bc-defibrotid-obvestilo-za-zdravstvene-delavce/2022-06-14T09:45:09+02:00https://www.jazmp.si/2022/06/15/varnostna-obvestila-za-medicinske-pripomocke-maj-2022/2022-06-15T10:24:48+02:00https://www.jazmp.si/2022/06/15/ema-priporocila-odvzem-dovoljenj-za-promet-z-zdravili-ki-vsebujejo-amfepramon/2022-06-15T17:19:24+02:00https://www.jazmp.si/2022/06/15/poudarki-s-seje-odbora-prac-9/2022-06-15T17:38:49+02:00https://www.jazmp.si/2022/06/17/deksmedetomidin-obvestilo-za-zdravstvene-delavce/2022-06-17T09:10:23+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2022-06-17T15:22:25+02:00https://www.jazmp.si/2022/06/21/kabazitaksel-accord-20-mg-ml-koncentrat-za-raztopino-za-infundiranje-obvestilo-za-zdravstvene-delavce/2022-06-21T09:58:54+02:00https://www.jazmp.si/2022/06/21/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-%ef%bf%bc/2022-06-21T12:43:51+02:00https://www.jazmp.si/2022/06/23/poziv-imetnikom-dzp-genotoksicna-zdravila/2022-06-23T11:08:44+02:00https://www.jazmp.si/2022/06/23/navodilo-za-porocanje-o-domnevnih-nezelenih-ucinkih-zdravil/2022-06-23T15:26:57+02:00https://www.jazmp.si/2022/06/24/odlocitev-evropske-komisije-o-zacasnem-odvzemu-dovoljenj-za-promet-raztopinam-za-infundiranje-ki-vsebujejo-hidroksietilskrob-hes-in-moznost-uporabe-nadaljnjih-18-mesecev/2022-06-24T13:04:31+02:00https://www.jazmp.si/2022/06/27/obvestilo-o-usposabljanju-ki-ga-organizira-edqm-na-podrocju-tkiv-in-celic/2022-06-27T15:01:30+02:00https://www.jazmp.si/2022/07/01/pomembne-informacije-za-sponzorje-klinicnih-preskusanj-zdravil/2022-07-01T08:58:04+02:00https://www.jazmp.si/2022/07/01/varnostna-obvestila-za-medicinske-pripomocke-junij-2022/2022-07-01T12:42:37+02:00https://www.jazmp.si/2022/07/08/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-11/2022-07-08T11:07:21+02:00https://www.jazmp.si/2022/07/11/prac-priporocil-nove-ukrepe-za-zmanjsanje-tveganja-za-meningiome-pri-zdravilih-ki-vsebujejo-klormadinon-ali-nomegestrol/2022-07-11T15:13:45+02:00https://www.jazmp.si/2022/07/11/poudarki-s-seje-odbora-prac-10/2022-07-11T15:21:23+02:00https://www.jazmp.si/2022/07/12/posodobitev-priporocil-za-dodatne-obnovitvene-odmerke-covid-19-mrna-cepiv/2022-07-12T12:31:17+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2022-07-13T15:31:17+02:00https://www.jazmp.si/2022/07/14/caprelsa%e2%96%bc-vandetanib-obvestilo-za-zdravstvene-delavce/2022-07-14T09:19:51+02:00https://www.jazmp.si/2022/07/19/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-12/2022-09-06T10:28:37+02:00https://www.jazmp.si/2022/07/27/priporocilo-o-omejeni-uporabi-zdravila-proti-raku-rubraca/2022-07-27T11:40:39+02:00https://www.jazmp.si/2022/07/27/ema-je-priporocila-odobritev-zdravila-imvanex-za-preprecevanje-bolezni-opicjih-koz/2022-07-27T11:39:14+02:00https://www.jazmp.si/2022/08/08/ponarejeni-medicinski-pripomocki-z-logotipom-proizvajalca-diaco-biofarmaceutici-s-r-l-italija/2022-08-08T13:09:45+02:00https://www.jazmp.si/2022/08/09/varnostna-obvestila-za-medicinske-pripomocke-julij-2022/2022-08-09T13:35:59+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2022-08-12T14:23:49+02:00https://www.jazmp.si/2022/08/16/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-5/2022-10-13T10:38:10+02:00https://www.jazmp.si/2022/08/26/podaljsanje-roka-uporabnosti-za-cepivo-spikevax-2/2022-08-26T13:42:40+02:00https://www.jazmp.si/2022/08/29/izid-drugega-dopolnila-k-peti-izdaji-formulariuma-slovenicuma-fs-5-2/2022-08-29T11:31:10+02:00https://www.jazmp.si/2022/08/30/obvestilo-za-uporabnike-sistema-ctis/2022-09-21T17:20:38+02:00https://www.jazmp.si/2022/08/31/podaljsanje-roka-uporabnosti-za-cepivo-comirnaty-4/2022-08-31T10:48:59+02:00https://www.jazmp.si/2022/09/02/1-septembra-2022-je-v-sloveniji-stopila-v-veljavo-medicrime-konvencija/2022-09-02T08:23:16+02:00https://www.jazmp.si/2022/09/02/priporocilo-za-odobritev-prvih-prilagojenih-obnovitvenih-cepiv-proti-bolezni-covid-19-v-eu/2022-09-02T12:31:57+02:00https://www.jazmp.si/2022/09/06/prac-zacel-pregled-uporabe-topiramata-v-nosecnosti-in-pri-zenskah-v-rodni-dobi/2022-09-06T15:28:32+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2022-09-06T16:13:05+02:00https://www.jazmp.si/2022/09/07/skupna-izjava-evropski-center-za-nadzor-in-preprecevanje-bolezni-ecdc-ter-evropske-agencije-za-zdravila-ema-o-pozivitvenem-cepljenju-z-omikronu-prilagojenimi-dvovalentnimi-cepivi-proti-covid-19/2022-09-07T11:41:30+02:00https://www.jazmp.si/2022/09/09/pregled-zdravil-ki-vsebujejo-folkodin/2022-09-12T09:26:57+02:00https://www.jazmp.si/2022/09/09/poudarki-s-seje-odbora-prac-11/2022-09-09T15:01:05+02:00https://www.jazmp.si/2022/09/12/spletni-seminar-o-oglasevanju-zdravil-z-dne-8-6-2022-govori-na-vprasanja-udelezencev/2022-09-12T11:36:35+02:00https://www.jazmp.si/2022/09/13/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-13/2022-09-13T13:06:34+02:00https://www.jazmp.si/2022/09/13/prilagojeno-cepivo-ki-cilja-na-originalni-sars-cov-2-ter-podrazlicici-omicron-ba-4-in-ba-5-je-priporoceno-za-odobritev/2022-09-13T13:25:45+02:00https://www.jazmp.si/2022/09/13/novi-ukrepi-za-zmanjsanje-tveganja-za-meningiome-pri-zdravilih-ki-vsebujejo-klormadinon-ali-nomegestrol/2022-09-13T13:51:40+02:00https://www.jazmp.si/2022/09/15/varnostna-obvestila-za-medicinske-pripomocke-avgust-2022/2022-09-15T09:38:17+02:00https://www.jazmp.si/2022/09/21/obvestilo-za-uporabnike-sistema-ctis-odpoved-dogodka/2022-09-21T18:30:18+02:00https://www.jazmp.si/2022/09/22/zamenljivost-bioloskih-in-podobnih-bioloskih-zdravil-odobrenih-v-eu/2022-09-22T09:12:42+02:00https://www.jazmp.si/2022/09/27/uporaba-nesteroidnih-protivnetnih-zdravil-nsaid-za-sistemsko-uporabo-med-nosecnostjo/2022-10-21T07:00:24+02:00https://www.jazmp.si/2022/09/28/prirocnik-za-distributerje-medicinskih-pripomockov/2025-10-16T10:57:55+02:00https://www.jazmp.si/2022/09/29/nulojix-belatacept-obvestilo-za-zdravstvene-delavce/2022-09-29T11:08:07+02:00https://www.jazmp.si/2022/09/29/neorecormon-epoetin-beta-obvestilo-za-zdravstvene-delavce/2022-09-29T11:13:02+02:00https://www.jazmp.si/2022/09/30/javna-razprava-glede-navodil-jazmp-o-oznacevanju-zdravil-ter-o-uporabi-mobilnih-tehnologij-npr-kode-qr/2022-09-30T08:32:53+02:00https://www.jazmp.si/2022/10/03/nova-priporocila-glede-terlipresina-pri-zdravljenju-hepatorenalnega-sindroma/2022-10-03T14:41:10+02:00https://www.jazmp.si/2022/10/03/poudarki-s-seje-odbora-prac-12/2022-10-03T14:58:53+02:00https://www.jazmp.si/2022/12/30/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-6/2023-02-28T13:21:15+01:00https://www.jazmp.si/2022/10/14/varnostna-obvestila-za-medicinske-pripomocke-september-2022/2022-10-14T13:44:41+02:00https://www.jazmp.si/2022/10/20/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-14/2022-10-20T16:49:39+02:00https://www.jazmp.si/2022/10/24/poziv-proizvajalcem-ucinkovin-vpisanih-v-register-proizvajalcev-ucinkovin-veletrgovcem-z-ucinkovinami-vpisanih-v-register-veletrgovcev-z-ucinkovinami-ter-uvoznikom-ucinkovin-vpisanih-v-register-uv-2/2022-10-24T10:15:13+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2022-10-24T16:18:23+02:00https://www.jazmp.si/2022/10/28/najava-dogodka-za-uporabnike-sistema-ctis-obvestilo-za-sponzorje/2022-10-28T14:01:25+02:00https://www.jazmp.si/2022/11/03/ukrepi-za-zmanjsanje-tveganja-za-resne-nezelene-ucinke-pri-zdravljenju-kronicnih-vnetnih-bolezni-z-zaviralci-janus-kinaz/2022-11-03T10:00:27+01:00https://www.jazmp.si/2022/11/03/poudarki-s-seje-odbora-prac-13/2022-11-03T11:32:44+01:00https://www.jazmp.si/2022/11/04/imbruvica-ibrutinib-obvestilo-za-zdravstvene-delavce/2022-11-04T12:48:43+01:00https://www.jazmp.si/2022/11/07/mednarodna-medijska-kampanja-medsafetyweek-za-spodbujanje-porocanja-o-nezelenih-ucinkih-zdravil/2022-11-14T12:28:50+01:00https://www.jazmp.si/2022/11/08/ozempic-semaglutid-obvestilo-za-zdravstvene-delavce/2022-11-08T08:18:18+01:00https://www.jazmp.si/2022/11/08/klormadinonacetat-in-nomegestrolacetat-obvestilo-za-zdravstvene-delavce/2022-11-08T08:59:02+01:00https://www.jazmp.si/2022/11/09/nulojix-belatacept-obvestilo-za-zdravstvene-delavce-2/2022-11-09T15:56:33+01:00https://www.jazmp.si/2022/11/14/xalkori-krizotinib-obvestilo-za-zdravstvene-delavce/2022-11-14T10:02:08+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2022-11-15T13:13:15+01:00https://www.jazmp.si/2022/11/16/varnostna-obvestila-za-medicinske-pripomocke-oktober-2022/2022-11-16T15:07:37+01:00https://www.jazmp.si/2022/11/18/predlog-tarife-jazmp/2022-11-18T15:45:56+01:00https://www.jazmp.si/2022/11/21/kampanji-ozavescanja-o-antibiotikih/2022-11-21T13:18:14+01:00https://www.jazmp.si/2022/12/01/obvestilo-o-stanju-izvajanja-uredbe-o-klinicnih-preskusanjih/2022-12-01T14:34:13+01:00https://www.jazmp.si/2022/12/02/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-15/2022-12-02T10:25:47+01:00https://www.jazmp.si/2022/12/02/ema-priporocila-umik-zdravil-ki-vsebujejo-folkodin-s-trga-eu/2022-12-02T14:49:30+01:00https://www.jazmp.si/2022/12/02/poudarki-s-seje-odbora-prac-14/2022-12-02T14:35:13+01:00https://www.jazmp.si/2022/12/09/animacija-spletni-strani-o-zdravilih-za-uporabo-v-veterinarski-medicini-in-nezelenih-ucinkih/2022-12-09T13:31:39+01:00https://www.jazmp.si/2022/12/09/ema-objavila-3-0-razlicica-prirocnika-ctis-za-sponzorje/2022-12-09T15:14:05+01:00https://www.jazmp.si/2022/12/13/porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2021/2022-12-13T09:34:00+01:00https://www.jazmp.si/2022/12/13/varnostna-obvestila-za-medicinske-pripomocke-november-2022/2022-12-13T14:56:33+01:00https://www.jazmp.si/2022/12/14/izjava-etf-o-izgubi-ucinkovitosti-monoklonskih-protiteles-ki-se-vezejo-na-konicni-protein-zaradi-zaskrbljujocih-razlicic-virusa-sars-cov-2-ki-se-pojavljajo/2022-12-14T00:26:39+01:00https://www.jazmp.si/2022/12/14/etf-opozarja-da-monoklonska-protitelesa-morda-ne-bodo-ucinkovita-proti-nastajajocim-sevom-virusa-sars-cov-2/2022-12-14T00:28:21+01:00https://www.jazmp.si/2022/12/15/caprelsa-vandetanib-obvestilo-za-zdravstvene-delavce/2022-12-15T16:01:41+01:00https://www.jazmp.si/2022/12/16/pregled-posodobitev-informacij-o-varnosti-cepiv-proti-covidu-19-16/2022-12-16T14:33:29+01:00https://www.jazmp.si/2022/12/19/ema-sprejela-stalisce-glede-zdravil-ki-vsebujejo-folkodin/2022-12-19T14:59:01+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2022-12-27T15:02:10+01:00https://www.jazmp.si/2022/12/30/objavljena-sprememba-tarife-jazmp/2022-12-30T12:38:51+01:00https://www.jazmp.si/2023/01/05/izjava-za-javnost-glede-dostopnosti-antibiotikov-v-obliki-peroralnih-suspenzij/2023-01-05T14:12:43+01:00https://www.jazmp.si/2023/01/05/dopolnitev-informacij-o-zdravilu-za-levotiroksin-mozen-vpliv-biotina-na-izide-testov-delovanja-scitnice-in-novi-interakciji/2023-01-05T15:58:17+01:00https://www.jazmp.si/2023/01/12/posodobitev-vprasanj-in-odgovorov-glede-cepiv-proti-covidu-19/2023-01-12T13:09:32+01:00https://www.jazmp.si/2023/01/13/varnostna-obvestila-za-medicinske-pripomocke-december-2022/2023-01-13T14:00:55+01:00https://www.jazmp.si/2023/01/17/poudarki-s-seje-odbora-prac-15/2023-01-17T11:28:01+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-01-17T16:07:11+01:00https://www.jazmp.si/2023/01/18/najava-dogodka-za-uporabnike-sistema-ctisin-prijava-na-e-novice/2023-01-18T14:23:36+01:00https://www.jazmp.si/2023/01/30/uredba-o-klinicnem-preskusanju-zdravil-vabilo-na-predstavitveni-dogodek/2023-01-30T11:43:24+01:00https://www.jazmp.si/2023/01/31/uredba-eu-st-536-2014-o-klinicnem-preskusanju-zdravil-za-uporabo-v-humani-medicini-hitri-vodnik-za-sponzorje/2023-01-31T15:19:55+01:00https://www.jazmp.si/2023/02/13/prac-zacel-pregled-varnosti-zdravil-ki-vsebujejo-psevdoefedrin/2023-02-13T13:48:36+01:00https://www.jazmp.si/2023/02/14/podaljsanje-roka-uporabnosti-za-cepivo-comirnaty-copy/2023-02-14T11:46:38+01:00https://www.jazmp.si/2023/02/15/varnostna-obvestila-za-medicinske-pripomocke-januar-2023/2023-02-15T15:59:33+01:00https://www.jazmp.si/2023/02/17/zolgensma%e2%96%bconasemnogen-abeparvovek-obvestilo-za-zdravstvene-delavce/2023-02-17T09:30:22+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-02-20T14:08:20+01:00https://www.jazmp.si/2023/02/28/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-8/2023-02-28T13:28:08+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-03-02T13:58:22+01:00https://www.jazmp.si/2023/03/03/registracija-gospodarskih-subjektov-in-medicinskih-pripomockov-v-eudamed/2023-03-03T09:55:20+01:00https://www.jazmp.si/2023/03/06/varnostna-obvestila-za-medicinske-pripomocke-februar-2023/2023-03-06T10:35:16+01:00https://www.jazmp.si/2023/03/13/zascitni-elementi-posodobljen-dokument-vprasanj-in-odgovorov-4/2023-03-13T13:03:29+01:00https://www.jazmp.si/2023/03/20/zaviralci-janusovih-kinaz-obvestilo-za-zdravstvene-delavce/2023-03-20T09:26:44+01:00https://www.jazmp.si/2023/03/20/poudarki-s-seje-odbora-prac-16/2023-03-20T14:17:48+01:00https://www.jazmp.si/2023/03/21/folkodin-obvestilo-za-zdravstvene-delavce/2023-03-21T08:32:52+01:00https://www.jazmp.si/2023/03/22/umik-zdravil-ki-vsebujejo-folkodin-s-trga-eu/2023-03-22T14:00:18+01:00https://www.jazmp.si/2023/03/24/ponarejeni-medicinski-pripomocki-z-logotipom-proizvajalca-bioteck-spa/2023-03-24T10:00:07+01:00https://www.jazmp.si/2023/04/11/varnostna-obvestila-za-medicinske-pripomocke-marec-2023/2023-04-11T13:02:55+02:00https://www.jazmp.si/2023/04/12/odpoklic-zdravil-lorsilan-1-mg-tablete-in-lorsilan-25-mg-tablete/2023-04-12T17:51:53+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-04-14T11:31:49+02:00https://www.jazmp.si/2023/04/17/poudarki-s-seje-odbora-prac-17/2023-04-17T08:54:45+02:00https://www.jazmp.si/2023/04/17/menopur-humani-menopavzni-gonadotropin-obvestilo-za-zdravstvene-delavce/2023-04-17T09:11:44+02:00https://www.jazmp.si/2023/05/12/simulect-baziliksimab-obvestilo-za-zdravstvene-delavce/2023-05-12T08:38:48+02:00https://www.jazmp.si/2023/05/15/varnostna-obvestila-za-medicinske-pripomocke-april-2023/2023-05-15T10:33:02+02:00https://www.jazmp.si/2023/05/23/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-%ef%bf%bc-2/2023-05-23T14:20:55+02:00https://www.jazmp.si/2023/05/23/fluorokinoloni-opomnik-glede-ukrepov-za-zmanjsanje-tveganja-za-resne-nezelene-ucinke-katerih-posledica-je-lahko-dolgotrajna-tudi-trajna-nezmoznost-ali-nesposobnost/2023-05-23T12:51:20+02:00https://www.jazmp.si/2023/05/23/poudarki-s-seje-odbora-prac-18/2023-05-23T13:11:24+02:00https://www.jazmp.si/2023/05/30/obvestilo-o-sprejetju-uredbe-eu-2023-607-z-dne-15-marca-2023-o-spremembi-uredb-eu-2017-745-in-eu-2017-746-v-zvezi-s-prehodnimi-dolocbami-za-nekatere-medicinske-pripomocke-in-in-vitro-diagnostic/2026-01-30T09:53:02+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-06-05T15:44:12+02:00https://www.jazmp.si/2023/06/08/porocanje-o-resnih-zapletih-z-medicinskimi-pripomocki-po-novem-tudi-preko-spletnega-obrazca/2023-06-08T14:48:42+02:00https://www.jazmp.si/2023/06/09/fluorokinoloni-obvestilo-za-zdravstvene-delavce-3/2023-06-09T09:53:08+02:00https://www.jazmp.si/2023/06/15/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-7/2023-06-15T07:46:43+02:00https://www.jazmp.si/2023/06/15/poudarki-s-seje-odbora-prac-19/2023-06-15T08:31:32+02:00https://www.jazmp.si/2023/06/16/gavreto%e2%96%bcpralsetinib-obvestilo-za-zdravstvene-delavce/2023-06-16T10:08:18+02:00https://www.jazmp.si/2023/06/16/varnostna-obvestila-za-medicinske-pripomocke-maj-2023/2023-06-16T14:08:08+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-06-28T16:16:01+02:00https://www.jazmp.si/2023/07/05/porocilo-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-veterinarski-medicini/2023-07-05T12:41:06+02:00https://www.jazmp.si/2023/07/10/poudarki-s-seje-odbora-prac-20/2023-07-10T09:41:44+02:00https://www.jazmp.si/2023/07/14/pregled-zdravil-iz-skupine-analogov-receptorjev-glp-1/2023-10-18T13:34:52+02:00https://www.jazmp.si/2023/07/17/varnostna-obvestila-za-medicinske-pripomocke-junij-2023/2023-07-17T13:06:11+02:00https://www.jazmp.si/2023/07/24/obvestilo-za-sponzorje/2023-07-24T11:49:29+02:00https://www.jazmp.si/2023/07/25/hidroksietilskrob-hes-ukinitev-dovoljenj-za-promet/2023-09-07T09:47:09+02:00https://www.jazmp.si/2023/07/28/objava-revidiranega-navodila-o-oznacevanju-zdravil-ter-objava-novega-navodila-o-uporabi-mobilnih-tehnologij/2023-07-28T11:07:52+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-07-28T14:42:02+02:00https://www.jazmp.si/2023/08/01/posodobitev-smernice-cmdh-za-podaljsanje-dovoljenja-za-promet-z-zdravilom/2023-08-01T10:19:16+02:00https://www.jazmp.si/2023/08/08/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-9/2023-08-08T09:11:39+02:00https://www.jazmp.si/2023/08/10/simponi-golimumab-50-mg-raztopina-za-injiciranje-v-napolnjenem-injekcijskem-peresniku-obvestilo-za-zdravstvene-delavce/2023-08-10T09:01:20+02:00https://www.jazmp.si/2023/08/11/varnostna-obvestila-za-medicinske-pripomocke-julij-2023/2023-08-11T13:45:06+02:00https://www.jazmp.si/2023/08/16/hemlibra-in-phesgo%e2%96%bc-obvestilo-za-zdravstvene-delavce/2023-08-16T09:59:34+02:00https://www.jazmp.si/2023/08/17/obvestilo-o-povecanem-povprasevanju-po-zdravilih-iz-skupine-agonistov-receptorjev-glukagonu-podobnega-peptida-1-glp-1-ra/2023-08-17T15:53:16+02:00https://www.jazmp.si/2023/08/22/oglasevanje-ter-prodaja-izdelka-snore-terminator-na-zavajajoc-nacin/2023-08-22T15:17:23+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-08-22T15:38:28+02:00https://www.jazmp.si/2023/08/29/izid-seste-izdaje-formulariuma-slovenicuma-fs-6-0/2023-08-29T09:19:35+02:00https://www.jazmp.si/2023/08/30/obisk-delegacije-administracije-za-zdravila-province-zhejiang/2023-08-30T13:20:20+02:00https://www.jazmp.si/2023/09/01/javni-natecaj-za-direktorja-javne-agencije-republike-slovenije-za-zdravila-in-medicinske-pripomocke-4/2023-09-20T10:24:18+02:00https://www.jazmp.si/2023/09/04/pregled-podatkov-o-izpostavljenosti-valproatu-preko-oceta/2023-09-04T15:46:55+02:00https://www.jazmp.si/2023/09/04/dodatni-ukrepi-za-preprecevanje-izpostavljenosti-topiramatu-med-nosecnostjo-nove-omejitve-uporabe-in-uvedba-programa-za-preprecevanje-nosecnosti/2023-09-04T16:12:33+02:00https://www.jazmp.si/2023/09/04/poudarki-s-seje-odbora-prac-21/2023-09-04T16:20:37+02:00https://www.jazmp.si/2023/09/12/varnostna-obvestila-za-medicinske-pripomocke-avgust-2023/2023-09-12T14:50:45+02:00https://www.jazmp.si/2023/09/26/podpis-sporazuma-med-jazmp-in-ima-za-dolgorocno-krepitev-sodelovanja-na-kljucnih-podrocjih-regulative-zdravil/2023-09-26T14:03:25+02:00https://www.jazmp.si/2023/10/02/poudarki-s-seje-odbora-prac-22/2023-10-02T11:23:57+02:00https://www.jazmp.si/2023/10/03/ozempic-semaglutid-obvestilo-za-zdravstvene-delavce-2/2023-10-03T10:35:26+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-10-04T15:23:30+02:00https://www.jazmp.si/2023/10/05/obvestilo-o-ukradenih-medicinskih-pripomockih-video-laringoskop-mcgrath-mac-ki-so-okvarjeni-in-neskladni-in-so-bili-s-strani-proizvajalca-namenjeni-unicenju/2023-10-05T09:41:17+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-10-09T13:47:15+02:00https://www.jazmp.si/2023/10/10/varnostna-obvestila-za-medicinske-pripomocke-september-2023/2023-10-10T08:49:59+02:00https://www.jazmp.si/2023/10/11/sprememba-pravil-preglednosti-za-informacijski-sistem-eu-o-klinicnih-preskusanjih-ctis/2023-10-11T19:48:59+02:00https://www.jazmp.si/2023/10/16/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-10/2023-10-16T13:41:18+02:00https://www.jazmp.si/2023/10/18/objava-letnih-podatkov-o-prodaji-zdravil-za-uporabo-v-veterinarski-medicini-v-eu-podatkovno-bazo-zdravil-upd/2023-10-18T11:43:22+02:00https://www.jazmp.si/2023/10/20/ema-opozarja-na-pojav-ponaredkov-zdravila-ozempic-v-evropski-uniji/2023-10-20T10:18:41+02:00https://www.jazmp.si/2023/10/20/pomanjkanje-zdravil-je-resen-globalni-izziv-s-katerim-se-sooca-tudi-slovenija/2023-10-20T10:59:38+02:00https://www.jazmp.si/2023/10/25/obravnavanje-kriticnega-pomanjkanja-zdravil-v-eu/2023-10-25T13:57:08+02:00https://www.jazmp.si/2023/10/26/zavajajoce-spletno-oglasevanje-izdelka-tonerin-z-zlorabo-identitete-dr-milana-kreka/2023-10-26T13:18:29+02:00https://www.jazmp.si/2023/10/27/topiramat-topamax-obvestilo-za-zdravstvene-delavce/2023-10-27T08:08:24+02:00https://www.jazmp.si/2023/10/27/obvestilo-za-sponzorje-tranzicija-klinicnih-preskusanj-z-direktive-2001-21-es-na-uredbo-eu-536-2014/2023-10-27T13:12:06+02:00https://www.jazmp.si/2023/11/03/integrilin-eptifibatid-obvestilo-za-zdravstvene-delavce/2023-11-03T08:08:20+01:00https://www.jazmp.si/2023/11/06/mednarodna-medijska-kampanja-medsafetyweek-za-spodbujanje-porocanja-o-nezelenih-ucinkih-zdravil-2/2023-11-06T10:48:46+01:00https://www.jazmp.si/2023/11/08/poudarki-s-seje-odbora-prac-23/2023-11-08T10:20:49+01:00https://www.jazmp.si/2023/11/09/zdravila-z-etilestri-omega-3-mascobnih-kislin-omacor-obvestilo-za-zdravstvene-delavce/2023-11-09T15:03:50+01:00https://www.jazmp.si/2023/11/09/simulect-baziliksimab-obvestilo-za-zdravstvene-delavce-2/2023-11-09T15:13:01+01:00https://www.jazmp.si/2023/11/10/nova-elektronska-postopka-namenjena-registraciji-dejavnosti-z-medicinskimi-pripomocki/2023-11-10T10:38:07+01:00https://www.jazmp.si/2023/11/14/ema-je-zacela-pregled-zdravil-z-ucinkovino-azitromicin/2023-11-14T08:34:25+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-11-14T08:36:22+01:00https://www.jazmp.si/2023/11/20/obvestilo-o-objavi-uredbe-o-izvajanju-uredbe-eu-o-zdravilih-za-uporabo-v-veterinarski-medicini/2023-11-20T09:13:56+01:00https://www.jazmp.si/2023/11/22/predlog-tarife-jazmp-2/2023-11-22T13:59:40+01:00https://www.jazmp.si/2023/11/30/varnostna-obvestila-za-medicinske-pripomocke-oktober-2023/2023-11-30T13:05:10+01:00https://www.jazmp.si/2023/12/04/voxzogo%e2%96%bcvosoritid-obvestilo-za-zdravstvene-delavce/2023-12-04T10:19:31+01:00https://www.jazmp.si/2023/12/04/prac-priporocil-ukrepe-za-zmanjsanje-tveganja-za-resne-nezelene-ucinke-pri-zdravilih-ki-vsebujejo-psevdoefedrin/2023-12-04T13:35:21+01:00https://www.jazmp.si/2023/12/04/poudarki-s-seje-odbora-prac-24/2023-12-04T13:31:59+01:00https://www.jazmp.si/2023/12/13/prva-razlicica-seznama-kriticnih-zdravil-unije-sprejeta-za-pomoc-pri-preprecevanju-morebitnega-pomanjkanja-v-eu/2023-12-13T13:16:58+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2023-12-18T15:55:31+01:00https://www.jazmp.si/2023/12/21/leqvio-inklisiran-obvestilo-za-zdravstvene-delavce/2023-12-21T10:25:52+01:00https://www.jazmp.si/2023/12/21/porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2022/2023-12-21T15:33:22+01:00https://www.jazmp.si/2024/01/03/bendamustin-accord-bendamustin-obvestilo-za-zdravstvene-delavce/2024-01-03T15:34:37+01:00https://www.jazmp.si/2024/01/03/obvestilo-za-imetnike-dovoljenj-za-promet-glede-sprememb-g-i-18/2024-01-03T15:41:03+01:00https://www.jazmp.si/2024/01/03/imenovanje-direktorja-javne-agencije-republike-slovenije-za-zdravila-in-medicinske-pripomocke/2024-01-03T17:42:02+01:00https://www.jazmp.si/2024/01/05/varnostna-obvestila-za-medicinske-pripomocke-november-2023/2024-01-05T13:21:55+01:00https://www.jazmp.si/2024/01/05/projekt-increasenet-sprejet-v-sofinanciranje-v-okviru-programa-eu4health/2024-01-05T13:42:24+01:00https://www.jazmp.si/2024/01/08/posodobitev-navodila-za-porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini/2024-01-08T15:34:38+01:00https://www.jazmp.si/2024/01/16/varnostna-obvestila-za-medicinske-pripomocke-december-2023/2024-01-16T08:28:23+01:00https://www.jazmp.si/2024/01/17/prac-priporocil-previdnostne-ukrepe-zaradi-moznega-tveganja-za-nevrorazvojne-motnje-pri-otrocih-rojenih-moskim-ki-se-zdravijo-z-valproatom/2024-01-17T15:51:25+01:00https://www.jazmp.si/2024/01/17/poudarki-s-seje-odbora-prac-25/2024-01-17T15:59:09+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2024-01-22T11:17:32+01:00https://www.jazmp.si/2024/01/23/mozne-motnje-v-delovanju-spletnega-obrazca-za-porocanje-o-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini/2024-01-23T11:35:22+01:00https://www.jazmp.si/2024/01/29/tranzicija-klinicnih-preskusanj-v-ctis-najava-usposabljanja-za-nekomercialne-sponzorje/2024-01-29T14:25:48+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2024-01-31T08:52:00+01:00https://www.jazmp.si/2024/02/02/uvodni-sestanek-projekta-skupnega-ukrepanja-increasenet/2024-02-12T14:57:53+01:00https://www.jazmp.si/2024/02/07/preklic-moznih-motenj-v-delovanju-spletnega-obrazca-za-porocanje-o-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini/2024-02-07T14:36:27+01:00https://www.jazmp.si/2024/02/12/zdravila-ki-vsebujejo-psevdoefedrin-obvestilo-za-zdravstvene-delavce/2024-02-12T10:28:25+01:00https://www.jazmp.si/2024/02/12/varnostna-obvestila-za-medicinske-pripomocke-januar-2024/2024-02-12T14:42:00+01:00https://www.jazmp.si/2024/02/12/poudarki-s-seje-odbora-prac-26/2024-02-12T15:36:17+01:00https://www.jazmp.si/2024/02/13/obvestilo-zdravstvenim-delavcem-o-pomenu-dodatnih-ukrepov-za-zmanjsevanje-tveganj/2024-02-13T14:39:18+01:00https://www.jazmp.si/2024/02/20/zdravila-ki-vsebujejo-valproat%e2%96%bc-obvestilo-za-zdravstvene-delavce/2024-02-20T11:33:39+01:00https://www.jazmp.si/2024/02/26/zdravila-ki-vsebujejo-etopozid-obvestilo-za-zdravstvene-delavce/2024-02-26T12:41:05+01:00https://www.jazmp.si/2024/03/04/poziv-za-izpolnitev-vprasalnika-o-izvajanju-farmakovigilancnih-storitev/2024-03-04T15:13:13+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2024-03-08T09:29:59+01:00https://www.jazmp.si/2024/03/08/poudarki-s-seje-odbora-prac-27/2024-03-08T13:19:12+01:00https://www.jazmp.si/2024/03/14/nov-nacin-porocanja-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-in-posodobitev-navodila-za-porocanje/2024-03-14T14:12:22+01:00https://www.jazmp.si/2024/03/19/klormadinonacetat-in-etinilestradiol-belara%e2%96%bc-obvestilo-za-zdravstvene-delavce/2024-03-19T09:14:15+01:00https://www.jazmp.si/2024/03/19/varnostna-obvestila-za-medicinske-pripomocke-februar-2024/2024-03-19T14:13:50+01:00https://www.jazmp.si/2024/03/22/paxlovid%e2%96%bc-nirmatrelvir-ritonavir-obvestilo-za-zdravstvene-delavce/2024-03-22T10:40:54+01:00https://www.jazmp.si/2024/03/28/obvestilo-o-ukradenih-medicinskih-pripomockih-altosa-xl-gemini-balloon-catheter/2024-03-28T14:38:59+01:00https://www.jazmp.si/2024/03/28/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-11/2024-08-27T12:33:27+02:00https://www.jazmp.si/2024/04/02/program-primerjalnega-spremljanja-evropskih-agencij-za-zdravila-bema/2024-04-02T09:08:07+02:00https://www.jazmp.si/2024/04/04/obvestilo-za-poslovne-subjekte-ki-imajo-ali-zelijo-pridobiti-dovoljenje-za-proizvodnjo-zdravil-veletrgovino-z-zdravili-na-debelo-potrdilo-o-vpisu-v-register-proizvajalcev-ucinkovin-v-register-vele/2024-04-04T14:16:26+02:00https://www.jazmp.si/2024/04/04/pomembno-obvestilo-glede-vpisov-v-eudragmdp-bazo-za-proizvajalce-zdravil-veletrgovce-z-zdravili-proizvajalce-ucinkovin-veletrgovce-z-ucinkovinami-ter-uvoznike-ucinkovin-2/2024-04-04T14:15:53+02:00https://www.jazmp.si/2024/04/04/letno-porocilo-proizvajalcev-ucinkovin-vpisani-v-register-proizvajalcev-ucinkovin-veletrgovcev-z-ucinkovinami-vpisani-v-register-veletrgovcev-z-ucinkovinami-ter-uvoznikov-ucinkovin-vpisani-v-register/2024-04-04T14:15:19+02:00https://www.jazmp.si/2024/04/04/synapse-zacasen-odvzem-dzp-za-vec-zdravil-zaradi-pomanjkljivih-studij/2024-04-04T12:40:45+02:00https://www.jazmp.si/2024/04/08/ponarejeni-medicinski-pripomocki-z-logotipom-proizvajalca-bioteck-spa-2/2024-04-10T15:30:26+02:00https://www.jazmp.si/2024/04/12/prenehanje-trzenja-zdravila-ladiomil-maprotilin/2024-04-12T13:16:01+02:00https://www.jazmp.si/2024/04/12/varnostna-obvestila-za-medicinske-pripomocke-marec-2024/2024-04-12T13:23:07+02:00https://www.jazmp.si/2024/04/16/poudarki-s-seje-odbora-prac-28/2024-04-16T14:08:47+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2024-04-29T10:57:49+02:00https://www.jazmp.si/2024/05/08/uvedba-spremenjenih-pravil-preglednosti-za-informacijski-sistem-eu-o-klinicnih-preskusanjih-ctis/2024-05-08T15:06:38+02:00https://www.jazmp.si/2024/05/10/anketa-soho-management-in-eu-hospitals-shaping-the-future/2024-05-10T10:09:28+02:00https://www.jazmp.si/2024/05/16/varnostna-obvestila-za-medicinske-pripomocke-april-2024/2024-05-16T14:50:59+02:00https://www.jazmp.si/2024/05/21/javna-razprava-o-predlogu-posodobljenega-dokumenta-hma-ema-ki-ureja-identifikacijo-osebnih-podatkov-in-poslovno-zaupnih-informacij-v-vlogah-za-pridobitev-dovoljenja-za-promet-z-zdravilom-za-uporabo-v/2024-05-21T14:45:49+02:00https://www.jazmp.si/2024/05/22/poudarki-s-seje-odbora-prac-29/2026-01-09T13:37:19+01:00https://www.jazmp.si/2024/05/24/giapreza%e2%96%bc-angiotenzin-ii-25-mg-ml-koncentrat-za-raztopino-za-infundiranje-1-ml-viala-obvestilo-za-zdravstvene-delavce/2024-05-24T08:38:44+02:00https://www.jazmp.si/2024/05/30/varnostno-obvestilo-za-medicinske-pripomocke-heartsine-samaritan-pad-350p-360p-450p-500p-omron-hdf-3500/2024-05-30T15:04:51+02:00https://www.jazmp.si/2024/06/03/vabilo-na-spletno-delavnico-esmp/2024-06-03T14:49:50+02:00https://www.jazmp.si/2024/06/04/posredovanje-podatkov-o-sifrah-zdravil-uporabljenih-v-edinstveni-oznaki-zdravil-in-pravilna-raba-standardov/2024-06-04T10:35:01+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2024-06-04T16:17:40+02:00https://www.jazmp.si/2024/06/06/obvestilo-v-zvezi-z-odpoklicem-zdravila-kextone-324-g-intraruminalni-sistem-s-kontinuiranim-sproscanjem-za-govedo-monenzin-za-uporabo-v-veterinarski-medicini/2024-06-06T14:17:43+02:00https://www.jazmp.si/2024/06/06/opozorilo-imetnikom-dovoljenj-za-promet-z-zdravili-glede-neustreznih-atd/2024-06-06T14:49:43+02:00https://www.jazmp.si/2024/06/07/varnostna-obvestila-za-medicinske-pripomocke-maj-2024/2024-06-07T14:07:49+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2024-06-12T13:55:26+02:00https://www.jazmp.si/2024/06/18/nelegalna-spletna-prodaja-zdravil-na-spletni-strani-shujsaj-com/2024-06-18T09:21:07+02:00https://www.jazmp.si/2024/06/19/nova-verzija-javnega-portala-za-klinicna-preskusanja/2024-06-19T11:24:44+02:00https://www.jazmp.si/2024/06/26/poudarki-s-seje-odbora-prac-30/2024-06-26T10:49:18+02:00https://www.jazmp.si/2024/06/26/metamizol-zacetek-pregleda-varnosti-zdravil/2024-06-26T10:47:32+02:00https://www.jazmp.si/2024/06/26/izsla-prva-stevilka-farmakovigilancnega-biltena-nova-e-publikacija-jazmp-za-zdravstvene-delavce/2024-06-26T11:05:23+02:00https://www.jazmp.si/2024/06/27/varnostna-obvestila-za-medicinske-pripomocke-junij-2024/2024-06-27T15:34:59+02:00https://www.jazmp.si/2024/05/10/ct-cure-podaljsuje-pospesen-pregled-mednarodnih-vlog-za-klinicna-preskusanja-zdravil-covid-19/2024-07-05T11:06:13+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2024-07-05T12:50:50+02:00https://www.jazmp.si/2024/07/16/obvestilo-o-objavi-uredbe-eu-2024-1860/2026-01-30T09:59:04+01:00https://www.jazmp.si/2024/07/17/oglasevanje-in-prodaja-izdelka-inteligentni-ojacevalnik-sluha-puresound-pulse-na-zavajajoc-nacin/2024-07-17T13:04:18+02:00https://www.jazmp.si/2024/07/18/kymriah%e2%96%bccar-t-celicno-zdravljenje-usmerjeno-proti-cd19-obvestilo-za-zdravstvene-delavce/2024-07-18T11:20:56+02:00https://www.jazmp.si/2024/07/25/poudarki-s-seje-odbora-prac-31/2024-07-25T10:54:02+02:00https://www.jazmp.si/2024/07/25/uredba-eu-2024-1938-evropskega-parlamenta-in-sveta-z-dne-13-junija-2024-o-standardih-kakovosti-in-varnosti-za-snovi-cloveskega-izvora-namenjene-za-uporabo-na-ljudeh/2024-07-25T10:35:23+02:00https://www.jazmp.si/2024/07/29/popravek-uredbe-eu-2024-1938-evropskega-parlamenta-in-sveta-z-dne-13-junija-2024/2024-07-29T14:14:04+02:00https://www.jazmp.si/2024/08/01/ocaliva%e2%96%bcobetiholna-kislina-obvestilo-za-zdravstvene-delavce/2024-08-01T13:19:12+02:00https://www.jazmp.si/2024/08/06/varnostna-obvestila-za-medicinske-pripomocke-julij-2024/2024-08-06T09:54:32+02:00https://www.jazmp.si/2024/08/09/ozempic-semaglutid-in-victoza-liraglutid-obvestilo-za-zdravstvene-delavce/2024-08-09T10:24:07+02:00https://www.jazmp.si/2024/08/16/glatiramerijev-acetat-copaxone-obvestilo-za-zdravstvene-delavce/2024-08-16T12:19:57+02:00https://www.jazmp.si/2024/08/19/evropska-komisija-objavila-poziv-za-prijavo-interesa-za-clanstvo-v-odboru-prac-za-predstavnike-zdravstvenih-delavcev-in-organizacij-pacientov/2024-08-19T12:45:22+02:00https://www.jazmp.si/2024/08/27/zavajajoce-spletno-oglasevanje-ter-prodaja-izdelkov-predstavljenih-z-lastnostmi-za-zdravljenje-12/2024-08-27T12:32:34+02:00https://www.jazmp.si/2024/08/29/izid-prvega-dopolnila-k-sesti-izdaji-formulariuma-slovenicuma-fs-6-1/2024-09-10T07:26:39+02:00https://www.jazmp.si/2024/09/02/sporocilo-za-javnost-o-velikem-povprasevanju-po-zdravilu-ozempic-skupna-prizadevanja-za-omilitev-tezav-s-preskrbo/2024-09-02T14:00:56+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2024-09-05T16:34:59+02:00https://www.jazmp.si/2024/09/13/metamizol-ema-priporoca-ukrepe-za-zmanjsevanje-resnih-posledic-agranulocitoze/2024-09-13T12:06:40+02:00https://www.jazmp.si/2024/09/16/namera-o-sklenitvi-neposredne-pogodbe-za-prodajo-racunalniske-in-kamp-opreme-3/2024-09-16T11:28:40+02:00https://www.jazmp.si/2024/09/16/poudarki-s-seje-odbora-prac-32/2024-09-16T10:54:15+02:00https://www.jazmp.si/2024/09/16/varnostna-obvestila-za-medicinske-pripomocke-avgust-2024/2024-09-16T11:21:58+02:00https://www.jazmp.si/2024/09/16/obvestilo-o-ukradenih-medicinskih-pripomockih-mr-q-slt-s-proizvajalca-meridian-medical-d-o-o/2024-09-16T14:16:23+02:00https://www.jazmp.si/2024/09/27/obvestilo-za-javnost-sars-cov-2-antigenski-testi-z-nazivom-deep-blue-s-pretecenim-datumom-uporabe/2024-09-27T15:56:33+02:00https://www.jazmp.si/2024/09/30/obvestilo-za-javnost-v-zvezi-s-prenehanjem-delovanja-podjetja-biobanka-popkovnicne-krvi-d-o-o/2024-09-30T13:14:36+02:00https://www.jazmp.si/2024/10/01/varnostna-obvestila-za-medicinske-pripomocke-september-2024/2024-10-01T14:14:02+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2024-10-01T15:55:27+02:00https://www.jazmp.si/2024/10/02/nove-zahteve-za-oznacevanje-zdravil-v-odmernih-inhalatorjih-pod-tlakom-ki-vsebujejo-fluorirane-toplogredne-pline/2024-10-02T12:52:07+02:00https://www.jazmp.si/2024/10/04/dodatno-obvestilo-za-javnost-v-zvezi-s-prenehanjem-delovanja-podjetja-biobanka-popkovnicne-krvi-d-o-o/2024-10-25T11:35:51+02:00https://www.jazmp.si/2024/10/08/medroksiprogesteronacetat-depo-provera-150-mg-ml-suspenzija-za-injiciranje-obvestilo-za-zdravstvene-delavce/2024-10-08T08:56:59+02:00https://www.jazmp.si/2024/10/08/finasterid-in-dutasterid-zacetek-pregleda-varnosti-zdravil/2024-10-08T13:17:07+02:00https://www.jazmp.si/2024/10/09/poudarki-s-seje-odbora-prac-33/2024-10-09T11:29:05+02:00https://www.jazmp.si/2024/10/22/izsla-druga-stevilka-farmakovigilancnega-biltena/2024-10-22T11:55:35+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2024-10-24T15:51:05+02:00https://www.jazmp.si/2024/10/25/fluorouracil-accord-5-fluorouracil-obvestilo-za-zdravstvene-delavce/2024-10-25T08:30:13+02:00https://www.jazmp.si/2024/10/25/dodatno-obvestilo-za-javnost-v-zvezi-s-prenehanjem-opravljanja-dejavnosti-preskrbe-s-tkivi-in-celicami-podjetja-biobanka-popkovnicne-krvi-d-o-o/2024-11-08T14:08:27+01:00https://www.jazmp.si/2024/11/04/kampanja-medsafetyweek-2024-za-spodbujanje-porocanja-nezelenih-ucinkov-zdravil/2024-11-04T10:15:27+01:00https://www.jazmp.si/2024/11/07/vabilo-na-spletni-dogodek-chessmen-multi-stakeholder-workshop-27-novembra-2024/2024-11-07T14:41:54+01:00https://www.jazmp.si/2024/11/07/pegasys-peginterferon-alfa-2a-obvestilo-za-zdravstvene-delavce/2024-11-07T10:07:47+01:00https://www.jazmp.si/2024/11/11/poudarki-s-seje-odbora-prac-34/2024-11-11T11:34:03+01:00https://www.jazmp.si/2024/11/11/varnostna-obvestila-za-medicinske-pripomocke-oktober-2024/2024-11-11T14:31:30+01:00https://www.jazmp.si/2024/11/12/preverjanje-avtenticnosti-zdravil-ki-so-bila-primarno-namenjena-dajanju-na-trg-v-veliki-britaniji/2024-11-12T13:46:54+01:00https://www.jazmp.si/2024/11/20/poziv-veletrgovcem-zdravil-za-preskrbo-z-zdravili/2024-11-20T18:48:56+01:00https://www.jazmp.si/2024/12/02/porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2023/2024-12-02T10:25:09+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2024-12-03T10:38:12+01:00https://www.jazmp.si/2024/12/05/kljucni-delezniki-usklajeni-kako-izboljsati-trenutne-prakse-pri-obvladovanju-pomanjkanja-zdravil-v-eu-egp/2024-12-05T10:06:10+01:00https://www.jazmp.si/2024/12/05/poudarki-s-seje-odbora-prac-35/2024-12-05T09:38:40+01:00https://www.jazmp.si/2024/12/06/prenehanje-trzenja-zdravila-ladiomil-maprotilin-2/2024-12-06T09:39:59+01:00https://www.jazmp.si/2024/12/10/metamizol-obvestilo-za-zdravstvene-delavce-2/2024-12-10T08:42:16+01:00https://www.jazmp.si/2024/12/11/oglasevanje-izdelka-hip-knee-magnetni-pas-proti-bolecinam-na-zavajajoc-nacin/2024-12-19T11:25:19+01:00https://www.jazmp.si/2024/12/12/varnostna-obvestila-za-medicinske-pripomocke-november-2024/2024-12-12T10:29:31+01:00https://www.jazmp.si/2024/12/12/obvestilo-o-novi-obveznosti-porocanja-gospodarskih-subjektov-in-nadaljnjega-obvescanja-v-primeru-prekinitve-ali-prenehanja-dobave-nekaterih-medicinskih-pripomockov/2025-03-26T14:16:38+01:00https://www.jazmp.si/2024/12/19/obvestilo-o-poslovnem-casu-in-uradnih-urah-pred-dela-prostima-dnevoma-24-in-31-12-2024/2024-12-31T10:31:24+01:00https://www.jazmp.si/2024/12/19/oglasevanje-in-prodaja-izdelka-stabilizator-kolena-knee-active-pro-na-zavajajoc-nacin/2025-08-04T09:22:59+02:00https://www.jazmp.si/2024/12/20/alofisel-darvadstrocel-obvestilo-za-zdravstvene-delavce/2024-12-20T13:15:37+01:00https://www.jazmp.si/2024/12/20/obvestilo-za-javnostv-zvezi-s-prenehanjem-opravljanja-dejavnosti-preskrbe-s-tkivi-in-celicami-podjetja-biobanka-popkovnicne-krvi-d-o-o/2025-01-09T13:16:54+01:00https://www.jazmp.si/2024/12/30/usmeritve-predlagateljem-glede-uporabe-delegirane-uredbe-komisije-o-spremembah-od-1-januarja-2025/2024-12-30T13:49:38+01:00https://www.jazmp.si/2024/12/31/obvestilo-o-predvideni-motnji-v-preskrbi-z-zdravilom-estriol-01-mg-g-001-vaginalna-krema/2024-12-31T10:30:43+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2025-01-10T16:36:02+01:00https://www.jazmp.si/2025/01/14/varnostna-obvestila-za-medicinske-pripomocke-december-2024/2025-02-07T11:20:01+01:00https://www.jazmp.si/2025/01/23/poudarki-s-seje-odbora-prac-36/2025-01-23T13:56:23+01:00https://www.jazmp.si/2025/01/28/izsla-tretja-stevilka-farmakovigilancnega-biltena/2025-01-28T13:11:25+01:00https://www.jazmp.si/2025/02/07/poudarki-s-foruma-ocenjevalcev-zdravil-increasenet-2025/2025-02-17T08:39:26+01:00https://www.jazmp.si/2025/02/10/opozorilo-o-nevarnem-izzivu-paracetamol-challenge-na-druzbenih-omrezjih/2025-02-11T17:42:33+01:00https://www.jazmp.si/2025/02/11/varnostna-obvestila-za-medicinske-pripomocke-januar-2025/2025-02-11T11:32:58+01:00https://www.jazmp.si/2025/02/19/poudarki-s-seje-odbora-prac-37/2025-02-19T10:46:35+01:00https://www.jazmp.si/2025/02/26/obvestilo-za-javnost-v-zvezi-s-shranjenimi-vzorci-pravne-osebe-biobanka-d-o-o/2025-02-26T14:47:10+01:00https://www.jazmp.si/2025/02/27/poziv-veletrgovcem-zdravil-za-preskrbo-z-zdravili-2/2025-02-27T14:09:31+01:00https://www.jazmp.si/2025/03/04/kljucne-aktivnosti-projekta-chessmen-v-letu-2024/2025-03-04T14:22:06+01:00https://www.jazmp.si/2025/03/05/obvestilo-o-zacetku-delovanja-interaktivnega-zemljevida-klinicnih-preskusanj/2025-03-07T14:34:18+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2025-03-05T10:59:26+01:00https://www.jazmp.si/2025/03/12/varnostna-obvestila-za-medicinske-pripomocke-februar-2025/2025-03-12T16:40:31+01:00https://www.jazmp.si/2025/03/13/neregulirana-zdravila-za-napredno-zdravljenje-predstavljajo-resno-tveganje-za-zdravje/2025-03-13T13:38:48+01:00https://www.jazmp.si/2025/03/25/kisqali-ribociklib-obvestilo-za-zdravstvene-delavce/2025-03-25T11:22:52+01:00https://www.jazmp.si/2025/03/26/poudarki-s-seje-odbora-prac-38/2025-03-26T10:32:36+01:00https://www.jazmp.si/2025/03/31/v-svici-odkrili-zelo-nevaren-ponaredek-zdravila-oxycontin-80-mg-tablete/2025-03-31T14:11:53+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2025-04-01T13:39:15+02:00https://www.jazmp.si/2025/04/10/socasno-nacionalno-znanstveno-svetovanje-snsa-nadaljnji-razvoj-v-letu-2025/2025-04-10T10:10:47+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2025-04-15T10:01:35+02:00https://www.jazmp.si/2025/04/15/varnostna-obvestila-za-medicinske-pripomocke-marec-2025/2025-04-15T14:49:26+02:00https://www.jazmp.si/2025/04/16/cyanokit-hidroksokobalamin-5-g-prasek-za-raztopino-za-infundiranje-obvestilo-za-zdravstvene-delavce/2025-04-16T08:06:13+02:00https://www.jazmp.si/2025/04/16/iberogast-peroralne-kapljice-raztopina-obvestilo-za-zdravstvene-delavce/2025-04-16T08:08:45+02:00https://www.jazmp.si/2025/04/17/obvestilo-who-o-uporabi-hitrih-diagnosticnih-testov-za-malarijo/2025-04-17T14:13:34+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2025-04-22T10:41:26+02:00https://www.jazmp.si/2025/04/23/pricetek-veljave-zakona-o-spremembah-in-dopolnitvah-zakona-o-zdravilih-zzdr-2b/2025-06-06T14:12:32+02:00https://www.jazmp.si/2025/04/24/poudarki-s-seje-odbora-prac-39/2025-04-24T09:23:23+02:00https://www.jazmp.si/2025/04/24/izsla-cetrta-stevilka-farmakovigilancnega-biltena/2025-04-24T10:36:57+02:00https://www.jazmp.si/2025/04/25/opzelura-15-mg-g-krema-ruksolitinib-v-obliki-fosfata-obvestilo-za-zdravstvene-delavce/2025-04-25T09:18:24+02:00https://www.jazmp.si/2025/04/30/varnostna-obvestila-za-medicinske-pripomocke-april-2025/2025-04-30T13:28:34+02:00https://www.jazmp.si/2025/05/14/poudarki-s-seje-odbora-prac-40/2025-05-14T13:45:06+02:00https://www.jazmp.si/2025/05/14/finasterid-in-dutasterid-ukrepi-za-zmanjsevanje-tveganja-samomorilnih-misli/2025-05-14T13:40:45+02:00https://www.jazmp.si/2025/05/16/obvestilo-za-javnost-v-zvezi-z-upravnimi-in-inspekcijskimi-postopki-pri-biobanki-d-o-o-odziv-jazmp-na-clanek-objavljen-na-necenzurirano-si-dne-15-5-2025/2025-05-16T13:34:08+02:00https://www.jazmp.si/2025/05/20/srecanje-clanov-evropske-baze-podatkov-o-cenah-zdravil-euripid/2025-05-20T16:06:45+02:00https://www.jazmp.si/2025/05/26/delavnica-o-zagotavljanju-trajnosti-dosezkov-projekta-jams-2-0/2025-05-26T10:45:34+02:00https://www.jazmp.si/2025/06/19/objava-zakona-o-medicinskih-pripomockih-zmedpri-1/2025-06-19T10:05:57+02:00https://www.jazmp.si/2025/06/09/oglasevanje-izdelkov-na-zavajajoc-nacin/2025-06-10T09:12:46+02:00https://www.jazmp.si/2025/06/11/semaglutid-naion-potrjen-kot-zelo-redek-nezeleni-ucinek/2025-06-11T09:50:58+02:00https://www.jazmp.si/2025/06/11/poudarki-s-seje-odbora-prac-41/2025-06-11T10:11:07+02:00https://www.jazmp.si/2025/06/17/varnostna-obvestila-za-medicinske-pripomocke-maj-2025/2025-06-17T07:39:43+02:00https://www.jazmp.si/2025/06/24/poziv-izvajaicem-zdravstvene-dejavnosti-za-predlog-kandidatov-za-komisijo-za-dolocanje-izrednih-visjih-dovoljenih-cen-zdravil/2025-06-24T10:16:29+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2025-06-24T13:17:12+02:00https://www.jazmp.si/2025/06/24/porocanje-o-domnevnih-nezelenih-ucinkih-zdravil-za-uporabo-v-humani-medicini-v-letu-2024/2025-06-24T14:45:47+02:00https://www.jazmp.si/2025/06/30/obvestilo-v-zvezi-z-nelegalno-prodajo-in-nakupi-zdravil-z-ucinkovino-semaglutid-prek-medmrezja/2025-06-30T13:00:49+02:00https://www.jazmp.si/2025/07/09/vabilo-na-spletno-izobrazevanje-obveznosti-poslovnih-subjektov-v-skladu-z-mdr-ivdr-in-zmedpri-1/2025-07-09T12:06:15+02:00https://www.jazmp.si/2025/07/14/varnostna-obvestila-za-medicinske-pripomocke-junij-2025/2025-07-14T22:12:47+02:00https://www.jazmp.si/2025/07/16/poudarki-s-seje-odbora-prac-42/2025-07-16T14:27:31+02:00https://www.jazmp.si/2025/07/24/35310/2025-07-25T09:10:13+02:00https://www.jazmp.si/2025/07/30/izsla-peta-stevilka-farmakovigilancnega-biltena/2025-07-30T13:49:36+02:00https://www.jazmp.si/2025/08/01/obvestilo-za-javnost-v-zvezi-s-shranjenimi-vzorci-pravne-osebe-biobanka-d-o-o-2/2025-08-04T09:25:02+02:00https://www.jazmp.si/2025/08/04/varnostne-informacije-glede-ponaredkov-zobnih-smol-proizvajalca-thermoplastic-comfort-systems-inc/2025-08-04T11:19:14+02:00https://www.jazmp.si/2025/08/04/nova-spletna-stran-ema-za-veterinarje/2025-08-05T11:39:38+02:00https://www.jazmp.si/2025/08/05/napovedujemo-kampanjo-medsafetyweek-2025-vabljeni-k-sodelovanju/2025-08-05T12:23:57+02:00https://www.jazmp.si/2025/08/12/odpoklic-medicinskih-pripomockov-heartsine-samaritan-pad-350p-360p-450p-500p/2025-08-12T09:32:58+02:00https://www.jazmp.si/2025/08/12/obvestilo-za-javnost-v-zvezi-shranjenimi-vzorci-biobanke-d-o-o/2025-08-12T12:34:41+02:00https://www.jazmp.si/2025/08/18/who-in-undoc-objavila-porocilo-o-kontaminaciji-zdravil-s-strupenimi-industrijskimi-kemikalijami/2025-08-18T08:01:50+02:00https://www.jazmp.si/2025/08/19/varnostna-obvestila-za-medicinske-pripomocke-julij-2025/2025-08-19T14:55:37+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2025-08-20T07:21:09+02:00https://www.jazmp.si/konoplja-in-kanabinoidi/zakon-o-konoplji-za-medicinske-in-znanstvene-namene/2025-09-19T13:16:19+02:00https://www.jazmp.si/2025/08/21/evrysdi%e2%96%bc-075-mg-ml-prasek-za-peroralno-raztopino-risdiplam-obvestilo-za-zdravstvene-delavce/2025-08-21T09:31:59+02:00https://www.jazmp.si/2025/08/21/izid-drugega-dopolnila-k-sesti-izdaji-formulariuma-slovenicuma-fs-6-2/2025-08-21T14:17:33+02:00https://www.jazmp.si/2025/08/25/obvestilo-glede-uporabe-titanovega-dioksida-v-zdravilih/2025-09-05T14:05:11+02:00https://www.jazmp.si/2025/08/29/revidirano-navodilo-za-dolocanje-stevilk-postopkov-3/2025-08-29T13:24:28+02:00https://www.jazmp.si/2025/09/03/varnostna-obvestila-za-medicinske-pripomocke-avgust-2025/2025-09-03T13:22:39+02:00https://www.jazmp.si/2025/09/04/mimpara-cinakalcet-prenehanje-trzenja-vseh-jakosti-zdravila-v-obliki-tablet-in-zrnc-v-kapsulah-za-odpiranje-obvestilo-za-zdravstvene-delavce/2025-10-21T12:29:46+02:00https://www.jazmp.si/2025/09/04/varnostne-informacije-glede-ponaredkov-izdelka-nosna-kanila-luer-lock-f-pvc-za-odrasle-proizvajalca-yuyao-hairui-medical-device-co-ltd/2025-09-04T14:27:21+02:00https://www.jazmp.si/2025/09/08/teden-ozavescanja-javnosti-o-varni-uporabi-zdravil-ki-se-izdajajo-brez-recepta-otc/2025-09-08T13:47:24+02:00https://www.jazmp.si/2025/09/09/klozapin-leponex-obvestilo-za-zdravstvene-delavce/2025-09-09T08:39:04+02:00https://www.jazmp.si/2025/09/12/finasterid-dutasterid-obvestilo-za-zdravstvene-delavce/2025-09-12T09:52:12+02:00https://www.jazmp.si/2025/09/12/levamizol-zacetek-pregleda-varnosti-zdravil/2025-09-12T10:04:37+02:00https://www.jazmp.si/2025/09/12/poudarki-s-seje-odbora-prac-43/2025-09-12T11:27:56+02:00https://www.jazmp.si/2025/09/16/risperidon-1-mg-ml-peroralna-raztopina-risperdal-rispolux-obvestilo-za-zdravstvene-delavce/2025-09-16T12:44:19+02:00https://www.jazmp.si/2025/09/24/paracetamol-priporocila-glede-uporabe-med-nosecnostjo-v-eu-nespremenjena/2025-09-24T11:05:15+02:00https://www.jazmp.si/2025/11/18/poziv-veletrgovcem-zdravil-za-preskrbo-z-zdravili-3/2026-01-09T15:45:04+01:00https://www.jazmp.si/2025/10/01/prihajajoci-dogodek-letno-srecanje-vecdelezniske-platforme-act-eu/2025-10-01T09:42:25+02:00https://www.jazmp.si/2025/10/01/podpora-nekomercialnim-sponzorjem-klinicnih-preskusanj/2025-10-01T09:47:07+02:00https://www.jazmp.si/2025/10/08/hma-ema-vecdelezniska-delavnica-o-umetni-inteligenci/2025-10-08T10:28:10+02:00https://www.jazmp.si/2025/10/08/anketa-o-prednostnih-nalogah-raziskav-na-podrocju-umetne-inteligence/2025-10-27T16:47:54+01:00https://www.jazmp.si/2025/10/08/podaljsan-cas-obravnave-vlog-za-registracijo-subjektov-po-zmedpri-1/2025-10-08T14:31:05+02:00https://www.jazmp.si/2025/10/10/crysvita-burosumab-obvestilo-za-zdravstvene-delavce/2025-10-10T08:30:45+02:00https://www.jazmp.si/2025/10/10/kaspofungin-obvestilo-za-zdravstvene-delavce/2025-10-10T08:33:56+02:00https://www.jazmp.si/2025/10/13/previdnost-pri-nakupu-in-uporabi-medicinskih-pripomockov/2025-10-13T09:52:26+02:00https://www.jazmp.si/2025/10/13/priporocilo-glede-uporabe-spletnih-elektronskih-obrazcev-eaf-za-vloge-za-spremembe-dovoljenja-za-promet-z-zdravili-za-uporabo-v-humani-medicini-ki-dovoljenja-za-promet-niso-pridobila-po-centralizir/2025-10-13T10:32:47+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2025-10-14T11:25:41+02:00https://www.jazmp.si/2025/10/15/usmeritve-glede-uporabe-novih-smernic-evropske-komisije-o-razvrstitvi-sprememb/2025-10-15T10:02:14+02:00https://www.jazmp.si/2025/10/20/varnostna-obvestila-za-medicinske-pripomocke-september-2025/2025-10-20T09:52:21+02:00https://www.jazmp.si/2025/10/21/zypadhera-olanzapinijev-pamoat-monohidrat-210-mg-300-mg-405-mg-prasek-in-vehikel-za-suspenzijo-za-injiciranje-s-podaljsanim-sproscanjem-motnje-v-preskrbi-zdravila-obvestilo-za-zdravstvene-delavc/2025-10-21T12:25:24+02:00https://www.jazmp.si/2025/10/22/poudarki-s-seje-odbora-prac-44/2025-10-22T13:51:36+02:00https://www.jazmp.si/2025/10/22/kampanja-healthnothype-ema-in-ustvarjalci-vsebin-skupaj-za-varno-in-odgovorno-uporabo-zdravil-z-agonisti-receptorjev-glp-1/2025-10-22T14:10:03+02:00https://www.jazmp.si/2025/10/24/izsla-sesta-stevilka-farmakovigilancnega-biltena/2025-10-24T12:23:57+02:00https://www.jazmp.si/2025/11/03/jubilejna-10-kampanja-medsafetyweek-2025-za-varnejso-uporabo-zdravil/2025-11-03T11:38:32+01:00https://www.jazmp.si/2025/11/03/nova-obrazca-za-porocanje-o-neustrezni-kakovosti-zdravil/2025-11-03T15:02:56+01:00https://www.jazmp.si/2025/11/10/poziv-imetnikom-dovoljenj-za-promet-z-zdravili-da-zagotovijo-popolnost-in-ustreznost-podatkov-v-simvs/2025-11-10T08:59:14+01:00https://www.jazmp.si/2025/11/10/napoved-spletnega-izobrazevanja-nova-zakonodaja-za-spremembe-dovoljenja-za-promet-za-zdravila-za-uporabo-v-humani-medicini/2025-11-10T09:31:25+01:00https://www.jazmp.si/2025/11/10/varnostna-obvestila-za-medicinske-pripomocke-oktober-2025/2025-11-10T12:53:28+01:00https://www.jazmp.si/2025/11/10/kampanjo-boj-proti-pomanjkanju-zdravil-potrebna-je-ekipa/2025-11-10T20:42:47+01:00https://www.jazmp.si/2025/11/10/libtayo-%e2%96%bc-cemiplimab-350-mg-koncentrat-za-raztopino-za-infundiranje-obvestilo-za-zdravstvene-delavce/2025-11-10T13:59:20+01:00https://www.jazmp.si/2025/11/11/predlog-tarife-jazmp-za-podrocje-medicinskih-pripomockov/2025-11-11T10:11:05+01:00https://www.jazmp.si/2025/11/11/obvestilo-za-javnost-v-zvezi-s-shranjenimi-vzorci-biobanke-d-o-o/2025-11-11T12:00:36+01:00https://www.jazmp.si/2025/11/18/dodatno-obvestilo-za-javnost-v-zvezi-s-shranjenimi-vzorci-biobanke-d-o-o/2025-11-18T13:23:14+01:00https://www.jazmp.si/2025/11/19/vabilo-na-spletno-izobrazevanja-nova-zakonodaja-za-spremembe-dovoljenja-za-promet-za-zdravila-za-uporabo-v-humani-medicini/2025-11-24T13:15:45+01:00https://www.jazmp.si/2025/11/24/objava-slovenskega-prevoda-klasifikacije-meddra/2025-11-24T08:14:25+01:00https://www.jazmp.si/2025/11/25/poudarki-s-seje-odbora-prac-45/2025-11-25T11:26:47+01:00https://www.jazmp.si/2025/11/28/objava-v-uradnem-listu-unije-o-polni-funkcionalnosti-stirih-modulov-eudamed/2025-11-28T09:10:24+01:00https://www.jazmp.si/2025/11/27/prenehanje-opravljanja-prometa-s-posameznimi-oblikami-pakiranj-srednjedolgodelujocega-insulina-insulin-izofan-humani-insulin-nph-100-enot-ml-suspenzija-za-injiciranje-ter-kratko-in-hitrodelujo/2025-11-28T14:42:57+01:00https://www.jazmp.si/2025/12/08/poudarki-s-seje-odbora-prac-46/2025-12-08T12:54:03+01:00https://www.jazmp.si/2025/12/09/varnostna-obvestila-za-medicinske-pripomocke-november-2025/2025-12-09T09:25:27+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2025-12-11T07:09:02+01:00https://www.jazmp.si/2025/12/11/trenolk-100-mg-ml-raztopina-za-injiciranje-traneksaminska-kislina-obvestilo-za-zdravstvene-delavce/2025-12-11T11:05:23+01:00https://www.jazmp.si/2025/12/19/obvestilo-o-poslovnem-casu-in-uradnih-urah-pred-dela-prostima-dnevoma-24-in-31-12-2025/2025-12-23T14:12:05+01:00https://www.jazmp.si/2025/12/22/odgovori-na-vprasanja-iz-izobrazevanja-deleznikov-z-dne-2-12-2025-nova-zakonodaja-za-spremembe-dovoljenja-za-promet-za-zdravila-za-uporabo-v-humani-medicini/2025-12-22T07:04:25+01:00https://www.jazmp.si/2025/12/23/poziv-starsem-in-polnoletnim-otrokom-v-zvezi-s-shranjenimi-vzorci-pravne-osebe-biobanka-d-o-o/2026-01-23T13:25:01+01:00https://www.jazmp.si/2026/01/09/poziv-veletrgovcem-zdravil-za-preskrbo-z-zdravili-4/2026-01-09T15:46:23+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2026-01-13T07:04:54+01:00https://www.jazmp.si/2026/01/19/poudarki-s-seje-odbora-prac-47/2026-01-19T10:33:01+01:00https://www.jazmp.si/2026/01/19/varnostna-obvestila-za-medicinske-pripomocke-december-2025/2026-01-19T14:19:47+01:00https://www.jazmp.si/2026/01/23/obvestilo-za-javnost-v-zvezi-s-shranjenimi-vzorci-biobanke-d-o-o-2/2026-01-23T13:24:25+01:00https://www.jazmp.si/2026/01/26/obvestilo-za-javnost-v-zvezi-s-shranjenimi-vzorci-biobanke-d-o-o-3/2026-01-26T10:41:52+01:00https://www.jazmp.si/2026/01/28/izsla-sedma-stevilka-farmakovigilancnega-biltena/2026-01-28T10:16:47+01:00https://www.jazmp.si/2026/01/28/fast-eu-facilitating-and-accelerating-strategic-clinical-trials-in-the-eu-eea-pilotni-projekt-pospesenega-ocenjevanja-multinacionalnih-klinicnih-preskusanj-v-eu-egp/2026-01-28T13:48:41+01:00https://www.jazmp.si/2026/01/30/jams-2-0-porocilo-o-kampanji-skupnih-inspekcij-proizvajalcev-medicinskih-pripomockov/2026-01-30T15:14:04+01:00https://www.jazmp.si/2026/02/02/objava-tarife-jazmp-za-podrocje-medicinskih-pripomockov/2026-02-02T08:59:22+01:00https://www.jazmp.si/2026/02/04/obvestilo-o-zacetku-uporabe-novele-zakona-o-splosnem-upravnem-postopku-zup-i/2026-02-04T13:28:35+01:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2026-02-05T08:29:47+01:00https://www.jazmp.si/2026/02/05/priporocila-za-sponzorje-klinicnih-preskusanj/2026-02-09T09:52:49+01:00https://www.jazmp.si/2026/02/09/arixtra-natrijev-fondaparinuksat-obvestilo-za-zdravstvene-delavce/2026-02-09T08:17:39+01:00https://www.jazmp.si/2026/02/06/kaj-oblikuje-ucinkovit-sistem-zunanjega-referencnega-vrednotenja-cen-zdravil-erp-v-danasnjem-casu/2026-02-09T15:13:47+01:00https://www.jazmp.si/2026/02/11/poziv-veletrgovcem-zdravil-za-preskrbo-z-zdravili-5/2026-02-11T14:22:39+01:00https://www.jazmp.si/2026/02/12/varnostna-obvestila-za-medicinske-pripomocke-januar-2026/2026-02-12T14:34:48+01:00https://www.jazmp.si/2026/02/12/poziv-veletrgovcem-zdravil-za-preskrbo-z-zdravili-6/2026-02-16T09:23:41+01:00https://www.jazmp.si/2026/02/16/levamizol-ema-priporoca-ukinitev-dovoljenj-za-promet-z-zdravili/2026-02-16T13:55:09+01:00https://www.jazmp.si/2026/02/16/poudarki-s-seje-odbora-prac-48/2026-03-18T09:37:53+01:00https://www.jazmp.si/2026/02/26/poziv-starsem-in-polnoletnim-otrokom-v-zvezi-s-shranjenimi-vzorci-cloveskih-tkiv-in-celic-pravne-osebe-biobanka-d-o-o/2026-02-26T13:49:52+01:00https://www.jazmp.si/2026/02/24/prenehanje-trzenja-zdravila-toviaz-fesoterodin/2026-02-27T16:18:04+01:00https://www.jazmp.si/2026/03/05/posodobljeni-odgovori-na-vprasanja-glede-nove-zakonodaje-za-spremembe-dovoljenja-za-promet-za-zdravila-za-uporabo-v-humani-medicini/2026-03-05T14:22:21+01:00https://www.jazmp.si/2026/03/09/varnostna-obvestila-za-medicinske-pripomocke-februar-2026/2026-03-09T13:39:16+01:00https://www.jazmp.si/2026/03/12/varnostne-informacije-glede-ponaredkov-moskih-kondomov-durex/2026-03-12T09:57:37+01:00https://www.jazmp.si/2026/03/12/vabilo-na-spletno-izobrazevanje-obveznosti-zdravstvenih-ustanov-v-skladu-zmdr-ivdr-in-zmedpri-1-1-4-2026/2026-03-12T10:00:45+01:00https://www.jazmp.si/2026/03/13/poudarki-s-simpozija-increasenet-2026-innovation-symposium/2026-03-13T13:24:58+01:00https://www.jazmp.si/2026/03/11/obvestilo-o-stalnem-prenehanju-trzenja-zdravil-glucotrol-xl-glipizid/2026-03-13T13:31:21+01:00https://www.jazmp.si/2026/03/13/poziv-veletrgovcem-zdravil-za-preskrbo-z-zdravili-7/2026-03-13T13:43:45+01:00https://www.jazmp.si/2026/03/16/poudarki-s-seje-odbora-prac-49/2026-03-18T09:36:50+01:00https://www.jazmp.si/2026/03/17/poziv-veletrgovcem-zdravil-za-preskrbo-z-zdravili-8/2026-03-17T14:22:39+01:00https://www.jazmp.si/2026/03/26/previdnost-pri-uporabi-kapljic-za-oko-desodrop/2026-03-26T09:58:28+01:00https://www.jazmp.si/2026/03/26/obvestilo-za-javnost-v-zvezi-s-shranjenimi-vzorci-biobanke-d-o-o-4/2026-03-26T14:17:59+01:00https://www.jazmp.si/2026/04/07/elektronsko-vrocanje-dokumentov-v-postopkih/2026-04-07T08:51:28+02:00https://www.jazmp.si/2026/04/08/dan-varne-uporabe-veterinarskih-zdravil-2026/2026-04-08T08:02:53+02:00https://www.jazmp.si/2026/04/09/varnostna-obvestila-za-medicinske-pripomocke-marec-2026/2026-04-09T11:18:35+02:00https://www.jazmp.si/humana-zdravila/zascitni-elementi/seznam-nacionalnih-identifikatorjev-s-siframi-proizvodov-pc/2026-04-09T14:27:53+02:00https://www.jazmp.si/2026/04/10/holoxan-ifosfamid-2-g-prasek-za-raztopino-za-infundiranje-motnje-v-preskrbi-zdravila-obvestilo-za-zdravstvene-delavce/2026-04-10T14:57:49+02:00https://www.jazmp.si/2026/04/10/endoxan-ciklofosfamid-200-mg-500-mg-1-g-prasek-za-raztopino-za-infundiranje-motnje-v-preskrbi-zdravilaobvestilo-za-zdravstvene-delavce/2026-04-10T15:03:14+02:00https://www.jazmp.si/2026/04/15/poudarki-s-seje-odbora-prac-50/2026-04-15T14:46:13+02:00https://www.jazmp.si/2026/04/22/obvestilo-o-posodobitvi-povzetka-glavnih-znacilnosti-zdravila-in-navodila-za-uporabo-za-zdravilo-ventolin-z-opozorili-glede-nenamerne-uporabe-praznega-odmernega-inhalatorja-pod-tlakom/2026-04-22T13:36:48+02:00https://www.jazmp.si/2026/04/23/opozorilo-glede-uporabe-peptidov-za-injiciranje/2026-04-23T09:13:12+02:00https://www.jazmp.si/2026/04/23/obvezna-uporaba-sistema-eudamed-od-28-maja-2026/2026-04-23T12:59:23+02:00https://www.jazmp.si/2026/04/24/izsla-osma-stevilka-farmakovigilancnega-biltena/2026-04-24T12:25:18+02:00https://www.jazmp.si/2026/04/24/obvestilo-za-javnost-v-zvezi-s-prenosom-vzorcev-biobanke-24-4-2026/2026-04-24T18:55:11+02:00